This document is an excerpt from the EUR-Lex website
Document 32009L0002
Commission Directive 2009/2/EC of 15 January 2009 amending, for the purpose of its adaptation to technical progress, for the 31st time, Council Directive 67/548/EEC on the approximation of the laws, regulations and administrative provisions relating to the classification, packaging and labelling of dangerous substances (Text with EEA relevance)
Richtlijn 2009/2/EG van de Commissie van 15 januari 2009 tot eenendertigste aanpassing aan de vooruitgang van de techniek van Richtlijn 67/548/EEG van de Raad betreffende de aanpassing van de wettelijke en bestuursrechtelijke bepalingen inzake de indeling, de verpakking en het kenmerken van gevaarlijke stoffen (Voor de EER relevante tekst)
Richtlijn 2009/2/EG van de Commissie van 15 januari 2009 tot eenendertigste aanpassing aan de vooruitgang van de techniek van Richtlijn 67/548/EEG van de Raad betreffende de aanpassing van de wettelijke en bestuursrechtelijke bepalingen inzake de indeling, de verpakking en het kenmerken van gevaarlijke stoffen (Voor de EER relevante tekst)
PB L 11 van 16.1.2009, p. 6–82
(BG, ES, CS, DA, DE, ET, EL, EN, FR, IT, LV, LT, HU, MT, NL, PL, PT, RO, SK, SL, FI, SV) Dit document is verschenen in een speciale editie.
(HR)
No longer in force, Date of end of validity: 31/05/2015; stilzwijgende opheffing door 32008R1272
Relation | Act | Comment | Subdivision concerned | From | To |
---|---|---|---|---|---|
Modifies | 31967L0548 | wijziging | bijlage 1 | 05/02/2009 |
Relation | Act | Comment | Subdivision concerned | From | To |
---|---|---|---|---|---|
Implicitly repealed by | 32008R1272 | 01/06/2015 |
16.1.2009 |
NL |
Publicatieblad van de Europese Unie |
L 11/6 |
RICHTLIJN 2009/2/EG VAN DE COMMISSIE
van 15 januari 2009
tot eenendertigste aanpassing aan de vooruitgang van de techniek van Richtlijn 67/548/EEG van de Raad betreffende de aanpassing van de wettelijke en bestuursrechtelijke bepalingen inzake de indeling, de verpakking en het kenmerken van gevaarlijke stoffen
(Voor de EER relevante tekst)
DE COMMISSIE VAN DE EUROPESE GEMEENSCHAPPEN,
Gelet op het Verdrag tot oprichting van de Europese Gemeenschap,
Gelet op Richtlijn 67/548/EEG van de Raad van 27 juni 1967 betreffende de aanpassing van de wettelijke en bestuursrechtelijke bepalingen inzake de indeling, de verpakking en het kenmerken van gevaarlijke stoffen (1), en met name op artikel 28,
Overwegende hetgeen volgt:
(1) |
In artikel 4, lid 3, van Richtlijn 67/548/EEG worden de criteria en de procedure voor de harmonisatie van de indeling en het kenmerken van stoffen vermeld. Krachtens de punten 4.1.3, 4.1.4 en 4.1.5 van bijlage VI bij Richtlijn 67/548/EEG moet het bedrijfsleven informatie aan de lidstaten verstrekken en moeten de lidstaten zo spoedig mogelijk voorstellen voor een geharmoniseerde indeling en kenmerking indienen wanneer er informatie beschikbaar komt op grond waarvan een stof voldoet aan de criteria om als mutagene, carcinogene of voor de voortplanting vergiftige stof te worden ingedeeld. |
(2) |
Bijlage I bij Richtlijn 67/548/EEG bevat een lijst van gevaarlijke stoffen, alsmede bijzonderheden over de indeling en kenmerking van elke stof. Deze lijst dient met aangemelde nieuwe stoffen en andere reeds bestaande stoffen te worden uitgebreid, terwijl de lijst tevens op een aantal punten aan de technische vooruitgang dient te worden aangepast. Bovendien is het nodig dat bepaalde stoffen uit die bijlage worden geschrapt. |
(3) |
Bijlage I bij Richtlijn 67/548/EEG bevat reeds talrijke groepsvermeldingen, met name voor metaalverbindingen die volgens een aanpak met groepering en „read across” op basis van de analogie tussen stoffen zijn beoordeeld. |
(4) |
Bijlage I bij Richtlijn 67/548/EEG bevat ook bepaalde groepsvermeldingen waarvoor de leden van de groep zijn geïdentificeerd en de indeling volgens een aanpak met groepering en „read across” is afgeleid, met name voor aardoliestromen en gassen. |
(5) |
In bijlage VI bij Richtlijn 67/548/EEG wordt bepaald dat de voor indeling en kenmerking vereiste gegevens uit een aantal verschillende bronnen kunnen worden verkregen, waaronder de resultaten van gevalideerde structuur/activiteit-relaties en het oordeel van deskundigen. |
(6) |
De indeling van de in deze richtlijn vermelde nikkelverbindingen is gebaseerd op de effecten van het Ni(2+)-ion en op de beschikbare gegevens voor nikkelverbindingen. De indeling is afgeleid door de nikkelverbindingen op basis van de oplosbaarheid in water in categorieën te groeperen (zoals groepen onoplosbare, slecht oplosbare en oplosbare nikkelverbindingen). De oplosbaarheid in water is gebruikt als eerste criterium om deze categorieën te definiëren, aangezien nikkelverbindingen met een vergelijkbare oplosbaarheid in water een vergelijkbare biologische beschikbaarheid van het Ni(2+)-ion en een vergelijkbare systemische toxiciteit zullen hebben. Dit rechtvaardigt een „read across” binnen groepen vanuit de stoffen waarvoor uit de beschikbare adequate testgegevens een specifiek systemisch effect blijkt, naar de stoffen waarvoor deze testgegevens ontbreken. Voor bepaalde effecten is een „read across” tussen groepen gerechtvaardigd, aangezien over het hele oplosbaarheidsinterval vergelijkbare effecten zijn waargenomen. Zo blijkt uit epidemiologisch onderzoek dat zowel oplosbare als onoplosbare nikkelverbindingen (aan beide uitersten van het oplosbaarheidscala) plaatselijke carcinogene effecten in de ademhalingswegen hebben. Er zijn daarom goede redenen om aan te nemen dat ook slecht oplosbare verbindingen (tussen deze uitersten in) vergelijkbare carcinogene eigenschappen hebben. |
(7) |
Als onderdeel van een beoordeling van alle beschikbare informatie over de nikkelverbindingen kan de oplosbaarheid in water voor veel effecten en stoffen als benadering van de systemische biologische beschikbaarheid van het Ni(2+)-ion worden gebruikt |
(8) |
De indeling en kenmerking van de in deze richtlijn opgenomen stoffen dient te worden herzien als er nieuwe wetenschappelijke kennis beschikbaar komt. In deze context moet, met name gelet op het feit dat de nikkelindustrie onlangs voorlopige, gedeeltelijke en niet intercollegiaal getoetste informatie heeft ingediend, bijzondere aandacht worden besteed aan de resultaten van de toekomstige besprekingen binnen het Internationaal Agentschap voor kankeronderzoek van de Wereldgezondheidsorganisatie (IARC) over de carcinogeniteit van nikkelverbindingen of aan relevante nieuwe wetenschappelijke conclusies of interpretaties van de gegevens die zijn gebruikt voor de totstandkoming van de indeling voor de nikkelverbindingen in deze richtlijn. |
(9) |
De in deze richtlijn vervatte maatregelen zijn in overeenstemming met het advies van het Comité voor de aanpassing aan de vooruitgang van de techniek van de richtlijnen met het oog op de opheffing van de technische handelsbelemmeringen voor de handel in gevaarlijke stoffen en preparaten, |
HEEFT DE VOLGENDE RICHTLIJN VASTGESTELD:
Artikel 1
Richtlijn 67/548/EEG wordt als volgt gewijzigd. Bijlage I wordt als volgt gewijzigd:
a) |
de vermeldingen die overeenkomen met de vermeldingen in bijlage 1A bij deze richtlijn worden vervangen door de in die bijlage opgenomen vermeldingen; |
b) |
de vermeldingen in bijlage 1B bij deze richtlijn worden ingevoegd overeenkomstig de volgorde van de in bijlage I bij Richtlijn 67/548/EEG opgenomen vermeldingen; |
c) |
de vermeldingen in bijlage 1C bij deze richtlijn worden geschrapt. |
Artikel 2
De lidstaten doen de nodige wettelijke en bestuursrechtelijke bepalingen in werking treden om uiterlijk op 1 juni 2009 aan deze richtlijn te voldoen. Zij stellen de Commissie onverwijld in kennis van de tekst van deze bepalingen en van een transponeringstabel ter weergave van het verband tussen die bepalingen en deze richtlijn.
Wanneer de lidstaten deze bepalingen aannemen, wordt daarin naar deze richtlijn verwezen of wordt hiernaar verwezen bij de officiële bekendmaking van de bepalingen. De regels voor deze verwijzing worden vastgesteld door de lidstaten.
De lidstaten delen de Commissie de tekst van de belangrijkste bepalingen van intern recht mee die zij op het onder deze richtlijn vallende gebied vaststellen.
Artikel 3
Deze richtlijn treedt in werking op de twintigste dag volgende op die van haar bekendmaking in het Publicatieblad van de Europese Unie.
Artikel 4
Deze richtlijn is gericht tot de lidstaten.
Gedaan te Brussel, 15 januari 2009.
Voor de Commissie
Stavros DIMAS
Lid van de Commissie
(1) PB 196 van 16.8.1967, blz. 1.
BIJLAGE 1A
Index No |
Chemische naam |
Nota's voor stoffen |
EC No |
CAS No |
Indeling |
Kenmerken |
Concentratiegrenzen |
Nota's voor preparaten |
001-002-00-4 |
lithiumaluminiumhydride |
|
240-877-9 |
16853-85-3 |
F; R15 C; R35 |
F; C R: 15-35 S: (1/2-)7/8-26-36/37/39-43-45 |
|
|
005-006-00-7 |
dibutyltinwaterstofboraat |
E |
401-040-5 |
75113-37-0 |
Muta. Cat. 3; R68 Repr. Cat. 2; R60-61 T; R48/25 Xn; R21/22 Xi; R41 R43 N; R50-53 |
T; N R: 60-61-21/22-41-43-48/25-68-50/53 S: 53-45-60-61 |
|
|
006-007-00-5 |
zouten van cyaanwaterstof met uitzondering van complexe cyaniden zoals ferro- en ferricyaniden en kwikoxycyanide |
A |
— |
— |
T+; R26/27/28 R32 N; R50-53 |
T+; N R: 26/27/28-32-50/53 S: (1/2-)7-28-29-45-60-61 |
|
|
006-015-00-9 |
diuron (ISO); 3-(3,4-dichloorfenyl)-1,1-dimethylureum |
|
206-354-4 |
330-54-1 |
Carc. Cat. 3; R40 Xn; R22-48/22 N; R50-53 |
Xn; N R: 22-40-48/22-50/53 S: (2-)13-36/37-46-60-61 |
C ≥ 25 %: Xn, N; R22-40-48/22-50/53 10 % ≤ C < 25 %: Xn, N; R40-48/22-50/53 2,5 % ≤ C < 10 %: Xn, N; R40-50/53 1 % ≤ C < 2,5 %: Xn, N; R40-51/53 0,25 % ≤ C < 1 %: N; R51/53 0,025 % ≤ C < 0,25 %: R52/53 |
|
006-076-00-1 |
mancozeb (ISO); mangaanethyleenbis(dithiocarbamaat) (polymeer), complex met zinkzout |
|
— |
8018-01-7 |
Repr. Cat. 3; R63 R43 N; R50 |
Xn; N R: 43-63-50 S: (2-)36/37-46-61 |
C ≥ 5 %: Xn, N; R43-63-50 2,5 ≤ C < 5 %: Xi, N; R43-50 1 % ≤ C < 2,5 %: Xi; R43 |
|
006-077-00-7 |
maneb (ISO); mangaanethyleenbis(dithiocarbamaat) (polymeer) |
|
235-654-8 |
12427-38-2 |
Repr. Cat. 3; R63 Xn; R20 Xi; R36 R43 N; R50-53 |
Xn; N R: 20-36-43-63-50/53 S: (2-)36/37-46-60-61 |
C ≥ 25 %: Xn, N; R20-36-43-63-50/53 20 % ≤ C < 25 %: Xn, N; R36-43-63-50/53 5 % ≤ C < 20 %: Xn, N; R43-63-50/53 2,5 % ≤ C < 5 %: Xi, N; R43-50/53 1 % ≤ C < 2,5 %: Xi, N; R43-51/53 0,25 % ≤ C < 1 %: N; R51/53 0,025 % ≤ C < 0,25 %: R52/53 |
|
006-084-00-5 |
carbosulfan (ISO); 2,3-dihydro-2,2-dimethyl-7-benzofuryl[(dibutylamino)thio]methylcarbamaat |
|
259-565-9 |
55285-14-8 |
T+; R26 T; R25 R43 N; R50-53 |
T+; N R: 25-26-43-50/53 S: (1/2-)28-36/37-38-45-63-60-61 |
|
|
006-088-00-7 |
benfuracarb (ISO); ethyl-N-[2,3-dihydro-2,2-dimethylbenzofuraan-7-yloxycarbonyl(methyl)aminothio]-N-isopropyl-β-alaninaat |
|
— |
82560-54-1 |
Repr. Cat. 3; R62 T; R23 Xn; R22 N; R50-53 |
T; N R: 22-23-62-50/53 S: (1/2-)36/37-45-60-61 |
|
|
007-002-00-0 |
stikstofdioxide; [1] distikstoftetraoxide [2] |
|
233-272-6 [1] 234-126-4 [2] |
10102-44-0 [1] 10544-72-6 [2] |
O; R8 T+; R26 C; R34 |
O; T+ R: 8-26-34 S: (1/2-)9-26-28-36/37/39-45 |
C ≥ 10 %: T+; R26-34 5 % ≤ C < 10 %: T; R23-34 1 % ≤ C < 5 %: T; R23-36/37/38 0,5 % ≤ C < 1 %: Xn; R20-36/37/38 0,1 % ≤ C < 0,5 %: Xn; R20 |
5 |
015-041-00-X |
malathion (ISO); 1,2-bis(ethoxycarbonyl)ethyl-O,O-dimethylfosforodithioaat; [met ≤ 0,03 % isomalathion] |
|
204-497-7 |
121-75-5 |
Xn; R22 R43 N; R50-53 |
Xn; N R: 22-43-50/53 S: (2-)24-37-46-60-61 |
C ≥ 25 %: Xn, N; R22-43-50/53 1 % ≤ C < 25 %: Xi, N; R43-50/53 0,025 % ≤ C < 1 %: N; R50/53 0,0025 % ≤ C < 0,025 %: N; R51/53 0,00025 % ≤ C < 0,0025 %: R52/53 |
|
015-100-00-X |
foxim [ISO]; α-(diethoxyfosfinothioylimino)fenylacetonitril |
|
238-887-3 |
14816-18-3 |
Repr. Cat. 3; R62 Xn; R22 R43 N; R50-53 |
Xn; N R: 22-43-62-50/53 S: (2-)36/37-46-60-61 |
C ≥ 25 %: Xn, N; R22-43-62-50/53 5 % ≤ C < 25 %: Xn, N; R43-62-50/53 1 % ≤ C < 5 %: Xi, N; R43-50/53 0,025 % ≤ C < 1 %: N; R50/53 0,0025 % ≤ C < 0,025 %: N; R51/53 0,00025 % ≤ C < 0,0025 %: R52/53 |
|
015-102-00-0 |
tris(2-chloorethyl)fosfaat |
E |
204-118-5 |
115-96-8 |
Carc. Cat. 3; R40 Repr. Cat. 2; R60 Xn; R22 N; R51-53 |
T; N R: 60-22-40-51/53 S: 53-45-61 |
|
|
015-155-00-X |
glufosinaat-ammonium (ISO); ammonium-2-amino-4-(hydroxymethylfosfinyl)butyraat |
E |
278-636-5 |
77182-82-2 |
Repr. Cat. 2; R60 Repr. Cat. 3; R63 Xn; R20/21/22-48/20/22 |
T R: 60-20/21/22-48/20/22-63 S: 53-45 |
|
|
016-009-00-8 |
dinatriumsulfide; natriumsulfide |
|
215-211-5 |
1313-82-2 |
T; R24 Xn; R22 C; R34 R31 N; R50 |
T; C; N R: 22-24-31-34-50 S: (1/2-)26-36/37/39-45-61 |
|
|
017-009-00-0 |
ammoniumperchloraat; [met ≥ 80 % deeltjes van 0-30 μm] |
T |
232-235-1 |
7790-98-9 |
E; R3 O; R9 |
E R: 3-9 S: (2-)14-16-36/37 |
|
|
024-004-00-7 |
natriumdichromaat |
E |
234-190-3 |
10588-01-9 |
O; R8 Carc. Cat. 2; R45 Muta. Cat. 2; R46 Repr. Cat. 2; R60-61 T+; R26 T; R25-48/23 Xn; R21 C; R34 R42/43 N; R50-53 |
O; T+; N R: 45-46-60-61-8-21-25-26-34-42/43-48/23-50/53 S: 53-45-60-61 |
C ≥ 25 %: T+, N; R45-46-60-61-21-25-26-34-42/43-48/23-50/53 10 % ≤ C < 25 %: T+, N; R45-46-60-61-22-26-34-42/43-48/23-51/53 7 % ≤ C < 10 %: T+, N; R45-46-60-61-22-26-36/37/38-42/43-48/20-51/53 5 % ≤ C < 7 %: T, N; R45-46-60-61-22-23-36/37/38-42/43-48/20-51/53 3 % ≤ C < 5 %: T, N; R45-46-60-61-22-23-42/43-48/20-51/53 2,5 % ≤ C < 3 %: T, N; R45-46-60-61-23-42/43-48/20-51/53 1 % ≤ C < 2,5 %: T; R45-46-60-61-23-42/43-48/20-52/53 0,5 % ≤ C < 1 %: T; R45-46-60-61-20-42/43-52/53 0,25 % ≤ C < 0,5 %: T; R45-46-20-42/43-52/53 0,2 % ≤ C < 0,25 %: T; R45-46-20-42/43 0,1 % ≤ C < 0,2 %: T; R45-46-20 |
3 |
027-002-00-4 |
kobaltoxide |
|
215-154-6 |
1307-96-6 |
Xn; R22 R43 N; R50-53 |
Xn; N R: 22-43-50/53 S: (2-)24-37-60-61 |
C ≥ 25 %: Xn, N; R22-43-50/53 2,5 % ≤ C < 25 %: Xi, N; R43-50/53 1 % ≤ C < 2,5 %: Xi, N; R43-51/53 0,25 % ≤ C < 1 %: N; R51/53 0,025 % ≤ C < 0,25 %: R52/53 |
|
027-003-00-X |
kobaltsulfide |
|
215-273-3 |
1317-42-6 |
R43 N; R50-53 |
Xi; N R: 43-50/53 S: (2-)24-37-60-61 |
C ≥ 2,5 %: Xi, N; R43-50/53 1 % ≤ C < 2,5 %: Xi, N; R43-51/53 0,25 % ≤ C < 1 %: N; R51/53 0,025 % ≤ C < 0,25 %: R52/53 |
|
028-003-00-2 |
nikkelmonoxide; [1] nikkeloxide; [2] bunseniet [3] |
E |
215-215-7 [1] 234-323-5 [2] - [3] |
1313-99-1 [1] 11099-02-8 [2] 34492-97-2 [3] |
Carc. Cat. 1; R49 T; R48/23 R43 R53 |
T R: 49-43-48/23-53 S: 53-45-61 |
|
|
028-004-00-8 |
nikkeldioxide |
E |
234-823-3 |
12035-36-8 |
Carc. Cat. 1; R49 T; R48/23 R43 R53 |
T R: 49-43-48/23-53 S: 53-45-61 |
|
|
028-005-00-3 |
dinikkeltrioxide |
E |
215-217-8 |
1314-06-3 |
Carc. Cat. 1; R49 T; R48/23 R43 R53 |
T R: 49-43-48/23-53 S: 53-45-61 |
|
|
028-006-00-9 |
nikkel(II)sulfide; [1] nikkelsulfide; [2] milleriet [3] |
E |
240-841-2 [1] 234-349-7 [2] - [3] |
16812-54-7 [1] 11113-75-0 [2] 1314-04-1 [3] |
Carc. Cat. 1; R49 Muta. Cat. 3; R68 T; R48/23 R43 N; R50-53 |
T; N R: 49-43-48/23-68-50/53 S: 53-45-60-61 |
|
|
028-007-00-4 |
trinikkeldisulfide; nikkelsubsulfide; [1] heazlewoodiet [2] |
E |
234-829-6 [1] - [2] |
12035-72-2 [1] 12035-71-1 [2] |
Carc. Cat. 1; R49 Muta. Cat. 3; R68 T; R48/23 R43 N; R50-53 |
T; N R: 49-43-48/23-68-50/53 S: 53-45-60-61 |
|
|
028-008-00-X |
nikkeldihydroxide; [1] nikkelhydroxide [2] |
E |
235-008-5 [1] 234-348-1 [2] |
12054-48-7 [1] 11113-74-9 [2] |
Carc. Cat. 1; R49 Repr. Cat. 2; R61 Muta. Cat. 3; R68 T; R48/23 Xn; R20/22 Xi; R38 R42/43 N; R50-53 |
T; N R: 49-61-20/22-38-42/43-48/23-68-50/53 S: 53-45-60-61 |
|
|
029-013-00-X |
trinatrium-(2-(α-(3-(4-chloor-6-(2-(2-(vinylsulfonyl)ethoxy)ethylamino)-1,3,5-triazine-2-ylamino)-2-oxido-5-sulfonatofenylazo)benzylideenhydrazino)-4-sulfonatobenzoato)koper(II) |
|
407-580-8 |
130201-51-3 |
Xi; R41 |
Xi R: 41 S: (2-)26-39 |
|
|
033-005-00-1 |
arseenzuur en zijn zouten, met uitzondering van de elders in deze bijlage met name genoemde |
AE |
— |
— |
Carc. Cat. 1; R45 T; R23/25 N; R50-53 |
T; N R: 45-23/25-50/53 S: 53-45-60-61 |
|
|
034-002-00-8 |
seleenverbindingen met uitzondering van cadmium sulfoselenide en met uitzondering van de elders in deze bijlage met name genoemde |
A |
— |
— |
T; R23/25 R33 N; R50-53 |
T; N R: 23/25-33-50/53 S: (1/2-)20/21-28-45-60-61 |
|
|
047-001-00-2 |
zilvernitraat |
|
231-853-9 |
7761-88-8 |
O; R8 C; R34 N; R50-53 |
O; C; N R: 8-34-50/53 S: (1/2-)26-36/37/39-45-60-61 |
|
|
050-002-00-0 |
cyhexatin (ISO); hydroxytricyclohexylstannaan; tri(cyclohexyl)tinhydroxide |
|
236-049-1 |
13121-70-5 |
Xn; R20/21/22 N; R50-53 |
Xn; N R: 20/21/22-50/53 S: (2-)13-60-61 |
C ≥ 25 %: Xn, N; R20/21/22-50/53 0,025 % ≤ C < 25 %: N; R50/53 0,0025 % ≤ C < 0,025 %: N; R51/53 0,00025 % ≤ C < 0,0025 %: R52/53 |
|
050-003-00-6 |
fentinacetaat (ISO); trifenyltinacetaat |
|
212-984-0 |
900-95-8 |
Carc. Cat. 3; R40 Repr. Cat. 3; R63 T+; R26 T; R24/25-48/23 Xi; R37/38-41 N; R50-53 |
T+; N R: 24/25-26-37/38-40-41-48/23-63-50/53 S: (1/2-)26-28-36/37/39-45-60-61 |
C ≥ 25 %: T+, N; R24/25-26-37/38-40-41-48/23-63-50/53 20 % ≤ C < 25 %: T+, N; R21/22-26-37/38-40-41-48/23-63-50/53 10 % ≤ C < 20 %: T+, N; R21/22-26-40-41-48/23-63-50/53 7 % ≤ C < 10 %: T+, N; R21/22-26-36-40-48/20-63-50/53 5 % ≤ C < 7 %: T, N; R21/22-23-36-40-48/20-63-50/53 3 % ≤ C < 5 %: T, N; R21/22-23-40-48/20-50/53 2,5 % ≤ C < 3 %: T, N; R23-40-48/20-50/53. 1 % ≤ C < 2,5 %: T, N; R23-40-48/20-51/53 0,25 % ≤ C < 1 %: Xn, N; R20-51/53 0,1 % ≤ C < 0,25 %: Xn; R20-52/53 0,025 % ≤ C < 0,1 %: R52/53 |
|
050-004-00-1 |
fentinhydroxide (ISO); trifenyltinhydroxide |
|
200-990-6 |
76-87-9 |
Carc. Cat. 3; R40 Repr. Cat. 3; R63 T+; R26 T; R24/25-48/23 Xi; R37/38-41 N; R50-53 |
T+; N R: 24/25-26-37/38-40-41-48/23-63-50/53 S: (1/2-)26-28-36/37/39-45-60-61 |
C ≥ 25 %: T+, N; R24/25-26-37/38-40-41-48/23-63-50/53 20 % ≤ C < 25 %: T+, N; R21/22-26-37/38-40-41-48/23-63-50/53 10 % ≤ C < 20 %: T+, N; R21/22-26-40-41-48/23-63-50/53 7 % ≤ C < 10 %: T+, N; R21/22-26-36-40-48/20-63-50/53 5 % ≤ C < 7 %: T, N; R21/22-23-36-40-48/20-63-50/53 3 % ≤ C < 5 %: T, N; R21/22-23-40-48/20-50/53 2,5 % ≤ C < 3 %: T, N; R23-40-48/20-50/53 1 % ≤ C < 2,5 %: T, N; R23-40-48/20-51/53 0,25 % ≤ C < 1 %: Xn, N; R20-51/53 0,1 % ≤ C < 0,25 %: Xn; R20-52/53 0,025 % ≤ C < 0,1 %: R52/53 |
|
050-008-00-3 |
tributyltinverbindingen, met uitzondering van de elders in deze bijlage met name genoemde |
A |
— |
— |
T; R25-48/23/25 Xn; R21 Xi; R36/38 N; R50-53 |
T; N R: 21-25-36/38-48/23/25-50/53 S: (1/2-)36/37/39-45-60-61 |
C ≥ 2,5 %: T, N; R21-25-36/38-48/23/25-50/53 1 % ≤ C < 2,5 %: T, N; R21-25-36/38-48/23/25-51/53 0,25 % ≤ C < 1 %: Xn, N; R22-48/20/22-51/53 0,025 % C < 0,25 %: R52/53 |
1 |
050-011-00-X |
trifenyltinverbindingen, met uitzondering van de elders in deze bijlage met name genoemde |
A |
— |
— |
T; R23/24/25 N; R50-53 |
T; N R: 23/24/25-50/53 S: (1/2-)26-27-28-45-60-61 |
C ≥ 1 %: T, N; R23/24/25-50/53 0,25 % ≤ C < 1 %: Xn, N; R20/21/22-50/53 0,025 % ≤ C < 0,25 %: N; R51/53 0,0025 % ≤ C < 0,025 %: R52/53 |
1 |
050-018-00-8 |
tin(II)methaansulfonaat |
|
401-640-7 |
53408-94-9 |
C; R34 Xn; R22 R43 N; R51-53 |
C; N R: 22-34-43-51/53 S: (1/2-)22-26-36/37/39-45-61 |
|
|
053-003-00-4 |
jodylbenzeen |
|
— |
696-33-3 |
E; R2 |
E R: 2 S: (2-)35 |
|
|
053-004-00-X |
calciumjodylbenzoaat |
C |
— |
— |
E; R2 |
E R: 2 S: (2-)35 |
|
|
080-001-00-0 |
kwik |
E |
231-106-7 |
7439-97-6 |
Repr. Cat. 2; R61 T+; R26 T; R48/23 N; R50-53 |
T+; N R: 61-26-48/23-50/53 S: 53-45-60-61 |
|
|
080-010-00-X |
kwikdichloride; kwik(II)chloride |
|
231-299-8 |
7487-94-7 |
Muta. Cat. 3; R68 Repr. Cat. 3; R62 T+; R28 T; R48/24/25 C; R34 N; R50-53 |
T+; N R: 28-34-48/24/25-62-68-50/53 S: (1/2-)26-36/37/39-45-60-61 |
|
|
092-002-00-3 |
uraniumverbindingen, met uitzondering van de elders in deze bijlage met name genoemde |
A |
— |
— |
T+; R26/28 R33 N; R51-53 |
T+; N R: 26/28-33-51/53 S: (1/2-)20/21-45-61 |
|
|
601-065-00-3 |
Een mengsel van: (1′-α,3′-α,6′-α)-2,2,3′,7′,7′-pentamethylspiro(1,3-dioxaan-5,2′-norcaraan); (1′α,3′β,6′α)-2,2,3′,7′,7′-pentamethylspiro(1,3-dioxaan-5,2′-norcaraan) |
|
416-930-9 |
— |
Xi; R38 N; R51-53 |
Xi; N R: 38-51/53 S: (2-)36/37-61 |
|
|
602-007-00-X |
bromoform; tribroommethaan |
|
200-854-6 |
75-25-2 |
T; R23 Xn; R22 Xi; R36/38 N; R51-53 |
T; N R: 22-23-36/38-51/53 S: (1/2-)28-45-63-61 |
|
|
602-030-00-5 |
1,3-dichloorpropeen; [1] (Z)-1,3-dichloorpropeen [2] |
C D |
208-826-5 [1] 233-195-8 [2] |
542-75-6 [1] 10061-01-5 [2] |
R10 T; R24/25 Xn; R20-65 Xi; R36/37/38 R43 N; R50-53 |
T; N R: 10-20-24/25-36/37/38-43-65-50/53 S: (1/2-)36/37-45-60-61 |
|
|
602-054-00-6 |
3-joodpropeen; allyljodide |
|
209-130-4 |
556-56-9 |
F; R11 C; R34 |
F; C R: 11-34 S: (1/2-)7-16-26-45 |
|
|
603-005-00-1 |
2-methylpropaan-2-ol; tert-butylalcohol |
|
200-889-7 |
75-65-0 |
F; R11 Xn; R20 Xi; R36/37 |
F; Xn R: 11-20-36/37 S: (2-)9-16-46 |
|
|
603-018-00-2 |
furfurylalcohol |
|
202-626-1 |
98-00-0 |
Carc. Cat. 3; R40 T; R23 Xn; R21/22-48/20 Xi; R36/37 |
T R: 21/22-23-36/37-40-48/20 S: (1/2-)36/37-45-63 |
|
|
603-023-00-X |
ethyleenoxide; oxiraan |
E |
200-849-9 |
75-21-8 |
F+; R12 R6 Carc. Cat. 2; R45 Muta. Cat. 2; R46 T; R23 Xi; R36/37/38 |
F+; T R: 45-46-6-12-23-36/37/38 S: 53-45 |
|
|
603-029-00-2 |
bis(2-chloorethyl)ether |
|
203-870-1 |
111-44-4 |
Carc. Cat. 3; R40 T+; R26/27/28 |
T+ R: 26/27/28-40 S: (1/2-)7/9-27-28-36/37-45 |
C ≥ 7 %: T+; R26/27/28-40 1 % ≤ C < 7 %: T; R23/24/25-40 0,1 % ≤ C < 1 %: Xn; R20/21/22 |
|
603-037-00-6 |
nitrocellulosen |
T |
— |
— |
E; R3 |
E R: 3 S: (2-)35 |
|
|
603-046-00-5 |
bis(chloormethyl)ether; oxybis(chloormethaan) |
E |
208-832-8 |
542-88-1 |
F; R11 Carc. Cat. 1; R45 T+; R26 T; R24 Xn; R22 |
F; T+ R: 45-11-22-24-26 S: 53-45 |
C ≥ 25 %: T+; R45-22-24-26 7 % ≤ C < 25 %: T+; R45-21-26 3 % ≤ C < 7 %: T; R45-21-23 1 % ≤ C < 3 %: T; R45-23 0,1 % ≤ C < 1 %: T; R45-20 0,001 % ≤ C < 0,1 %: T; R45 |
|
603-064-00-3 |
1-methoxypropaan-2-ol; propyleenglycolmonomethylether |
|
203-539-1 |
107-98-2 |
R10 R67 |
R: 10-67 S: (2-) |
|
|
603-066-00-4 |
1,2-epoxy-4-epoxyethylcyclohexaan; 4-vinylcyclohexeendiepoxide |
|
203-437-7 |
106-87-6 |
Carc. Cat. 3; R40 T; R23/24/25 |
T R: 23/24/25-40 S: (1/2-)36/37-45-63 |
C ≥ 1 %: T; R23/24/25-40 0,1 % ≤ C < 1 %: Xn; R20/21/22 |
|
605-004-00-1 |
2,4,6-trimethyl-1,3,5-trioxaan; paraldehyde |
|
204-639-8 |
123-63-7 |
R10 |
R: 10 S: (2-)29 |
|
|
605-005-00-7 |
2,4,6,8-tetramethyl-1,3,5,7-tetraoxacyclooctaan; metaldehyde |
|
203-600-2 |
108-62-3 |
F; R11 Xn; R22 |
F; Xn R: 11-22 S: (2-)13-16-25-46 |
|
|
606-021-00-7 |
N-methyl-2-pyrrolidon; 1-methyl-2-pyrrolidon |
|
212-828-1 |
872-50-4 |
Repr. Cat. 2; R61 Xi; R36/37/38 |
T R: 61-36/37/38 S: 53-45 |
C ≥ 10 %: T; R61-36/37/38 5 % ≤ C < 10 %: T; R61 |
|
607-007-00-3 |
zouten van oxaalzuur, met uitzondering van de elders in deze bijlage met name genoemde |
A |
— |
— |
Xn; R21/22 |
Xn R: 21/22 S: (2-)24/25 |
C ≥ 5 %: Xn; R21/22 |
|
607-012-00-0 |
benzoylchloride |
|
202-710-8 |
98-88-4 |
Xn; R20/21/22 C; R34 R43 |
C R: 20/21/22-34-43 S: (1/2-)26-36/37/39-45 |
|
|
607-037-00-7 |
2-ethoxyethylacetaat; ethylglycolacetaat |
E |
203-839-2 |
111-15-9 |
R10 Repr. Cat. 2; R60-61 Xn; R20/21/22 |
T R: 60-61-10-20/21/22 S: 53-45 |
|
|
607-051-00-3 |
MCPA (ISO); 4-chloor-o-tolyloxyazijnzuur |
|
202-360-6 |
94-74-6 |
Xn; R22 Xi; R38-41 N; R50-53 |
Xn; N R: 22-38-41-50/53 S: (2-)26-37-39-60-61 |
|
|
607-052-00-9 |
zouten en esters van MCPA |
A |
— |
— |
Xn; R20/21/22 N; R50-53 |
Xn; N R: 20/21/22-50/53 S: (2-)13-60-61 |
|
|
607-085-00-9 |
zouten en esters van MCPA |
|
204-402-9 |
120-51-4 |
Xn; R22 N; R51-53 |
Xn; N R: 22-51/53 S: (2-)25-46-61 |
|
|
607-095-00-3 |
maleïnezuur |
|
203-742-5 |
110-16-7 |
Xn; R22 Xi; R36/37/38 R43 |
Xn R: 22-36/37/38-43 S: (2-)24-26-28-37-46 |
C ≥ 25 %: Xn; R22-36/37/38-43 20 % ≤ C <25 %: Xi; R36/37/38-43 0,1 % ≤ C < 20 %: Xi; R43 |
|
607-103-00-5 |
barnsteenzuuranhydride |
|
203-570-0 |
108-30-5 |
Xn; R22 Xi; R36/37 |
Xn R: 22-36/37 S: (2-)25-46 |
C ≥ 5 %: Xn; R22-36/37 1 % ≤ C < 5 %: Xi; R36/37 |
|
607-142-00-8 |
propylchloorformiaat; chloormierenzuur, propylester; n-propylchloorformiaat |
|
203-687-7 |
109-61-5 |
F; R11 T; R23 C; R34 |
F; T R: 11-23-34 S: (1/2-)16-26-36-45 |
|
|
607-195-00-7 |
2-methoxy-1-methylethylacetaat |
|
203-603-9 |
108-65-6 |
R10 |
R: 10 S: (2-) |
|
|
607-216-00-X |
glutaminezuur, reactieprodukten met N-(C12-14-alkyl)propyleendiamine |
|
403-950-8 |
— |
T+; R26 Xn; R22 C; R34 N; R50 |
T+; N R: 22-26-34-50 S: (1/2-)26-36/37/39-38-45-61 |
|
|
607-231-00-1 |
clopyralid (ISO); 3,6-dichloorpyridine-2-carbonzuur |
|
216-935-4 |
1702-17-6 |
Xi; R41 |
Xi R: 41 S: (2-)26-39 |
|
|
607-245-00-8 |
tert-butylacrylaat |
D |
216-768-7 |
1663-39-4 |
F; R11 Xn; R20/21/22 Xi; R37/38 R43 N; R51-53 |
F; Xn; N R: 11-20/21/22-37/38-43-51/53 S: (2-)16-25-37-61 |
C ≥ 25 %: Xn; R20/21/22-37/38-43-51/53 20 % ≤ C < 25 %: Xi; R37/38-43-52/53 2,5 % ≤ C < 20 %: Xi; R43-52/53 1 % ≤ C < 2,5 %: Xi; R43 |
|
607-397-00-5 |
een mengsel van: Ca-salicylaten (vertakt C10-14 en C18-30 gealkyleerd); Ca-fenolaten (vertakt C10-14 en C18-30 gealkyleerd); Ca-gesulfureerde fenolaten (vertakt C10-14 en C18-30 gealkyleerd) |
|
415-930-6 |
— |
Repr. Cat. 3; R62 R43 |
Xn R: 43-62 S: (2-)23-36/37 |
|
|
608-005-00-5 |
n-butyronitril |
|
203-700-6 |
109-74-0 |
F; R11 T; R23/24/25 |
F; T R: 11-23/24/25 S: (1/2-)16-36/37-45-63 |
|
|
608-011-00-8 |
oxalonitril; cyanogeen |
|
207-306-5 |
460-19-5 |
F+; R12 T; R23 N; R50-53 |
F+; T; N R: 12-23-50/53 S: (1/2-)9-16-23-33-45-63-60-61 |
|
|
608-044-00-8 |
2-cyclohexylideen-2-fenyl-acetonitril |
|
423-740-1 |
10461-98-0 |
Xn; R22 N; R51-53 |
Xn; N R; 22-51/53 S: (2-)46-61 |
|
|
609-007-00-9 |
2,4-dinitrotolueen; [1] dinitrotolueen [2] |
E |
204-450-0 [1] 246-836-1 [2] |
121-14-2 [1] 25321-14-6 [2] |
Carc. Cat. 2; R45 Muta. Cat. 3; R68 Repr. Cat. 3; R62 T; R23/24/25 Xn; R48/22 N; R50-53 |
T; N R: 45-23/24/25-48/22-62-68-50/53 S: 53-45-60-61 |
|
|
611-028-00-3 |
C,C′-azodi(formamide) |
|
204-650-8 |
123-77-3 |
E; R2 R42 |
E; Xn R: 2-42 S: (2-)22-24-37 |
|
|
611-035-00-1 |
tetralithium-6-amino-4-hydroxy-3-[7-sulfonato-4-(5-sulfonato-2-naftylazo)-1-naftylazo]naftaleen-2,7-disulfonaat |
|
403-660-1 |
107246-80-0 |
N; R51-53 |
N R: 51/53 S: 61 |
|
|
612-044-00-3 |
N,N′-diacetylbenzidine |
E |
210-338-2 |
613-35-4 |
Carc. Cat. 2; R45 Muta. Cat. 3; R68 Xn; R20/21/22 |
T R: 45-20/21/22-68 S: 53-45 |
|
|
612-050-00-6 |
cyclohexylamine |
|
203-629-0 |
108-91-8 |
R10 Repr. Cat. 3; R62 Xn; R21/22 C; R34 |
C R: 10-21/22-34-62 S: (1/2-)26-36/37/39-45 |
C ≥ 25 %: C; R21/22-34-62 10 % ≤ C < 25 %: C; R34-62 5 % ≤ C < 10 %: Xn; R36/38-62 2 % ≤ C < 5 %: Xi; R36/38 |
|
612-076-00-8 |
ethyldimethylamine |
|
209-940-8 |
598-56-1 |
F; R11 Xn; R20/22 C; R34 |
F; C R: 11-20/22-34 S: (1/2-)3-16-26-36-45 |
|
|
612-099-00-3 |
4-methyl-m-fenyleendiamine; 2,4-tolueendiamine |
E |
202-453-1 |
95-80-7 |
Carc. Cat. 2; R45 Muta. Cat. 3; R68 Repr. Cat. 3; R62 T; R25 Xn; R21-48/22 R43 N; R51-53 |
T; N R: 45-21-25-43-48/22-62-68-51/53 S: 53-45-61 |
|
|
612-101-00-2 |
methenamine; hexamethyleentetramine |
|
202-905-8 |
100-97-0 |
F; R11 R43 |
F; Xi R: 11-43 S: (2-)24-37 |
|
|
612-151-00-5 |
methylfenyleendiamine; diaminotolueen; [technisch product - mengsel van 4-methyl-m-fenyleendiamine (EC-nr. 202-453-1) en 2-methyl-m-fenyleendiamine (EC-nr. 212-513-9)] |
E |
— |
— |
Carc. Cat. 2; R45 Muta. Cat. 3; R68 Repr. Cat. 3; R62 T; R25 Xn; R21-48/22 Xi; R36 R43 N; R51-53 |
T; N R: 45-21-25-36-43-48/22-62-68-51/53 S: 53-45-61 |
|
|
612-237-00-2 |
hydroxylammoniumwaterstofsulfaat; [1] hydroxylaminefosfaat; [2] hydroxylaminediwaterstoffosfaat; [3] hydroxylamine-4-methylbenzeensulfonaat [4] |
T |
233-154-4 [1] 244-077-0 [2] 242-818-2 [3] 258-872-5 [4] |
10046-00-1 [1] 20845-01-6 [2] 19098-16-9 [3] 53933-48-5 [4] |
E; R2 Carc. Cat. 3; R40 Xn; R21/22-48/22 Xi; R36/38 R43 N; R50 |
E; Xn; N R: 21/22-36/38-40-43-48/22-50 S: (2-)36/37-61 |
|
|
613-116-00-7 |
tolylfluanide (ISO); dichloor-N-[(dimethylamino)sulfonyl]fluor-N-(p-tolyl)methaansulfenamide; met ≥ 0,1 % (g/g) deeltjes met een aerodynamische diameter van minder dan 50 μm] |
|
211-986-9 |
731-27-1 |
T+; R26 T; R48/23 Xi; R36/37/38 R43 N; R50 |
T+; N R: 26-36/37/38-43-48/23-50 S: (1/2-)28-36/37/39-45-63-61 |
C ≥ 20 %: T+, N; R26-36/37/38-43-48/23-50 10 % ≤ C < 20 %: T+, N; R26-43-48/23-50 7 % ≤ C < 10 %: T+, N; R26-43-48/20-50 2,5 % ≤ C < 7 %: T, N; R23-43-48/20-50 1 % ≤ C < 2,5 %: T; R23-43-48/20 0,1 % ≤ C < 1 %: Xn; R20 |
|
615-001-00-7 |
methylisocyanaat |
|
210-866-3 |
624-83-9 |
F; R11 Repr. Cat. 3; R63 T+; R26 T; R24/25 R42/43 Xi; R37/38-41 |
F; T+ R: 11-24/25-26-37/38-41-42/43-63 S: (1/2-)16-26-27/28-36/37/39-45-63 |
|
|
615-004-00-3 |
zouten van thiocyaanzuur, met uitzondering van de elders in deze bijlage met name genoemde |
A |
— |
— |
Xn; R20/21/22 R32 R52-53 |
Xn R: 20/21/22-32-52/53 S: (2-)13-36/37-46-61 |
|
|
615-028-00-4 |
ethyl-2-(isocyanatosulfonyl)benzoaat |
|
410-220-2 |
77375-79-2 |
R14 Xn; R22-48/22 Xi; R41 R42/43 |
Xn R: 14-22-41-42/43-48/22 S: (2-)8-23-26-30-35-36/37/39 |
|
|
615-030-00-5 |
alkalizouten en aardalkalizouten van thiocyaanzuur, met uitzondering van de elders in deze bijlage met name genoemde |
A |
— |
— |
Xn; R20/21/22 R32 R52-53 |
Xn R: 20/21/22-32-52/53 S: (2-)13-36/37-46-61 |
|
|
615-031-00-0 |
thalliumthiocyanaat |
|
222-571-7 |
3535-84-0 |
T+; R26/28 Xn; R21 R32 R33 N; R51-53 |
T+; N R: 21-26/28-32-33-51/53 S: (1/2-)13-28-36/37-45-61 |
|
|
615-032-00-6 |
metaalzouten van thiocyaanzuur, met uitzondering van de elders in deze bijlage met name genoemde |
A |
— |
— |
Xn; R20/21/22 R32 N; R50-53 |
Xn; N R: 20/21/22-32-50/53 S: (2-)13-36/37-46-60-61 |
|
|
616-124-00-9 |
lithiumbis(trifluormethylsulfonyl)imide |
|
415-300-0 |
90076-65-6 |
T; R24/25 Xn; R48/22 C; R34 R52-53 |
T R: 24/25-34-48/22-52/53 S: (1/2-)22-26-36/37/39-45-61 |
|
|
617-017-00-X |
een mengsel van: 2,2′-bis(tert-pentylperoxy)-p-diisopropylbenzeen; 2,2′-bis(tert-pentylperoxy)-m-diisopropylbenzeen |
T |
412-140-3 |
32144-25-5 |
E; R2 O; R7 R53 |
E R: 2-7-53 S: (2-)3/7-14-36/37/39-61 |
|
|
650-016-00-2 |
Minerale vezels, met uitzondering van de elders in deze bijlage met name genoemde; [Synthetische (silicaat)glasvezels met een willekeurige oriëntatie en een gehalte aan alkali- en aardalkalioxiden (Na2O + K2O + CaO + MgO + BaO) van meer dan 18 gewichtsprocent] |
AQR |
— |
— |
Carc. Cat. 3; R40 |
Xn R: 40 S: (2-)36/37 |
|
|
650-017-00-8 |
Vuurvaste keramische vezels, Vezels voor speciale toepassingen, met uitzondering van de elders in deze bijlage met name genoemde; [Synthetische (silicaat)glasvezels met een willekeurige oriëntatie en een gehalte aan alkali- en aardalkalioxiden (Na2O + K2O + CaO + MgO + BaO) van ten hoogste 18 gewichtsprocent] |
AR |
— |
— |
Carc. Cat. 2; R49 |
T R: 49 S: 53-45 |
|
|
BIJLAGE 1B
Index No |
Chemische naam |
Nota's voor stoffen |
EC No |
CAS No |
Indeling |
Kenmerken |
Concentratiegrenzen |
Nota's voor preparaten |
003-003-00-5 |
(2-methylpropyl)lithium; isobutyllithium |
|
440-620-2 |
920-36-5 |
F; R15-17 R14 C; R35 R67 N; R50-53 |
F; C; N R: 14/15-17-35-67-50/53 S: (1/2-)6-16-26-30-33-36/37/39-43-45-60-61 |
|
|
005-013-00-5 |
diethylmethoxyboraan |
|
425-380-9 |
7397-46-8 |
F; R17 Xn; R20/21/22-48/22 C; R34 R43 R53 |
F; C R: 17-20/21/22-34-43-48/22-53 S: (1/2-)6-26-36/37/39-43-45-61 |
|
|
005-014-00-0 |
4-formylfenylboronzuur |
|
438-670-5 |
87199-17-5 |
R43 |
Xi R: 43 S: (2-)24-37 |
|
|
005-017-00-7 |
natriumperboraat; [1] perboorzuur, natriumzout; [2] perboorzuur, natriumzout, monohydraat; [3] natriumperoxometaboraat; [4] perboorzuur (HBO(O2)), natriumzout, monohydraat; [5] natriumperoxoboraat; [met < 0,1 % (g/g) deeltjes met een aerodynamische diameter van minder dan 50 μm] |
E |
239-172-9 [1] 234-390-0 [2] - [3] 231-556-4 [4] - [5] |
15120-21-5 [1] 11138-47-9 [2] 12040-72-1 [3] 7632-04-4 [4] 10332-33-9 [5] |
O; R8 Repr. Cat. 2; R61 Repr. Cat. 3; R62 Xn; R22 Xi; R37-41 |
O; T R: 61-8-22-37-41-62 S: 53-45 |
C ≥ 25 %: T; R61-22-37-41-62 22 % ≤ C < 25 %: T; R61-37-41-62 20 % ≤ C < 22 %: T; R61-36/37-62 14 % ≤ C < 20 %: T; R61-36-62 9 % ≤ C < 14 %: T; R61-62 6,5 % ≤ C < 9 %: T; R61 |
|
005-017-01-4 |
natriumperboraat; [1] perboorzuur, natriumzout; [2] perboorzuur, natriumzout, monohydraat; [3] natriumperoxometaboraat; [4] perboorzuur (HBO(O2)), natriumzout, monohydraat; [5] natriumperoxoboraat; [met ≥ 0,1 % (g/g) deeltjes met een aerodynamische diameter van minder dan 50 μm] |
E |
239-172-9 [1] 234-390-0 [2] - [3] 231-556-4 [4] - [5] |
15120-21-5 [1] 11138-47-9 [2] 12040-72-1 [3] 7632-04-4 [4] 10332-33-9 [5] |
O; R8 Repr. Cat. 2; R61 Repr. Cat. 3; R62 T; R23 Xn; R22 Xi; R37-41 |
O; T R: 61-8-22-23-37-41-62 S: 53-45 |
C ≥ 25 %: T; R61-22-23-37-41-62 22 % ≤ C < 25 %: T; R61-20-37-41-62 20 % ≤ C < 22 %: T; R61-20-36/37-62 14 % ≤ C < 20 %: T; R61-20-36-62 9 % ≤ C < 14 %: T; R61-20-62 6,5 % ≤ C < 9 %: T; R61-20 3 % ≤ C < 6,5 %: Xn; R20 |
|
005-018-00-2 |
perboorzuur (H3BO2(O2)), mononatriumzout, trihydraat; [1] perboorzuur, natriumzout, tetrahydraat; [2] perboorzuur (HBO(O2)), natriumzout, tetrahydraat; [3] natriumperoxoboraat, hexahydraat; [met < 0,1 % (g/g) deeltjes met een aerodynamische diameter van minder dan 50 μm] |
|
- [1] - [2] - [3] |
13517-20-9 [1] 37244-98-7 [2] 10486-00-7 [3] |
Repr. Cat. 2; R61 Repr. Cat. 3; R62 Xi; R37-41 |
T R: 61-37-41-62 S: 53-45-47 |
C ≥ 36 %: T; R61-37-41-62 22 % ≤ C < 36 %: T; R61-36/37-62 20 % ≤ C < 22 %: T; R61-37-62 14 % ≤ C < 20 %: T; R61-62 10 % ≤ C < 14 %: T; R61 |
|
005-018-01-X |
perboorzuur (H3BO2(O2)), mononatriumzout, trihydraat; [1] perboorzuur, natriumzout, tetrahydraat; [2] perboorzuur (HBO(O2)), natriumzout, tetrahydraat; [3] natriumperoxoboraat, hexahydraat; [met ≥ 0,1 % (g/g) deeltjes met een aerodynamische diameter van minder dan 50 μm] |
E |
- [1] - [2] - [3] |
13517-20-9 [1] 37244-98-7 [2] 10486-00-7 [3] |
Repr. Cat. 2; R61 Repr. Cat. 3; R62 Xn; R20 Xi; R37-41 |
T R: 61-20-37-41-62 S: 53-45-47 |
C ≥ 36 %: T; R61-20-37-41-62 25 % ≤ C < 36 %: T; R61-20-36/37-62 22 % ≤ C < 25 %: T; R61-36/37-62 20 % ≤ C < 22 %: T; R61-37-62 14 % ≤ C < 20 %: T; R61-62 10 % ≤ C < 14 %: T; R61 |
|
006-097-00-6 |
1-fenyl-3-(p-tolueensulfonyl)ureum |
|
424-620-1 |
13909-63-2 |
Xn; R22-48/22 R52-53 |
Xn R: 22-48/22-52/53 S: (2-)22-36-61 |
|
|
006-098-00-1 |
tert-butyl-(1R,5S)-3-azabicyclo[3.1.0]hex-6-ylcarbamaat |
|
429-170-8 |
134575-17-0 |
Xn; R22-48/22 Xi; R41 R43 |
Xn R: 22-41-43-48/22 S: (2-)22-26-36/37/39 |
|
|
006-099-00-7 |
N-(p-tolueensulfonyl)-N′-(3-(p-tolueensulfonyloxy)fenyl)ureum; 3-({[(4-methylfenyl)sulfonyl]carbamoyl}amino)fenyl-4-methylbenzeensulfonaat |
|
432-520-2 |
232938-43-1 |
N; R51-53 |
N R: 51/53 S: 22-61 |
|
|
006-101-00-6 |
mengsel van: N,N″-(methyleendi-4,1-fenyleen)bis[N′-fenylureum]; N-(4-[[4-[[(fenylamino)carbonyl]amino]fenylmethyl]fenyl]-N′-cyclohexylureum; N,N″-(methyleendi-4,1-fenyleen)bis[N′-cyclohexylureum] |
|
423-070-8 |
— |
R53 |
R: 53 S: 61 |
|
|
006-102-00-1 |
O-hexyl-N-ethoxycarbonylthiocarbamaat |
E |
432-750-3 |
— |
Carc. Cat. 2; R45 Muta. Cat. 2; R46 Xn; R22-48/22 R43 N; R51-53 |
T; N R: 45-46-22-43-48/22-51/53 S: 53-45-61 |
|
|
006-103-00-7 |
N,N″-(methyleendi-4,1-fenyleen)bis[N′-octyl]ureum |
|
445-760-8 |
— |
Xi; R41 R42 N; R50-53 |
Xn; N R: 41-42-50/53 S: (2-)22-26-39-45-60-61 |
C ≥10 %: Xn, N; R41-42-50/53 5 % ≤ C < 10 %: Xn, N; R36-42-50/53 1 % ≤ C < 5 %: Xn, N; R42-50/53 0,25 % ≤ C < 1 %: N; R50/53 0,025 % ≤ C < 0,25 %: N; R51/53 0,0025 ≤ C < 0,025 %: R52/53 |
|
007-029-00-8 |
diethyldimethylammoniumhydroxide |
|
419-400-5 |
95500-19-9 |
Xn; R21/22 C; R35 |
C R: 21/22-35 S: (1/2-)26-36/37/39-45 |
|
|
012-004-00-X |
aluminium-magnesium-carbonaat-hydroxide-perchloraat-hydraat |
|
422-150-1 |
— |
N; R50-53 |
N R: 50/53 S: 60-61 |
|
|
014-036-00-X |
(4-ethoxyfenyl)(3-(3-fenoxy-4-fluorfenyl)propyl)dimethylsilaan |
|
405-020-7 |
105024-66-6 |
Repr.Cat.2; R60 N; R50-53 |
T; N R: 60-50/53 S: 53-45-60-61 |
C ≥ 0,5 %: T, N; R60-50/53 0,025 % ≤ C < 0,5 %: N; R50/53 0,0025 % ≤ C < 0,025 %: N; R51/53 0,00025 % ≤ C < 0,0025 %: R52/53 |
|
014-037-00-5 |
butaan-2-on-O,O′,O″-(fenylsilylidyn)trioxim |
|
433-360-6 |
34036-80-1 |
Xn; R48/22 R43 R52-53 |
Xn R: 43-48/22-52/53 S: (2-)36/37-61 |
|
|
014-038-00-0 |
S-(3-(triethoxysilyl)propyl)octaanthioaat |
|
436-690-9 |
220727-26-4 |
R43 |
Xi R: 43 S: (2-)24-37 |
|
|
014-039-00-6 |
(2,3-dimethylbut-2-yl)trimethoxysilaan |
|
439-360-2 |
142877-45-0 |
Xi; R38-41 R52-53 |
Xi R: 38-41-52/53 S: (2-)26-37/39-61 |
|
|
014-041-00-7 |
N,N-bis(trimethylsilyl)aminopropylmethyldiethoxysilaan |
|
445-890-5 |
201290-01-9 |
Xn; R22 R43 |
Xn R: 22-43 S: (2-)24-37 |
|
|
014-042-00-2 |
mengsel van: O,O′,O″,O‴-silaantetrayltetrakis(4-methyl-2-pentanonoxim) (3 stereoisomeren) |
|
423-010-0 |
— |
Xi; R41 |
Xi R: 41 S: (2-)26-39 |
|
|
014-043-00-8 |
reactieproduct van amorfe silica (50-85%), butyl(1-methylpropyl)magnesium (3-15%), tetraethylorthosilicaat (5-15%) en titaantetrachloride (5-20%) |
|
432-200-2 |
— |
F; R11 Xi; R37/38-41 R52-53 |
F; Xi R: 11-37/38-41-52/53 S: (2-)6-26-36/39-61 |
|
|
014-044-00-3 |
3-[(4′-acetoxy-3′-methoxyfenyl)propyl]trimethoxysilaan |
|
433-050-0 |
— |
N; R51-53 |
N R: 51/53 S: 61 |
|
|
014-045-00-9 |
magnesiumnatriumfluoridesilicaat |
|
442-650-1 |
— |
Xn; R48/20 |
Xn R: 48/20 S: (2-)22-36 |
|
|
015-190-00-0 |
bis(2,4-dicumylfenyl)neopentyldifosfiet; 3,9-bis[2,4-bis(1-fenyl-1-methylethyl)fenoxy]-2,4,8,10-tetraoxa-3,9-difosfaspiro[5.5]undecaan |
|
421-920-2 |
154862-43-8 |
R53 |
R: 53 S: 61 |
|
|
015-191-00-6 |
dodecyldifenylfosfaat |
|
431-760-5 |
27460-02-2 |
Xi; R38 R52-53 |
Xi R: 38-52/53 S: (2-)37-61 |
|
|
015-192-00-1 |
tetrakis(2,6-dimethylfenyl)-m-fenyleenbifosfaat |
|
432-770-2 |
139189-30-3 |
R43 R53 |
Xi R: 43-53 S: (2-)24-37-61 |
|
|
015-193-00-7 |
trifenyl(fenylmethyl)fosfonium 1,1,2,2,3,3,4,4,4-nonafluor-N-methyl-1-butaansulfonamide (1:1) |
|
442-960-7 |
332350-93-3 |
T; R25 Xi; R41 N; R50-53 |
T; N R: 25-41-50/53 S: (1/2-)26-39-45-60-61 |
|
|
015-194-00-2 |
tetrabutylfosfoniumnonafluor-1-butaansulfonaat |
|
444-440-5 |
220689-12-3 |
Xn; R22 R52-53 |
Xn R: 22-52/53 S: (2-)61 |
|
|
015-195-00-8 |
mengsel van: kalium-o-tolueenfosfonaat; kalium-m-tolueenfosfonaat; kalium-p-tolueenfosfonaat |
|
433-860-4 |
— |
Xi; R36 R43 R52-53 |
Xi R: 36-43-52/53 S: (2-)24-26-37-61 |
|
|
015-196-00-3 |
mengsel van: dimethyl(2-(hydroxymethylcarbamoyl)ethyl)fosfonaat; diethyl(2-(hydroxymethylcarbamoyl)ethyl)fosfonaat; methylethyl(2-(hydroxymethylcarbamoyl)ethyl)fosfonaat |
|
435-960-3 |
— |
Carc.Cat.2; R45 Muta.Cat.2; R46 R43 |
T R: 45-46-43 S: 53-45 |
|
|
015-197-00-9 |
bis(2,4,4-trimethylpentyl)dithiofosfonzuur |
|
420-160-9 |
107667-02-7 |
R10 T; R23 Xn; R22 C; R34 N; R51-53 |
T; N R: 10-22-23-34-51/53 S: (1/2-)9-26-36/37/39-45-61 |
|
|
015-198-00-4 |
(4-fenylbutyl)fosfinezuur |
|
420-450-5 |
86552-32-1 |
Carc.Cat.3; R40 Xi; R41 |
Xn R: 40-41 S: (2-)23-26-36/37/39 |
|
|
016-094-00-1 |
zwavel |
|
231-722-6 |
7704-34-9 |
Xi; R38 |
Xi R: 38 S: (2-)46 |
|
|
016-097-00-8 |
1-amino-2-methyl-2-propaanthiol hydrochloride |
|
434-480-1 |
32047-53-3 |
Xn; R22 C; R34 R43 R52-53 |
C R: 22-34-43-52/53 S: (1/2-)22-26-36/37/39-45-61 |
|
|
017-009-01-8 |
ammoniumperchloraat; [met < 80 % deeltjes van 0-30 μm] |
T |
232-235-1 |
7790-98-9 |
E; R2 O; R9 |
E R: 2-9 S: (2-)14-16-36/37 |
|
|
022-004-00-1 |
kaliumtitaanoxide (K2Ti6O13) |
|
432-240-0 |
12056-51-8 |
Carc.Cat.3; R40 |
Xn R: 40 S: (2-)22-36/37 |
|
|
022-005-00-7 |
[N-(1,1-dimethylethyl)-1,1-dimethyl-1-[(1,2,3,4,5-η)-2,3,4,5-tetramethyl-2,4-cyclopentadieen-1-yl]silanaminato(2-)-κN][1,2,3,4-η)-1,3-pentadieen]-titaan |
|
419-840-8 |
169104-71-6 |
F; R11 C; R34 R43 R53 |
F; C R: 11-34-43-53 S: (1/2-)6-9-16-26-36/37/39-45-61 |
|
|
028-002-01-4 |
nikkelpoeder; [deeltjes met diameter < 1 mm] |
|
231-111-4 |
7440-02-0 |
Carc. Cat. 3; R40 T; R48/23 R43 R52-53 |
T R: 40-43-48/23-52/53 S: (2-)36/37/39-45-61 |
|
|
028-013-00-7 |
nikkel, mat |
E, H |
273-749-6 |
69012-50-6 |
Carc. Cat. 1; R49 T; R48/23 R43 N; R50-53 |
T; N R: 49-43-48/23-50/53 S: 53-45-60-61 |
|
|
028-014-00-2 |
afvalslik en bezinksel, elektrolytische koperzuivering, ontkoperd, nikkelsulfaat |
E |
295-859-3 |
92129-57-2 |
Carc. Cat. 1; R49 Muta. Cat. 3; R68 Repr. Cat. 2; R61 T; R48/23 Xn; R20/22 Xi; R38 R42/43 N; R50-53 |
T; N R: 49-61-20/22-38-42/43-48/23-68-50/53 S: 53-45-60-61 |
C ≥ 25 %: T, N; R49-61-20/22-38-42/43-48/23-68-50/53 20 % ≤ C < 25 %: T, N; R49-61-38-42/43-48/23-68-51/53 2,5 % ≤ C < 20 %: T, N; R49-61-42/43-48/23-68-51/53 1 % ≤ C < 2,5 %: T; R49-61-42/43-48/23-68-52/53 0,5 % ≤ C < 1 %: T; R49-61-43-48/20-52/53 0,25 % ≤ C < 0,5 %: T; R49-43-48/20-52/53 0,1 % ≤ C < 0,25 %: T; R49-43-48/20 0,01 % ≤ C < 0,1 %: Xi; R43 |
|
028-015-00-8 |
afvalslik en bezinksel, elektrolytische koperzuivering, ontkoperd |
E, H |
305-433-1 |
94551-87-8 |
Carc. Cat. 1; R49 Muta. Cat. 3; R68 Repr. Cat. 1; R61 Repr. Cat. 3; R62 T; R48/23 R42/43 N; R50-53 |
T; N R: 49-61-42/43-48/23-62-68-50/53 S: 53-45-60-61 |
|
|
028-016-00-3 |
nikkeldiperchloraat; perchloorzuur, nikkel(II)zout |
E, H |
237-124-1 |
13637-71-3 |
Carc. Cat. 1; R49 Muta. Cat. 3; R68 Repr. Cat. 2; R61 T; R48/23 C; R34 R42/43 N; R50-53 |
T; N R: 49-61-34-42/43-48/23-68-50/53 S: 53-45-60-61 |
C ≥ 25 %: T, N; R49-61-34-42/43-48/23-68-50/53 5 % ≤ C < 25 %: T, N; R49-61-34-42/43-48/23-68-51/53 2,5 % ≤ C < 5 %: T, N; R49-61-36/38-42/43-48/23-68-51/53 1 % ≤ C < 2,5 %: T; R49-61-36/38-42/43-48/23-68-52/53 0,5 % ≤ C < 1 %: T; R49-61-43-48/20-52/53 0,25 % ≤ C < 0,5 %: T; R49-43-48/20-52/53 0,1 % ≤ C < 0,25 %: T; R49-43-48/20 0,01 % ≤ C < 0,1 %: Xi; R43 |
|
028-017-00-9 |
dikaliumnikkelbis(sulfaat); [1] diammoniumnikkelbis(sulfaat) [2] |
E, H |
237-563-9 [1] 239-793-2 [2] |
13842-46-1 [1] 15699-18-0 [2] |
Carc. Cat. 1; R49 Muta. Cat. 3; R68 Repr. Cat. 2; R61 T; R48/23 Xn; R20/22 R42/43 N; R50-53 |
T; N R: 49-61-20/22-42/43-48/23-68-50/53 S: 53-45-60-61 |
C ≥ 25 %: T, N; R49-61-20/22-42/43-48/23-68-50/53 2,5 % ≤ C < 25 %: T, N; R49-61-42/43-48/23-68-51/53 1 % ≤ C < 2,5 %: T; R49-61-42/43-48/23-68-52/53 0,5 % ≤ C < 1 %: T; R49-61-43-48/20-52/53 0,25 % ≤ C < 0,5 %: T; R49-43-48/20-52/53 0,1 % ≤ C < 0,25 %: T; R49-43-48/20 0,01 % ≤ C < 0,1 %: Xi; R43 |
|
028-018-00-4 |
nikkelbis(sulfamidaat); nikkelsulfamaat |
E, H |
237-396-1 |
13770-89-3 |
Carc. Cat. 1; R49 Muta. Cat. 3; R68 Repr. Cat. 2; R61 T; R48/23 R42/43 N; R50-53 |
T; N R: 49-61-42/43-48/23-68-50/53 S: 53-45-60-61 |
C ≥ 25 %: T, N; R49-61-42/43-48/23-68-50/53 2,5 % ≤ C < 25 %: T, N; R49-61-42/43-48/23-68-51/53 1 % ≤ C < 2,5 %: T; R49-61-42/43-48/23-68-52/53 0,5 % ≤ C < 1 %: T; R49-61-43-48/20-52/53 0,25 % ≤ C < 0,5 %: T; R49-43-48/20-52/53 0,1 % ≤ C < 0,25 %: T; R49-43-48/20 0,01 % ≤ C < 0,1 %: Xi; R43 |
|
028-019-00-X |
nikkelbis(tetrafluorboraat) |
E, H |
238-753-4 |
14708-14-6 |
Carc. Cat. 1; R49 Muta. Cat. 3; R68 Repr. Cat. 2; R61 T; R48/23 R42/43 N; R50-53 |
T; N R: 49-61-42/43-48/23-68-50/53 S: 53-45-60-61 |
C ≥ 25 %: T, N; R49-61-42/43-48/23-68-50/53 2,5 % ≤ C < 25 %: T, N; R49-61-42/43-48/23-68-51/53 1 % ≤ C < 2,5 %: T; R49-61-42/43-48/23-68-52/53 0,5 % ≤ C < 1 %: T; 49-61-43-48/20-52/53 0,25 % ≤ C < 0,5 %: T; R49-43-48/20-52/53 0,1 % ≤ C < 0,25 %: T; R49-43-48/20 0,01 % ≤ C < 0,1 %: Xi; R43 |
|
028-021-00-0 |
nikkeldiformiaat; [1] mierenzuur, nikkelzout; [2] mierenzuur, kopernikkelzout [3] |
E, H |
222-101-0 [1] 239-946-6 [2] 268-755-0 [3] |
3349-06-2 [1] 15843-02-4 [2] 68134-59-8 [3] |
Carc. Cat. 1; R49 Muta. Cat. 3; R68 Repr. Cat. 2; R61 T; R48/23 R42/43 N; R50-53 |
T; N R: 49-61-42/43-48/23-68-50/53 S: 53-45-60-61 |
C ≥ 25 %: T, N; R49-61-42/43-48/23-68-50/53 2,5 % C < 25 %: T, N; R49-61-42/43-48/23-68-51/53 1 % ≤ C < 2,5%: T; R49-61-42/43-48/23-68-52/53 0,5 % ≤ C < 1 %: T; R49-61-43-48/20-52/53 0,25 % ≤ C < 0,5 %: T; R49-43-48/20-52/53 0,1 % ≤ C < 0,25 %: T; R49-43-48/20 0,01 % ≤ C 0,1 %: Xi; R43 |
|
028-022-00-6 |
nikkeldi(acetaat); [1] nikkelacetaat [2] |
E, H |
206-761-7 [1] 239-086-1 [2] |
373-02-4 [1] 14998-37-9 [2] |
Carc. Cat. 1; R49 Muta. Cat. 3; R68 Repr. Cat. 2; R61 T; R48/23 Xn; R20/22 R42/43 N; R50-53 |
T; N R: 49-61-20/22-42/43-48/23-68-50/53 S: 53-45-60-61 |
C ≥ 25 %: T, N; R49-61-20/22-42/43-48/23-68-50/53 2,5 % ≤ C < 25 %: T, N: R49-61-42/43-48/23-68-51/53 1 % ≤ C < 2,5 %: T; R49-61-42/43-48/23-68-52/53 0,5 % ≤ C < 1 %: T; R49-61-43-48/20-52/53 0,25 % ≤ C 0,5 %: T; R49-43-48/20-52/53 0,1 % ≤ C < 0,25 %: T; R49-43-48/20 0,01 % ≤ C < 0,1 %: Xi; R43 |
|
028-024-00-7 |
nikkeldibenzoaat |
E, H |
209-046-8 |
553-71-9 |
Carc. Cat. 1; R49 Muta. Cat. 3; R68 Repr. Cat. 2; R61 T; R48/23 R42/43 N; R50-53 |
T; N R: 49-61-42/43-48/23-68-50/53 S: 53-45-60-61 |
C ≥ 25 %: T, N; R49-61-42/43-48/23-68-50/53 2,5 % ≤ C < 25 %: T, N; R49-61-42/43-48/23-68-51/53 1 % ≤ C < 2,5 %: T; R49-61-42/43-48/23-68-52/53 0,5 % ≤ C < 1 %: T; R49-61-43-48/20-52/53 0,25 % ≤ C < 0,5 %: T; R49-43-48/20-52/53 0,1 % ≤C < 0,25 %: T; R49-43-48/20 0,01 % ≤ C < 0,1 %: Xi; R43 |
|
028-025-00-2 |
nikkelbis(4-cyclohexylbutyraat) |
E, H |
223-463-2 |
3906-55-6 |
Carc. Cat. 1; R49 Muta. Cat. 3; R68 Repr. Cat. 2; R61 T; R48/23 R42/43 N; R50-53 |
T; N R: 49-61-42/43-48/23-68-50/53 S: 53-45-60-61 |
C ≥ 25 %: T, N; R49-61-42/43-48/23-68-50/53 2,5 % ≤ C < 25 %: T, N; R49-61-42/43-48/23-68-51/53 1 % ≤ C < 2,5 %: T; R49-61-42/43-48/23-68-52/53 0,5 % ≤ C < 1 %: T; R49-61-43-48/20-52/53 0,25 % ≤ C < 0,5 %: T; R49-43-48/20-52/53 0,1 % ≤ C < 0,25 %: T; R49-43-48/20 0,01 % ≤ C < 0,1 %: Xi; R43 |
|
028-026-00-8 |
nikkel(II)stearaat; nikkel(II)octadecanoaat |
E, H |
218-744-1 |
2223-95-2 |
Carc. Cat. 1; R49 Muta. Cat. 3; R68 Repr. Cat. 2; R61 T; R48/23 R42/43 N; R50-53 |
T; N R: 49-61-42/43-48/23-68-50/53 S: 53-45-60-61 |
C ≥ 25 %: T, N; R49-61-42/43-48/23-68-50/53 2,5 % ≤ C < 25 %: T, N; R49-61-42/43-48/23-68-51/53 1 % ≤ C < 2,5 %: T; R49-61-42/43-48/23-68-52/53 0,5 % ≤ C < 1 %: T; R49-61-43-48/20-52/53 0,25 % ≤ C < 0,5 %: T; R49-43-48/20-52/53 0,1 % ≤ C < 0,25 %: T; R49-43-48/20 0,01 % ≤ C < 0,1 %: Xi; R43 |
|
028-027-00-3 |
nikkeldilactaat |
E, H |
— |
16039-61-5 |
Carc. Cat. 1; R49 Muta. Cat. 3; R68 Repr. Cat. 2; R61 T; R48/23 R42/43 N; R50-53 |
T; N R: 49-61-42/43-48/23-68-50/53 S: 53-45-60-61 |
C ≥ 25 %: T, N; R49-61-42/43-48/23-68-50/53 2,5 % ≤ C < 25 %: T, N; R49-61-42/43-48/23-68-51/53 1 % ≤ C < 2,5 %: T; R49-61-42/43-48/23-68-52/53 0,5 % ≤ C < 1 %: T; R49-61-43-48/20-52/53 0,25 % ≤ C < 0,5 %: T; R49-43-48/20-52/53 0,1 % ≤ C < 0,25 %: T; R49-43-48/20 0,01 % ≤ C < 0,1 %: Xi; R43 |
|
028-028-00-9 |
nikkel(II)octanoaat |
E, H |
225-656-7 |
4995-91-9 |
Carc. Cat. 1; R49 Muta. Cat. 3; R68 Repr. Cat 2; R61 T; R48/23 C; R35 R42/43 N; R50-53 |
T; C; N R: 49-61-35-42/43-48/23-68-50/53 S: 53-45-60-61 |
C ≥ 25 %: T, C, N; R49-61-35-42/43-48/23-68-50/53 10 % ≤ C < 25 %: T, C, N; R49-61-35-42/43-48/23-68-51/53 5 % ≤ C < 10 %: T, N; R49-61-34-42/43-48/23-68-51/53 2,5 % ≤ C < 5 %: T, N; R49-61-36/38-42/43-48/23-68-51/53 1 % ≤ C < 2,5 %: T; R49-61-36/38-42/43-48/23-68-52/53 0,5 % ≤ C < 1 %: T; R49-61-43-48/20-52/53 0,25 % ≤ C < 0,5 %: T; R49-43-48/20-52/53 0,1 % ≤ C < 0,25 %: T; R49-43-48/20 0,01 % ≤ C < 0,1 %: Xi; R43 |
|
028-029-00-4 |
nikkeldifluoride; [1] nikkeldibromide; [2] nikkeldijodide; [3] nikkelkaliumfluoride [4] |
E, H |
233-071-3 [1] 236-665-0 [2] 236-666-6 [3] - [4] |
10028-18-9 [1] 13462-88-9 [2] 13462-90-3 [3] 11132-10-8 [4] |
Carc. Cat. 1; R49 Muta. Cat. 3; R68 Repr. Cat. 2; R61 T; R48/23 R42/43 N; R50-53 |
T; N R: 49-61-42/43-48/23-68-50/53 S: 53-45-60-61 |
C ≥ 25 %: T, N; R49-61-42/43-48/23-68-50/53 2,5 % ≤ C < 25 %: T, N; R49-61-42/43-48/23-68-51/53 1 % ≤ C < 2,5 %: T; 49-61-42/43-48/23-68-52/53 0,5 % ≤ C < 1 %: T; R49-61-43-48/20-52/53 0,25 % ≤ C < 0,5 %: T; 49-43-48/20-52/53 0,1 % ≤ C < 0,25 %: T; R49-43-48/20 0,01 % ≤ C < 0,1 %: Xi; R43 |
|
028-030-00-X |
nikkelhexafluorsilicaat |
E, H |
247-430-7 |
26043-11-8 |
Carc. Cat. 1; R49 Muta. Cat. 3; R68 Repr. Cat. 2; R61 T; R48/23 R42/43 N; R50-53 |
T; N R: 49-61-42/43-48/23-68-50/53 S: 53-45-60-61 |
C ≥ 25 %: T, N; R49-61-42/43-48/23-68-50/53 2,5 % ≤ C < 25 %: T, N; R49-61-42/43-48/23-68-51/53 1 % ≤ C < 2,5 %: T; R49-61-42/43-48/23-68-52/53 0,5 % ≤ C < 1 %: T; R49-61-43-48/20-52/53 0,25 % ≤ C < 0,5 %: T; R49-43-48/20-52/53 0,1 % ≤ C < 0,25 %: T; R49-43-48/20 0,01 % ≤ C < 0,1 %: Xi; R43 |
|
028-031-00-5 |
nikkelselenaat |
E, H |
239-125-2 |
15060-62-5 |
Carc. Cat. 1; R49 Muta. Cat. 3; R68 Repr. Cat. 2; R61 T; R48/23 R42/43 N; R50-53 |
T; N R: 49-61-42/43-48/23-68-50/53 S: 53-45-60-61 |
C ≥ 25 %: T, N; R49-61-42/43-48/23-68-50/53 2,5 % ≤ C < 25 %: T, N; R49-61-42/43-48/23-68-51/53 1 % ≤ C < 2,5 %: T; R49-61-42/43-48/23-68-52/53 0,5 % ≤ C < 1 %: T; R49-61-43-48/20-52/53 0,25 % ≤ C < 0,5 %: T; R49-43-48/20-52/53 0,1 % ≤ C < 0,25 %: T; R49-43-48/20 0,01 % ≤ C < 0,1 %: Xi; R43 |
|
028-032-00-0 |
nikkelwaterstoffosfaat; [1] nikkelbis(diwaterstoffosfaat); [2] trinikkelbis(orthofosfaat); [3] dinikkeldifosfaat; [4] nikkelbis(fosfinaat); [5] nikkelfosfinaat; [6] fosforzuur, calciumnikkelzout; [7] difosforzuur, nikkel(II)zout [8] |
E, H |
238-278-2 [1] 242-522-3 [2] 233-844-5 [3] 238-426-6 [4] 238-511-8 [5] 252-840-4 [6] - [7] - [8] |
14332-34-4 [1] 18718-11-1 [2] 10381-36-9 [3] 14448-18-1 [4] 14507-36-9 [5] 36026-88-7 [6] 17169-61-8 [7] 19372-20-4 [8] |
Carc. Cat. 1; R49 T; R48/23 R42/43 N; R50-53 |
T; N R: 49-42/43-48/23-50/53 S: 53-45-60-61 |
|
|
028-033-00-6 |
diammoniumnikkelhexacyanoferraat |
E, H |
— |
74195-78-1 |
Carc. Cat. 1; R49 T; R48/23 R42/43 N; R50-53 |
T; N R: 49-42/43-48/23-50/53 S: 53-45-60-61 |
|
|
028-034-00-1 |
nikkeldicyanide |
E, H |
209-160-8 |
557-19-7 |
Carc. Cat. 1; R49 T; R48/23 R42/43 R32 N; R50-53 |
T; N R: 49-32-42/43-48/23-50/53 S: 53-45-60-61 |
|
|
028-035-00-7 |
nikkelchromaat |
E, H |
238-766-5 |
14721-18-7 |
Carc. Cat. 1; R49 T; R48/23 R42/43 N; R50-53 |
T; N R: 49-42/43-48/23-50/53 S: 53-45-60-61 |
|
|
028-036-00-2 |
nikkel(II)silicaat; [1] dinikkelorthosilicaat; [2] nikkelsilicaat(3:4); [3] kiezelzuur, nikkelzout; [4] triwaterstofhydroxybis[orthosilicato(4-)]trinikkelaat(3-) [5] |
E, H |
244-578-4 [1] 237-411-1 [2] 250-788-7 [3] 253-461-7 [4] 235-688-3 [5] |
21784-78-1 [1] 13775-54-7 [2] 31748-25-1 [3] 37321-15-6 [4] 12519-85-6 [5] |
Carc. Cat. 1; R49 T; R48/23 R43 N; R50-53 |
T; N R: 49-43-48/23-50/53 S: 53-45-60-61 |
|
|
028-037-00-8 |
dinikkelhexacyanoferraat |
E, H |
238-946-3 |
14874-78-3 |
Carc. Cat. 1; R49 T; R48/23 R43 N; R50-53 |
T; N R: 49-43-48/23-50/53 S: 53-45-60-61 |
|
|
028-038-00-3 |
trinikkelbis(arsenaat); nikkel(II)arsenaat |
E, H |
236-771-7 |
13477-70-8 |
Carc. Cat. 1; R45 T; R48/23 R43 N; R50-53 |
T; N R: 45-43-48/23-50/53 S: 53-45-60-61 |
|
|
028-039-00-9 |
nikkeloxalaat; [1] oxaalzuur, nikkelzout [2] |
E, H |
208-933-7 [1] 243-867-2 [2] |
547-67-1 [1] 20543-06-0 [2] |
Carc. Cat. 1; R49 T; R48/23 R43 N: R50-53 |
T; N R: 49-43-48/23-50/53 S: 53-45-60-61 |
|
|
028-040-00-4 |
nikkeltelluride |
E, H |
235-260-6 |
12142-88-0 |
Carc. Cat. 1; R49 T; R48/23 R43 N; R50-53 |
T; N R: 49-43-48/23-50/53 S: 53-45-60-61 |
|
|
028-041-00-X |
trinikkeltetrasulfide |
E, H |
— |
12137-12-1 |
Carc. Cat. 1; R49 T; R48/23 R43 N; R50-53 |
T; N R: 49-43-48/23-50/53 S: 53-45-60-61 |
|
|
028-042-00-5 |
trinikkelbis(arseniet) |
E, H |
— |
74646-29-0 |
Carc. Cat. 1; R49 T; R48/23 R43 N; R50-53 |
T; N R: 49-43-48/23-50/53 S: 53-45-60-61 |
|
|
028-043-00-0 |
kobaltnikkel grijze periklaas; C.I. Pigment Black 25; C.I. 77332; [1] kobaltnikkeldioxide; [2] kobaltnikkeloxide [3] |
E, H |
269-051-6 [1] 261-346-8 [2] - [3] |
68186-89-0 [1] 58591-45-0 [2] 12737-30-3 [3] |
Carc. Cat. 1; R49 T; R48/23 R43 |
T R: 49-43-48/23 S: 53-45 |
|
|
028-044-00-6 |
nikkeltintrioxide; nikkelstannaat |
E, H |
234-824-9 |
12035-38-0 |
Carc. Cat. 1; R49 T; R48/23 R43 |
T R: 49-43-48/23 S: 53-45 |
|
|
028-045-00-1 |
nikkeltriuraandecaoxide |
E, H |
239-876-6 |
15780-33-3 |
Carc. Cat. 1; R49 T; R48/23 R43 |
T R: 49-43-48/23 S: 53-45 |
|
|
028-046-00-7 |
nikkeldithiocyanaat |
E, H |
237-205-1 |
13689-92-4 |
Carc. Cat. 1; R49 Muta. Cat. 3;R68 Repr. Cat. 2; R61 T; R48/23 R42/43 R32 N; R50-53 |
T; N R: 49-61-32-42/43-48/23-68-50/53 S: 53-45-60-61 |
C ≥ 25 %: T, N; R49-61-42/43-48/23-68-50/53 2,5 % ≤ C < 25 %: T, N; R49-61-42/43-48/23-68-51/53 1 % ≤ C < 2,5 %: T; R49-61-42/43-48/23-68-52/53 0,5 % ≤ C < 1 %: T; R49-61-43-48/20-52/53 0,25 % ≤ C < 0,5 %: T: R49-61-43-48/20-52/53 0,1 % ≤ C < 0,25 %: T; R49-43-48/20 0,01 % ≤ C < 0,1 %: Xi; R43 |
|
028-047-00-2 |
nikkeldichromaat |
E, H |
239-646-5 |
15586-38-6 |
Carc. Cat. 1; R49 Muta. Cat. 3; R68 Repr. Cat. 2; R61 T; R48/23 R42/43 N; R50-53 |
T; N R: 49-61-42/43-48/23-68-50/53 S: 53-45-60-61 |
C ≥ 25 %: T, N; R49-61-42/43-48/23-68-50/53 2,5 % ≤ C < 25 %: T, N; R49-61-42/43-48/23-68-51/53 1 % ≤ C < 2,5 %: T; R49-61-42/43-48/23-68-52/53 0,5 % ≤ C < 1 %: T; 49-61-43-48/20-52/53 0,25 % ≤ C < 0,5 %: T; R49-43-48/20-52/53 0,1 % ≤ C < 0,25 %: T; R49-43-48/20 0,01 % ≤ C 0,1 %: Xi; R43 |
|
028-048-00-8 |
nikkel(II)seleniet |
E, H |
233-263-7 |
10101-96-9 |
Carc. Cat. 1; R49 T; R48/23 R42/43 N; R50-53 |
T; N R: 49-42/43-48/23-50/53 S: 53-45-60-61 |
|
|
028-049-00-3 |
nikkelselenide |
E, H |
215-216-2 |
1314-05-2 |
Carc. Cat. 1; R49 T; R48/23 R43 N; R50-53 |
T; N R: 49-43-48/23-50/53 S: 53-45-60-61 |
|
|
028-050-00-9 |
kiezelzuur, loodnikkelzout |
E, H |
— |
68130-19-8 |
Carc. Cat. 1: R49 Repr. Cat. 1: R61 Repr. Cat. 3; R62 T; R48/23 R43 N; R50-53 |
T; N R: 49-61-43-48/23-62-50/53 S: 53-45-60-61 |
|
|
028-051-00-4 |
nikkeldiarsenide; [1] nikkelarsenide [2] |
E, H |
235-103-1 [1] 248-169-1 [2] |
12068-61-0 [1] 27016-75-7 [2] |
Carc. Cat. 1; R49 T; R48/23 R43 N; R50-53 |
T; N R: 49-43-48/23-50/53 S: 53-45-60-61 |
|
|
028-052-00-X |
nikkelbariumtitaan lichtgeel prideriet; C.I. Pigment Yellow 157; C.I. 77900 |
E, H |
271-853-6 |
68610-24-2 |
Carc. Cat. 1: R49 T; R48/23 R43 |
T R: 49-43-48/23 S: 53-45 |
|
|
028-053-00-5 |
nikkeldichloraat; [1] nikkeldibromaat; [2] ethylwaterstofsulfaat, nikkel(II)zout [3] |
E, H |
267-897-0 [1] 238-596-1 [2] 275-897-7 [3] |
67952-43-6 [1] 14550-87-9 [2] 71720-48-4 [3] |
Carc. Cat. 1; R49 Muta. Cat. 3; R68 Repr. Cat. 2; R61 T; R48/23 R42/43 N; R50-53 |
T; N R: 49-61-42/43-48/23-68-50/53 S: 53-45-60-61 |
C ≥ 25 %: T, N; R49-61-42/43-48/23-68-50/53 2,5 % ≤ C < 25 %: T, N: R49-61-42/43-48/23-68-51/53 1 % ≤ C < 2,5 %: T: R49-61-42/43-48/23-68-52/53 0,5 % ≤ C < 1 %: T; R49-61-43-48/20-52/53 0,25 % ≤ C < 0,5 %: T; R49-43-48/20-52/53 0,1 % ≤ C < 0,25 %: T: R49-43-48/20 0,01 % ≤ C < 0,1 %: Xi; R43 |
|
028-054-00-0 |
nikkel(II)trifluoracetaat; [1] nikkel(II)propionaat; [2] nikkelbis(benzeensulfonaat); [3] nikkel(II)waterstofcitraat; [4] citroenzuur, ammoniumnikkelzout; [5] citroenzuur, nikkelzout; [6] nikkelbis(2-ethylhexanoaat); [7] 2-ethylhexaanzuur, nikkelzout; [8] dimethylhexaanzuur, nikkelzout; [9] nikkel(II)isooctanoaat; [10] nikkelisooctanoaat; [11] nikkelbis(isononanoaat); [12] nikkel(II)neononanoaat; [13] nikkel(II)isodecanoaat; [14] nikkel(II)neodecanoaat; [15] neodecaanzuur, nikkelzout; [16] nikkel(II)neoundecanoaat; [17] bis(D-gluconato-O 1,O 2)nikkel; [18] nikkel-3,5-bis(tert-butyl)-4-hydroxybenzoaat (1:2); [19] nikkel(II)palmitaat; [20] (2-ethylhexanoato-O)(isononanoato-O)nikkel; [21] (isononanoato-O)(isooctanoato-O)nikkel; [22] (isooctanoato-O)(neodecanoato-O)nikkel; [23] (2-ethylhexanoato-O)(isodecanoato-O)nikkel; [24] (2-ethylhexanoato-O)(neodecanoato-O)nikkel; [25] (isodecanoato-O)(isooctanoato-O)nikkel; [26] (isodecanoato-O)(isononanoato-O)nikkel; [27] (isononanoato-O)(neodecanoato-O)nikkel; [28] vetzuren, C6-19-vertakte, nikkelzouten; [29] vetzuren, C8-18-en C18-onverzadigd, nikkelzouten; [30] 2,7-naftaleendisulfonzuur, nikkel(II)zout; [31] |
E, H |
240-235-8 [1] 222-102-6 [2] 254-642-3 [3] 242-533-3 [4] 242-161-1 [5] 245-119-0 [6] 224-699-9 [7] 231-480-1 [8] 301-323-2 [9] 249-555-2 [10] 248-585-3 [11] 284-349-6 [12] 300-094-6 [13] 287-468-1 [14] 287-469-7 [15] 257-447-1 [16] 300-093-0 [17] 276-205-6 [18] 258-051-1 [19] 237-138-8 [20] 287-470-2 [21] 287-471-8 [22] 284-347-5 [23] 284-351-7 [24] 285-698-7 [25] 285-909-2 [26] 284-348-0 [27] 287-592-6 [28] 294-302-1 [29] 283-972-0 [30] - [31] |
16083-14-0 [1] 3349-08-4 [2] 39819-65-3 [3] 18721-51-2 [4] 18283-82-4 [5] 22605-92-1 [6] 4454-16-4 [7] 7580-31-6 [8] 93983-68-7 [9] 29317-63-3 [10] 27637-46-3 [11] 84852-37-9 [12] 93920-10-6 [13] 85508-43-6 [14] 85508-44-7 [15] 51818-56-5 [16] 93920-09-3 [17] 71957-07-8 [18] 52625-25-9 [19] 13654-40-5 [20] 85508-45-8 [21] 85508-46-9 [22] 84852-35-7 [23] 84852-39-1 [24] 85135-77-9 [25] 85166-19-4 [26] 84852-36-8 [27] 85551-28-6 [28] 91697-41-5 [29] 84776-45-4 [30] 72319-19-8 [31] |
Carc. Cat. 1; R49 Muta. Cat. 3; R68 Repr. Cat. 2; R61 T; R48/23 R42/43 N; R50-53 |
T; N R: 49-61-42/43-48/23-68-50/53 S: 53-45-60-61 |
C ≥ 25 %: T, N; R49-61-42/43-48/23-68-50/53 2,5 % ≤ C < 25 %: T, N; R49-61-42/43-48/23-68-51/53 1 % ≤ C < 2,5 %: T; R49-61-42/43-48/23-68-52/53 0,5 % ≤ C < 1 %: T; R49-61-43-48/20-52/53 0,25 % ≤ C < 0,5 %: T; R49-43-48/20-52/53 0,1 % ≤ C < 0,25 %: T; R49-43-48/20 0,01 % ≤ C < 0,1 %: Xi; R43 |
|
028-055-00-6 |
nikkel(II)sulfiet; [1] nikkeltelluurtrioxide; [2] nikkeltelluurtetraoxide; [3] molybdeennikkelhydroxideoxidefosfaat [4] |
E, H |
231-827-7 [1] 239-967-0 [2] 239-974-9 [3] 268-585-7 [4] |
7757-95-1 [1] 15851-52-2 [2] 15852-21-8 [3] 68130-36-9 [4] |
Carc. Cat. 1; R49 T; R48/23 R42/43 N; R50-53 |
T; N R: 49-42/43-48/23-50/53 S: 53-45-60-61 |
|
|
028-056-00-1 |
nikkelboride (NiB); [1] dinikkelboride; [2] trinikkelboride; [3] nikkelboride; [4] dinikkelsilicide; [5] nikkeldisilicide; [6] dinikkelfosfide; [7] nikkelboorfosfide [8] |
E, H |
234-493-0 [1] 234-494-6 [2] 234-495-1 [3] 235-723-2 [4] 235-033-1 [5] 235-379-3 [6] 234-828-0 [7] - [8] |
12007-00-0 [1] 12007-01-1 [2] 12007-02-2 [3] 12619-90-8 [4] 12059-14-2 [5] 12201-89-7 [6] 12035-64-2 [7] 65229-23-4 [8] |
Carc. Cat. 1; R49 T; R48/23 R43 N; R50-53 |
T; N R: 49-43-48/23-50/53 S: 53-45-60-61 |
|
|
028-057-00-7 |
dialuminiumnikkeltetraoxide; [1] nikkeltitaantrioxide; [2] nikkeltitaanoxide; [3] nikkeldivanadiumhexaoxide; [4] kobaltdimolybdeennikkeloctaoxide; [5] nikkelzirkoniumtrioxide; [6] molybdeennikkeltetraoxide; [7] nikkelwolfraamtetraoxide; [8] olivijn, nikkelgroen; [9] lithiumnikkeldioxide; [10] molybdeennikkeloxide; [11] |
E, H |
234-454-8 [1] 234-825-4 [2] 235-752-0 [3] 257-970-5 [4] 268-169-5 [5] 274-755-1 [6] 238-034-5 [7] 238-032-4 [8] 271-112-7 [9] - [10] - [11] |
12004-35-2 [1] 12035-39-1 [2] 12653-76-8 [3] 52502-12-2 [4] 68016-03-5 [5] 70692-93-2 [6] 14177-55-0 [7] 14177-51-6 [8] 68515-84-4 [9] 12031-65-1 [10] 12673-58-4 [11] |
Carc. Cat. 1; R49 T; R48/23 R43 |
T R: 49-43-48/23 S: 53-45 |
|
|
028-058-00-2 |
kobaltlithiumnikkeloxide |
E |
442-750-5 |
— |
Carc. Cat. 1; R49 T+; R26 T; R48/23 R43 N; R50-53 |
T+; N R: 49-26-43-48/23-50/53 S: 53-45-60-61 |
|
|
029-014-00-5 |
mengsel van: 2,2′-[[cis-1,2-cyclohexaandiylbis(nitrilomethylideen)]bis[fenolaat]](2-)N,N′,O,O′-kopercomplex; 2,2′-[[trans-1,2-cyclohexaandiylbis(nitrilomethylidyne)]bis[fenolaat]](2-)N,N′,O,O′-kopercomplex |
|
419-610-7 |
171866-24-3 |
Xn; R48/22 N; R51-53 |
Xn; N R: 48/22-51/53 S: (2-)22-36-61 |
|
|
030-012-00-1 |
aluminium-magnesium-zink-carbonaat-hydroxide |
|
423-570-6 |
169314-88-9 |
R52-53 |
R: 52/53 S: 61 |
|
|
030-015-00-8 |
tetrazink(2+)bis(hexacyanokobalt(3+))diacetaat |
|
440-060-9 |
— |
N; R51-53 |
N R: 51/53 S: 61 |
|
|
042-005-00-0 |
mengsel van: mono-en diglycerolen van canola-olie; canola-oliezuuramide van N-[3-(tridecyloxy)propyl]-1,3-propaandiamine, vertakt; N,N-diorganodithiocarbamaatmolybdeencomplex |
|
434-240-6 |
— |
R43 N; R51-53 |
Xi; N R: 43-51/53 S: (2-)24-37-61 |
|
|
050-023-00-5 |
mengsel van: bis[(2-ethyl-1-oxohexyl)oxy]dioctylstannaan; bis[((2-ethyl-1-oxohexyl)oxy)dioctylstannyl]oxide; bis(1-fenyl-1,3-decaandionyl)dioctylstannaan; ((2-ethyl-1-oxohexyl)oxy)-(1-fenyl-1,3-decaandionyl)dioctylstannaan |
|
422-920-5 |
— |
Xn; R48/22 N; R50-53 |
Xn; N R: 48/22-50/53 S: (2-)23-36-60-61 |
C ≥ 10 %: Xn, N; R48/22-50/53 2,5 % ≤ C < 10 %: N; R50/53 0,25 % ≤ C < 2,5 %: N; R51/53 0,025 % ≤ C < 0,25 %: R52/53 |
|
050-024-00-0 |
mengsel van: tri-p-tolyltinhydroxide; hexa-p-tolyldistannoxaan |
|
432-230-6 |
— |
T; R48/25 Xn; R22 Xi; R38-41 R43 N; R50-53 |
T; N R: 22-38-41-43-48/25-50/53 S: (1/2-)22-26-36/37/39-45-60-61 |
|
|
064-001-00-8 |
gadolinium(III)sulfiet, trihydraat |
|
456-900-2 |
51285-81-5 |
N; R51-53 |
N R: 51/53 S: 61 |
|
|
078-011-00-5 |
hydroxydisulfitoplatina(II)zuur |
|
423-310-1 |
61420-92-6 |
Xn; R22-48/20/21/22 C; R35 R42/43 R52-53 |
C R: 22-35-42/43-48/20/21/22-52/53 S: (1/2-)23-24-26-28-36/37/39-45-61 |
|
|
078-012-00-0 |
platina(IV)nitraat/salpeterzuuroplossing |
|
432-400-1 |
— |
C; R35 N; R50-53 |
C; N R: 35-50/53 S: (1/2-)26-36/37/39-45-60-61 |
|
|
082-012-00-6 |
barium calcium cesium lood samarium strontium bromide chloride fluoride jodide europium-gedoteerd |
|
431-780-4 |
199876-46-5 |
Xn; R22-48/22 N; R51-53 |
Xn; N R: 22-48/22-51/53 S: (2-)22-36-61 |
|
|
601-080-00-5 |
mengsel van: sec-butylfenyl(fenyl)methaan, mengsel van isomeren; 1-(sec-butylfenyl(fenyl)-2-fenylethaan, mengsel van isomeren; 1-(sec-butylfenyl-1-fenylethaan, mengsel van isomeren |
|
431-100-6 |
— |
N; R50-53 |
N R: 50/53 S: 60-61 |
|
|
601-081-00-0 |
cyclohexadeca-1,9-dieen |
|
431-730-1 |
4277-06-9 |
Xi; R38 R43 R53 |
Xi R: 38-43-53 S: (2-)36/37-61 |
|
|
601-082-00-6 |
mengsel van: endo-2-methyl-exo-3-methyl-exo-2-[(exo-3-methylbicyclo[2.2.1]hept-exo-2-yl)methyl]bicyclo[2.2.1]heptaan; exo-2-methyl-exo-3-methyl-endo-2-[(endo-3-methylbicyclo[2.2.1]hept-exo-2-yl)methyl]bicyclo[2.2.1]heptaan |
|
434-420-4 |
— |
Xi; R38-41 N; R50-53 |
Xi; N R: 38-41-50/53 S: (2-)23-26-37/39-57-60-61 |
|
|
601-083-00-1 |
5-endo-hexylbicyclo[2.2.1]hept-2-een |
|
435-000-3 |
22094-83-3 |
Xn; R65 Xi; R38 R53 |
Xn R: 38-65-53 S: (2-)37-62-61 |
|
|
601-084-00-7 |
mengsel van: 5-endo-butylbicyclo[2.2.1]hept-2-een; 5-exo-butylbicyclo[2.2.1]hept-2-een (80:20) |
|
435-180-3 |
— |
Xn; R65 Xi; R38 N; R50-53 |
Xn; N R: 38-65-50/53 S: (2-)37-62-60-61 |
|
|
602-105-00-2 |
natrium-1,1,2,2,3,3,4,4,4-nonafluor-1-butaansulfinaat |
|
422-100-7 |
102061-82-5 |
Xi; R41 R43 |
Xi R: 41-43 S: (2-)24-26-37/39 |
|
|
602-106-00-8 |
2-broom-4,6-difluoraniline |
|
429-430-0 |
444-14-4 |
Xn; R22 N; R51-53 |
Xn; N R: 22-51/53 S: (2-)25-61 |
|
|
602-107-00-3 |
3,3,4,4-tetrafluor-4-joodbut-1-een |
|
439-500-2 |
33831-83-3 |
Xn; R22 Xi; R38 N; R51-53 |
Xn; N R: 22-38-51/53 S: (2-)37-61 |
|
|
602-108-00-9 |
(2,3,5,6-tetrafluorfenyl)methanol |
|
443-840-7 |
4084-38-2 |
Xn; R22 Xi; R36 R43 |
Xn R: 22-36-43 S: (2-)26-36/37 |
|
|
603-211-00-1 |
2,3-epoxypropyltrimethylammoniumchloride …%; glycidyltrimethylammoniumchloride …% |
B E |
221-221-0 |
3033-77-0 |
Carc. Cat. 2; R45 Muta. Cat. 3; R68 Repr. Cat. 3; R62 Xn; R21/22-48/22 Xi; R41 R43 R52-53 |
T R: 45-21/22-41-43-48/22-62-68-52/53 S: 53-45-61 |
|
|
603-212-00-7 |
1,3,4,6,7,8-hexahydro-4,6,6,7,8,8-hexamethylindeno[5,6-c]pyraan; galaxolide; (HHCB) |
|
214-946-9 |
1222-05-5 |
N; R50-53 |
N R: 50/53 S: 60-61 |
|
|
603-213-00-2 |
2-methoxy-2-methylbutaan; tert-amylmethylether |
|
213-611-4 |
994-05-8 |
F; R11 Xn; R22 R67 |
F; Xn R: 11-22-67 S: (2-)9-16-23-33 |
|
|
603-214-00-8 |
1,1-diisopropoxycyclohexaan |
|
413-740-8 |
1132-95-2 |
C; R34 |
C R: 34 S: (1/2-)23-26-36/37/39-45 |
|
|
603-215-00-3 |
1-hydroxy-4-fluor-1,4-diazoniabicyclo[2.2.2]octaanbis(tetrafluorboraat) |
|
418-330-2 |
162241-33-0 |
E; R2 Xn; R22-48/22 Xi; R41 R43 N; R50-53 |
E; Xn; N R: 2-22-41-43-48/22-50/53 S: (2-)22-26-36/37/39-60-61 |
|
|
603-216-00-9 |
cis-1-amino-2,3-dihydro-1H-indeen-2-ol |
|
422-660-2 |
7480-35-5 |
Xi; R41 R43 R52-53 |
Xi R: 41-43-52/53 S: (2-)24-26-37/39-61 |
|
|
603-217-00-4 |
2,4,6-tri-tert-butylfenyl-2-butyl-2-ethyl-1,3-propaandiolfosfiet |
|
423-560-1 |
161717-32-4 |
R43 R53 |
Xi R: 43-53 S: (2-)24-37/39-61 |
|
|
603-220-00-0 |
1-{benzyl[2-(2-methoxyfenoxy)ethyl]amino}-3-(9H-carbazol-4-yloxy)propaan-2-ol |
|
432-890-5 |
72955-94-3 |
R53 |
R: 53 S: 61 |
|
|
603-221-00-61 |
1-(2-amino-5-chloorfenyl)-2,2,2-trifluor-1,1-ethaandiol hydrochloride; [met < 0,1 % 4-chlooraniline (EC-nr. 203-401-0)] |
|
433-580-2 |
214353-17-0 |
Xn; R22 C; R34 N; R51-53 |
C; N R: 22-34-51/53 S: (1/2-)26-36/37/39-45-61 |
|
|
603-221-01-3 |
1-(2-amino-5-chloorfenyl)-2,2,2-trifluor-1,1-ethaandiol hydrochloride; [met ≥ 0,1 % 4-chlooraniline (EC-nr. 203-401-0)] |
E |
433-580-2 |
214353-17-0 |
Carc. Cat. 2; R45 Xn; R22 C; R34 N; R51-53 |
T; N R: 45-22-34-51/53 S: 53-45-61 |
|
|
603-222-00-1 |
(2R,3S,4R,5R,7R,9R,10R,11S,12S,13R)-10-[(4-dimethylamino-3-brohydroxy-6-methyltetrahydropyraan-2-yl)oxy]-2-ethyl-3,4,12-trihydroxy-9-methoxy-3,5,7,9,11,13-hexamethyl-6,14-oxo-1-oxacyclotetradecaan |
|
433-820-6 |
118058-74-5 |
Xi; R36 |
Xi R: 36 S: (2-)26 |
|
|
603-223-00-7 |
2-cyclopentylideencyclopentanol; 1,1′-bi(cyclopentylideen)-2-ol |
|
434-270-1 |
6261-30-9 |
Xi; R38-41 R52-53 |
Xi R: 38-41-52/53 S: (2-)26-37/39-61 |
|
|
603-224-00-2 |
3-ethoxy-1,1,1,2,3,4,4,5,5,6,6,6-dodecafluor-2-(trifluormethyl)hexaan |
|
435-790-1 |
297730-93-9 |
R53 |
R: 53 S: 61 |
|
|
603-225-00-8 |
erytromycine A9-oxime (E); (3R,4S,5S,6R,7R,9R,11R,12R,13S,14R)-4-((2,6-didesoxy-3-C-methyl-3-O-methyl-α-L-ribohexopiranosyl)oxy)-14-ethyl-7,12,13-trihydroxy-3,5,7,9,11,13-hexamethyl-6-((3,4,6-tridesoxy-3-dimethylamino-β-D-xylohexapiranosyl)oxy)oxacyclotetradecaan-2-on-10-oxime (E) |
|
437-070-0 |
13127-18-9 |
N; R51-53 |
N R: 51/53 S: 61 |
|
|
603-226-00-3 |
4,4′-(4-(4-methoxyfenyl)-1,3,5-triazine-2,4-diyl)bisbenzeen-1,3-diol |
|
444-500-0 |
1440-00-2 |
R52-53 |
R: 52/53 S: 61 |
|
|
603-227-00-9 |
α-hydro-ω-[[[(1,1-dimethylethyl)dioxy]carbonyl]oxy]poly[oxy(methyl-1,2-ethaandiyl)], ether met 2,2-bis(hydroxymethyl)propaan-1,3-diol (4:1); reactieproduct van: α-hydro-ω-((chloorcarbonyl)oxy)poly(oxy(methyl-1,2-ethaandiyl)), ether met 2,2-bis(hydroxymethyl)propaan-1,3-diol, met kalium-1,1-dimethylethylperoxalaat |
|
445-060-2 |
203574-04-3 |
O; R7 N; R50-53 |
O; N R: 7-50/53 S: (2-)3/7-14-36/37/39-60-61 |
|
|
603-228-00-4 |
(+/-)-(R*,R*)-6-fluor-3,4-dihydro-2-oxiranyl-2H-1-benzopyraan; 6-fluor-2-(2-oxiranyl)chromaan |
|
419-620-1 |
— |
R43 N; R51-53 |
Xi; N R: 43-51/53 S: (2-)36/37-61 |
|
|
603-229-00-X |
natrium-(Z)-3-chloor-3-(4-chloorfenyl)-1-hydroxy-2-propeen-1-sulfonaat |
|
420-800-7 |
— |
Xi; R38-41 R43 N; R50-53 |
Xi; N R: 38-41-43-50/53 S: (2-)24-26-37/39-60-61 |
|
|
603-230-00-5 |
2,6,6,7,8,8-hexamethyldecahydro-2H-indeno[4,5-b]furaan |
|
440-030-5 |
— |
Xi; R38-41 R53 |
Xi R: 38-41-53 S: (2-)26-37/39-61 |
|
|
603-231-00-0 |
(S)-1,1-difenylpropaan-1,2-diol |
|
443-220-6 |
— |
R52-53 |
R: 52/53 S: 22-61 |
|
|
603-232-00-6 |
3,3,8,8,10,10-hexamethyl-9-[1-(4-oxiranylmethoxyfenyl)ethoxy]-1,5-dioxa-9-azaspiro[5.5]undecaan |
|
444-420-6 |
— |
R53 |
R: 53 S: 61 |
|
|
603-233-00-1 |
mengsel van: 4-(1,3a,4,6,7,7a-hexahydro-4,7-methanoindeen-5-ylideen)-3-methylbutaan-2-ol; 4-(3,3a,4,6,7,7a-hexahydro-4,7-methanoindeen-5-ylideen)-3-methylbutaan-2-ol; 1-(1,3a,4,6,7,7a-hexahydro-4,7-methanoindeen-5-ylideen)pentaan-3-ol; 1-(3,3a,4,6,7,7a-hexahydro-4,7-methanoindeen-5-ylideen)pentaan-3-ol; (E)-4-(3a,4,5,6,7,7a-hexahydro-1H-4,7-methanoindeen-5-yl)-3-methylbut-3-een-2-ol; (E)-4-(3a,4,5,6,7,7a-hexahydro-3H-4,7-methanoindeen-5-yl)-3-methylbut-3-een-2-ol |
|
444-430-0 |
— |
N; R51-53 |
N R: 51/53 S: 61 |
|
|
603-234-00-7 |
(1R,4R)-4-methoxy-2,2,7,7-tetramethyltricyclo[6.2.1.0(1,6)]undec-5-een |
|
444-480-3 |
— |
Xi; R38 N; R51-53 |
Xi; N R: 38-51/53 S: (2-)37-61 |
|
|
604-074-00-0 |
tetrabroombisfenol-A; 2,2′,6,6′-tetrabroom-4,4′-isopropylideendifenol |
|
201-236-9 |
79-94-7 |
N; R50-53 |
N R: 50/53 S: 60-61 |
|
|
604-075-00-6 |
4-(1,1,3,3-tetramethylbutyl)fenol; 4-tert-octylfenol |
|
205-426-2 |
140-66-9 |
Xi; R38-41 N; R50-53 |
Xi; N R: 38-41-50/53 S: (2-)26-37/39-60-61 |
C ≥ 20 %: Xi, N; R38-41-50/53 10 % ≤ C < 20 %: Xi, N; R41-50/53 5 % ≤ C < 10 %: Xi, N; R36-50/53 2,5 % ≤ C < 5 %: N; R50/53 0,25 % ≤ C < 2,5 %: N; R51/53 0,025 % ≤ C < 0,25 %: R52/53 |
|
604-076-00-1 |
fenolftaleïne |
|
201-004-7 |
77-09-8 |
Carc. Cat. 2; R45 Muta. Cat. 3; R68 Repr. Cat. 3; R62 |
T R: 45-62-68 S: 53-45 |
C ≥ 5 %: T; R45-62-68 1 % ≤ C < 5 %: T; R45-68 |
|
604-077-00-7 |
2-benzotriazool-2-yl-4-methyl-6-(2-methylallyl)fenol |
|
419-750-9 |
98809-58-6 |
R53 |
R: 53 S: 61 |
|
|
604-079-00-8 |
4,4′-(1,3-fenyleenbis(1-methylethylideen))bisfenol |
|
428-970-4 |
13595-25-0 |
Repr.Cat.3; R62 R43 N; R51-53 |
Xn; N R: 43-62-51/53 S: (2-)22-36/37-61 |
|
|
604-080-00-3 |
4-fluor-3-trifluormethylfenol |
|
432-560-0 |
61721-07-1 |
Xn; R20 C; R35 R43 N; R51-53 |
C; N R: 20-35-43-51/53 S: (1/2-)26-28-36/37/39-45-61 |
|
|
604-081-00-9 |
1,1-bis(4-hydroxyfenyl)-1-fenylethaan |
|
433-130-5 |
1571-75-1 |
N; R50-53 |
N R: 50/53 S: 25-60-61 |
|
|
604-082-00-4 |
2-chloor-6-fluorfenol |
E |
433-890-8 |
2040-90-6 |
Muta.Cat.2; R46 Repr.Cat.3; R62 Xn; R22 C; R34 R43 N; R51-53 |
T; N R: 46-22-34-43-62-51/53 S: 53-45-61 |
|
|
604-083-00-X |
4,4′-sulfonylbisfenol, polymeer met ammoniumchloride (NH4Cl), pentachloorfosforaan en fenol |
|
439-270-3 |
260408-02-4 |
R53 |
R: 53 S: 61 |
|
|
604-084-00-5 |
1-ethoxy-2,3-difluorbenzeen |
|
441-000-4 |
121219-07-6 |
Xn; R22 R52-53 |
Xn R: 22-52/53 S: (2-)23-61 |
|
|
604-087-00-1 |
mengsel van: 1,2-naftochinondiazide-5-sulfonylchloride (of -sulfonzuur), monoester met 4,4′-(1-(4-(1-(4-hydroxyfenyl)-1-methylethyl)fenyl)ethylideen)bisfenol; 1,2-naftochinondiazide-5-sulfonylchloride (of -sulfonzuur), diester met 4,4′-(1-(4-(1-(4-hydroxyfenyl)-1-methylethyl)fenyl)ethylideen)bisfenol; 1,2-naftochinondiazide-5-sulfonylchloride (of -sulfonzuur), triester met 4,4′-(1-(4-(1-(4-hydroxyfenyl)-1-methylethyl)fenyl)ethylideen)bisfenol |
|
433-640-8 |
— |
F; R17 R44 R53 |
F R: 17-44-53 S: (2-)15-22-61 |
|
|
604-089-00-2 |
2-methyl-5-tert-butylthiofenol |
|
444-970-7 |
— |
R10 Repr.Cat.3; R63 Xn; R48/20/22-65 Xi; R36/38 R43 R67 N; R50-53 |
Xn; N R: 10-36/38-43-48/20/22-63-65-67-50/53 S: (2-)26-36/37-62-60-61 |
|
|
605-037-00-1 |
trans-3-[2-(7-chloor-2-chinolinyl)vinyl]benzaldehyde; 3-[(E)-2-(7-chloor-2-chinolinyl)vinyl]benzaldehyde |
|
421-800-1 |
120578-03-2 |
R53 |
R: 53 S: 22-61 |
|
|
605-038-00-7 |
5-fenyl-3-methylpentaan-1-al |
|
433-900-0 |
55066-49-4 |
Xn; R22 Xi; R38 R43 N; R51-53 |
Xn; N R: 22-38-43-51/53 S: (2-)36/37-61 |
|
|
605-039-00-2 |
3,4-dihydroxy-5-nitrobenzaldehyde |
|
441-810-8 |
116313-85-0 |
Xn; R22 Xi; R41 R43 |
Xn R: 22-41-43 S: (2-)22-24-26-37/39 |
|
|
606-124-00-7 |
1-cyclopropyl-3-(2-methylthio-4-trifluormethylfenyl)-1,3-propaandion |
|
421-080-7 |
161462-35-7 |
Xn; R48/22 N; R50-53 |
Xn; N R: 48/22-50/53 S: (2-)36-60-61 |
|
|
606-125-00-2 |
1-benzylimidazolidine-2,4-dion |
|
421-340-1 |
6777-05-5 |
Xn; R22 |
Xn R: 22 S: (2-)22 |
|
|
606-126-00-8 |
1,4-bis(2,3-dihydroxypropylamino)antrachinon |
|
421-470-7 |
99788-75-7 |
N; R51-53 |
N R: 51/53 S: 61 |
|
|
606-128-00-9 |
2,2′-(1,3-fenyleen)bis[5-chloor-1H-isoindool]-1,3(2H)-dion |
|
422-650-8 |
148935-94-8 |
R53 |
R: 53 S: 61 |
|
|
606-129-00-4 |
5-amino-[2S-di(methylfenyl)amino]-1,6-difenyl-4Z-hexeen-3-on; (2S,4Z)-5-amino-2-(dibenzylamino)-1,6-difenylhex-4-een-3-on |
|
423-090-7 |
156732-13-7 |
R53 |
R: 53 S: 61 |
|
|
606-130-00-X |
4-(1,4-dioxaspiro[4.5]dec-8-yl)cyclohexanon |
|
423-860-2 |
56309-94-5 |
R43 R52-53 |
Xi R: 43-52/53 S: (2-)24-37-61 |
|
|
606-131-00-5 |
cyclisch 3-(1,2-ethaandiylacetaal)oestra-5(10),9(11)-dieen-3,17-dion |
E |
427-230-8 |
5571-36-8 |
Repr. Cat. 2; R60 Xn; R48/22 N; R51-53 |
T; N R: 60-48/22-51/53 S: 53-45-61 |
|
|
606-132-00-0 |
(6β)-6,19-epoxyandrost-4-een-3,17-dion |
|
433-490-3 |
6563-83-3 |
R43 R52-53 |
Xi R: 43-52/53 S: (2-)24-37-61 |
|
|
606-134-00-1 |
androsta-1,4,9(11)-trieen-3,17-dion |
|
433-560-3 |
15375-21-0 |
Repr. Cat.3; R62 |
Xn R: 62 S: (2-)22-36/37 |
|
|
606-135-00-7 |
cyclohexadecanon |
|
438-930-8 |
2550-52-9 |
R53 |
R: 53 S: 61 |
|
|
606-136-00-2 |
(3S,6R,9S,12R,15S,18R,21S,24R)-6,18-dibenzyl-3,9,15,21-tetraisobutyl-4,10,12,16,22,24-hexamethyl-1,7,13,19-tetraoxa-4,10,16,22-tetraazacyclotetracosaan-2,5,8,11,14,17,20,23-octaon |
|
444-350-6 |
133413-70-4 |
Xi; R36 R53 |
Xi R: 36-53 S: (2-)26-61 |
|
|
606-137-00-8 |
trans-7,7′-dimethyl-(4H,4H′)-(2,2′)bi[benzo[1,4]thiazinylideen]-3,3′-dion |
|
444-750-0 |
211387-26-7 |
R53 |
R: 53 S: 22-61 |
|
|
606-138-00-3 |
(2-butyl-5-nitrobenzofuraan-3-yl)[4-(3-dibutylaminopropoxy)fenyl]methanon |
|
444-800-1 |
141645-23-0 |
R10 Xn; R22-48/22 Xi; R38-41 R43 N; R50-53 |
Xn; N R: 10-22-38-41-43-48/22-50/53 S: (2-)23-26-36/37/39-60-61 |
C ≥ 25 %: Xn, N; R22-38-41-43-48/22-50/53 20 % ≤ C < 25 %: Xn, N; R38-41-43-48/22-50/53 10 % ≤ C < 20 %: Xn, N; R41-43-48/22-50/53 5 % ≤ C < 10 %: Xi, N; R36-43-50/53 2,5 % ≤ C < 5 %: Xi, N; R43-50/53 1 % ≤ C < 2,5 %: Xi, N; R43-51/53 0,25 % ≤ C < 1 %: N; R51/53 0,025 % ≤ C < 0,25 %: R52/53 |
|
606-139-00-9 |
(S)-4-(3,4-dichloorfenyl)-3,4-dihydro-2H-naftaleen-1-on |
|
444-830-5 |
124379-29-9 |
R53 |
R: 53 S: 61 |
|
|
606-140-00-4 |
2-hydroxy-1-(4-(4-(2-hydroxy-2-methylpropionyl)benzyl)fenyl)-2-methylpropaan-1-on |
|
444-860-9 |
474510-57-1 |
Xn; R48/22 N; R50-53 |
Xn; N R: 48/22-50/53 S: (2-)22-36-60-61 |
|
|
606-141-00-X |
natrium-3-(methoxycarbonyl)-4-oxo-3,4,5,6-tetrahydro-2-pyridinolaat |
|
418-410-7 |
— |
Xi; R36 |
Xi R: 36 S: (2-)26 |
|
|
606-142-00-5 |
mengsel van: (1RS,2SR,7SR,8SR,E)-9 en 10-ethylideen-3-oxatricyclo[6.2.1.0(2,7)]undecaan-4-on; (1RS,2SR,7SR,8SR,Z)-10-ethylideen-3-oxatricyclo[6.2.1.0(2,7)]undecaan-4-on; (1RS,2SR,7SR,8SR,Z)-9-ethylideen-3-oxatricyclo[6.2.1.0(2,7)]undecaan-4-on |
|
434-290-9 |
— |
Xn; R22 N; R51-53 |
Xn; N R: 22-51/53 S: (2-)61 |
|
|
607-580-00-X |
ethyl-7-chloor-1-(2,4-difluorfenyl)-6-fluor-1,4-dihydro-4-oxo-1,8-naftyridine-3-carboxylaat |
|
422-360-1 |
100491-29-0 |
R43 N; R51-53 |
Xi; N R: 43-51/53 S: (2-)22-24-37-61 |
|
|
607-618-00-5 |
menadionnatriumbisulfiet; 1,2,3,4-tetrahydro-2-methyl-1,4-dioxonaftaleen-2-sulfonzuur, natriumzout |
|
204-987-0 |
130-37-0 |
Xi; R36/38 N; R50-53 |
Xi; N R: 36/38-50/53 S: (2-)24/25-60-61 |
|
|
607-619-00-0 |
menadionnicotinamidebisulfiet; 1,2,3,4-tetrahydro-2-methyl-1,4-dioxonaftaleen-2-sulfonzuur, verbinding met nicotinamide (1:1) |
|
277-543-7 |
73581-79-0 |
Xi; R36/38 N; R50-53 |
Xi; N R: 36/38-50/53 S: (2-)24/25-60-61 |
|
|
607-620-00-6 |
trinatriumnitrilotriacetaat |
|
225-768-6 |
5064-31-3 |
Carc. Cat. 3; R40 Xn; R22 Xi; R36 |
Xn R: 22-36-40 S: (2-)26-36/37-46 |
C ≥ 25 %: Xn; R22-36-40 20 ≤ % C < 25 %: Xn; R36-40 5 ≤ % C < 20 %: Xn; R40 |
|
607-621-00-1 |
milbemectin (ISO); [mengsel van milbemycine A3 (CAS-nr. 51596-10-2) en milbemycine A4 (CAS-nr. 51596-11-3) (30:70)] |
|
— |
— |
Xn; R20/22 N; R50-53 |
Xn; N R: 20/22-50/53 S: (2-)46-60-61 |
C ≥ 25 %: Xn, N; R20/22-50/53 0,25 % ≤ C < 25 %: N; R50/53 0,025 % ≤ C < 0,25 %: N; R51/53 0,0025 % ≤ C < 0,025 %: R52/53 |
|
607-622-00-7 |
2-ethylhexyl-2-ethylhexanoaat |
|
231-057-1 |
7425-14-1 |
Repr. Cat. 3; R63 |
Xn R: 63 S: (2-)36/37 |
|
|
607-623-00-2 |
diisobutylftalaat |
|
201-553-2 |
84-69-5 |
Repr. Cat. 2; R61 Repr. Cat. 3; R62 |
T R: 61-62 S: 53-45 |
C ≥ 25 %: T; R61-62 5 % ≤ C < 25 %: Xn; R62 |
|
607-624-00-8 |
perfluoroctaansulfonzuur; heptadecafluoroctaan-1-sulfonzuur; [1] kaliumperfluoroctaansulfonaat; kaliumheptadecafluoroctaan-1-sulfonaat; [2] diethanolamineperfluoroctaansulfonaat; [3] ammoniumperfluoroctaansulfonaat; ammoniumheptadecafluoroctaansulfonaat; [4] lithiumperfluoroctaansulfonaat; lithiumheptadecafluoroctaansulfonaat [5] |
E |
217-179-8 [1] 220-527-1 [2] 274-460-8 [3] 249-415-0 [4] 249-644-6 [5] |
1763-23-1 [1] 2795-39-3 [2] 70225-14-8 [3] 29081-56-9 [4] 29457-72-5 [5] |
Carc. Cat. 3; R40 Repr. Cat. 2; R61 T; R48/25 Xn; R20/22 R64 N; R51-53 |
T; N R: 61-20/22-40-48/25-64-51/53 S: 53-45-61 |
|
|
607-625-00-3 |
clodinafop-propargyl (ISO) |
|
— |
105512-06-9 |
Xn; R22-48/22 R43 N; R50-53. |
Xn; N R: 22-43-48/22-50/53 S: (2-)24-36/37-46-60-61 |
C ≥ 25 %: Xn, N; R22-43-48/22-50/53 10 % ≤ C < 25 %: Xn, N; R43-48/22-51/53 2,5 % ≤ C < 10 %: Xi, N; R43-51/53 0,25 % ≤ C < 2,5 %: Xi; R43-52/53 0,001 % ≤ C < 0,25 %: Xi; R43 |
|
607-626-00-9 |
ethyl-1-(2,4-dichloorfenyl)-5-(trichloormethyl)-1H-1,2,4-triazool-3-carboxylaat |
|
401-290-5 |
103112-35-2 |
Carc.Cat.2; R45 N; R50-53 |
T; N R: 45-50/53 S: 53-45-60-61 |
|
|
607-627-00-4 |
[(4S,5S)-4-benzyl-2-oxo-5-oxazolidinyl]methyl-4-nitrobenzeensulfonaat |
|
416-360-0 |
162221-28-5 |
R43 |
Xi R: 43 S: (2-)22-24-37 |
|
|
607-628-00-X |
4-oxo-4-(p-tolyl)boterzuur, adduct met 4-ethylmorfoline |
|
419-240-6 |
171054-89-0 |
Xi; R41 |
Xi R: 41 S: (2-)26-39 |
|
|
607-629-00-5 |
[[2-methyl-1-(1-oxopropoxy)propoxy](4-fenylbutyl)fosfinyl]azijnzuur |
|
419-270-1 |
123599-82-6 |
Xi; R36 |
Xi R: 36 S: (2-)26 |
|
|
607-630-00-0 |
acrylzuur, 3-(trimethoxysilyl)propylester |
|
419-560-6 |
4369-14-6 |
Xn; R20 C; R34 R43 R52-53 |
C R: 20-34-43-52/53 S: (1/2-)26-36/37/39-45-61 |
|
|
607-631-00-6 |
mengsel van: 2-(2-((oxo(fenyl)acetyl)oxy)ethoxy)ethyloxo(fenyl)acetaat; (2-(2-hydroxyethoxy)ethyl)oxo(fenyl)acetaat |
|
442-300-8 |
— |
R43 |
Xi R: 43 S: (2-)24-37 |
|
|
607-632-00-1 |
N-[3-(2,4-di(1,1-dimethylpropyl)fenoxy)propyl]-1-hydroxy-5-(2-methylpropyloxycarbonylamino)naftamide |
|
420-210-1 |
111244-14-5 |
R53 |
R: 53 S: 61 |
|
|
607-633-00-7 |
trinatrium-5-{[4-chloor-6-(1-naftylamino)-1,3,5-triazine-2-yl]amino}-4-hydroxy-3-[(E)-(4-methoxy-2-sulfonatofenyl)diazenyl]-2,7-naftaleendisulfonaat |
|
440-480-2 |
341026-59-3 |
Xi; R41 R43 |
Xi R: 41-43 S: (2-)22-24-26-37/39 |
|
|
607-634-00-2 |
(S)-(-)-2-acetoxypropionylchloride; (1S)-2-chloor-1-methyl-2-oxoethylacetaat |
|
420-610-4 |
36394-75-9 |
Xn; R22 C; R34 R43 |
C R: 22-34-43 S: (1/2-)23-26-36/37/39-45 |
|
|
607-635-00-8 |
trinatrium-N-(3-propionato)-L-aspartaat |
|
422-090-4 |
172737-80-3 |
Xi; R41 |
Xi R: 41 S: (2-)26-39 |
|
|
607-636-00-3 |
1-broom-2-methylpropylpropionaat |
|
422-900-6 |
158894-67-8 |
R10 Carc.Cat.3; R40 C; R34 R43 |
C R: 10-34-40-43 S: (1/2-)7/9-8-23-26-36/37/39-45 |
|
|
607-637-00-9 |
dinatrium-8-amino-5-{4-[2-(sulfonatoethoxy)sulfonyl]fenylazo}naftaleen-2-sulfonaat |
|
423-730-5 |
250688-43-8 |
Xi; R41 |
Xi R: 41 S: (2-)26-39 |
|
|
607-638-00-4 |
2-hydroxybenzoëzuur, 2-butyloctylester |
|
431-090-3 |
190085-41-7 |
R53 |
R: 53 S: 61 |
|
|
607-639-00-X |
2-(2-oxo-5-(1,1,3,3-tetramethylbutyl)-2,3-dihydro-1-benzofuraan-3-yl)-4-(1,1,3,3-tetramethylbutyl)fenylacetaat |
|
431-770-1 |
216698-07-6 |
R53 |
R: 53 S: 61 |
|
|
607-641-00-0 |
2-(formylamino)-3-thiofeencarbonzuur; 2-formamido-3-thiofeencarbonzuur |
|
431-930-9 |
43028-69-9 |
Xn; R22 R43 |
Xn R: 22-43 S: (2-)22-24-37 |
|
|
607-642-00-6 |
3,6,9-trithiaundecamethyleen-1,11-dimethacrylaat |
|
432-210-7 |
141631-22-3 |
N; R50-53 |
N R: 50/53 S: 60-61 |
|
|
607-643-00-1 |
dimethyl (2S)-2-hydroxysuccinaat |
|
432-310-0 |
617-55-0 |
R10 Xi; R41 R43 |
Xi R: 10-41-43 S: (2-)24-26-37/39-43 |
|
|
607-644-00-7 |
methyl-2,2-dimethyl-6-methyleencyclohexaancarboxylaat |
|
432-350-9 |
81752-87-6 |
Xi; R38 |
Xi R: 38 S: (2-)37 |
|
|
607-645-00-2 |
tetranatrium-2-(4-fluor-6-(methyl(2-(sulfatoethylsulfonyl)ethyl)amino)-1,3,5-triazine-2-ylamino)-5-hydroxy-6-(4-methyl-2-sulfonatofenylazo)naftaleen-1,7-disulfonaat |
|
432-550-6 |
243858-01-7 |
Xi; R41 |
Xi R: 41 S: (2-)22-26-39 |
|
|
607-646-00-8 |
D-erytro-hexaanzuur, 2,4-dideoxy-3,5-O-(1-methylethylideen)-1,1-dimethylethylester; tert-butyl-2-[(4R,6S)-6-(hydroxymethyl)-2,2-dimethyl-1,3-dioxaan-4-yl]acetaat |
|
432-960-5 |
124655-09-0 |
Xn; R22 |
Xn R: 22 S: (2-)25 |
|
|
607-647-00-3 |
5-acetoxy-2-(R,S)-butyryloxymethyl-1,3-oxathiolaan |
|
433-530-1 |
143446-73-5 |
Xn; R22 R43 N; R50 |
Xn; N R: 22-43-50 S: (2-)24-37-57-61 |
|
|
607-649-00-4 |
[3-(chloorcarbonyl)-2-methylfenyl]acetaat |
|
433-690-0 |
167678-46-8 |
C; R35 R43 |
C R: 35-43 S: (1/2-)7/8-26-36/37/39-45 |
|
|
607-650-00-X |
2-methyl-1,5-pentaandiamine-1,3-benzeendicarboxylaat |
|
433-910-5 |
145153-52-2 |
R43 |
Xi R: 43 S: (2-)24-37 |
|
|
607-651-00-5 |
natrium-2-(nonanoyloxy)benzeensulfonaat |
|
434-360-9 |
91125-43-8 |
Xi; R41 R43 |
Xi R: 41-43 S: (2-)24-26-37/39 |
|
|
607-652-00-0 |
ethyl-N 2-dodecanoyl-L-argininaat hydrochloride |
|
434-630-6 |
60372-77-2 |
Xi; R41 N; R50 |
Xi; N R: 41-50 S: (2-)26-39-61 |
|
|
607-653-00-6 |
tetrakis(bis(2-hydroxyethyl)methylammonium)-3-(4-(7-acetylamino-1-hydroxy-3-sulfonatonaftaleen-2-ylazo)-5-methoxy-2-sulfonatofenylazo)-7-(4-amino-3-sulfonatofenylamino)-4-hydroxynaftaleen-2-sulfonaat |
|
434-840-8 |
225786-91-4 |
N; R51-53 |
N R: 51/53 S: 61 |
|
|
607-654-00-1 |
(S)-3-hydroxy-γ-butyrolacton |
|
434-990-4 |
7331-52-4 |
R43 |
Xi R: 43 S: (2-)23-24-37 |
|
|
607-655-00-7 |
ethyl-6,8-dichlooroctanoaat |
|
435-080-1 |
1070-64-0 |
R43 N; R51-53 |
Xi; N R: 43-51/53 S: (2-)24-37-61 |
|
|
607-656-00-2 |
natriumzout van 4-amino-3,6-bis[[5-[[4-chloor-6-[(2-methyl-4-sulfofenyl)amino]-1,3,5-triazine-2-yl]amino]-2-sulfofenyl]azo]-5-hydroxy-2,7-naftaleendisulfonzuur |
|
435-350-7 |
141250-43-3 |
Xi; R41 R52-53 |
Xi R: 41-52/53 S: (2-)22-26-39-61 |
|
|
607-657-00-8 |
pentanatrium-7-(4-(4-(3-(2-sulfatoethaansulfonyl)fenylamino)-6-(4-(2-sulfatoethaansulfonyl)fenylamino)-1,3,5-triazine-2-ylamino)-2-ureidofenylazo)naftaleen-1,3,6-trisulfonaat |
|
436-920-8 |
172399-10-9 |
Xi; R41 |
Xi R: 41 S: (2-)22-26-39 |
|
|
607-658-00-3 |
3,10-diamino-6,13-dichloor-2-((6-(((4-(1,1-dimethylethyl)fenyl)sulfonyl)amino)-2-naftalenyl)sulfonyl)-4,11-trifenodioxazinedisulfonzuur, lithiumkaliumnatriumzout |
|
440-770-9 |
371921-63-0 |
Xi; R41 R52-53 |
Xi R: 41-52/53 S: (2-)26-39-61 |
|
|
607-659-00-9 |
pentanatrium-N-[5-[[4-[[3-[(aminocarbonyl)amino]-4-[(3,6,8-trisulfonatonaftaleen-2-yl)azo]fenyl]amino]-6-chloor-1,3,5-triazine-2-yl]amino]-2-sulfonato-4-[[4-[[-2-(oxysulfonato)ethyl]sulfonyl]fenyl]azo]fenyl]-3-aminopropaanzuur |
|
442-030-0 |
321912-47-4 |
Xi; R41 |
Xi R: 41 S: (2-)22-26-39 |
|
|
607-660-00-4 |
2-{4-[4-[4-fluor-6-(2-(2-vinylsulfonylethoxy)ethylamino)-1,3,5-triazine-2-ylamino]fenylazo]fenylazo}naftaleen-4,6,8-trisulfonzuur, trinatriumzout |
|
442-230-8 |
321679-52-1 |
Xi; R41 |
Xi R: 41 S: (2-)22-26-39 |
|
|
607-661-00-X |
1,1-dimethylethyl-4′-(broommethyl)bifenyl-2-carboxylaat |
|
442-850-9 |
114772-40-6 |
R43 R53 |
Xi R: 43-53 S: (2-)22-24-37-61 |
|
|
607-662-00-5 |
methyl-2-(acetylamino)-3-chloorpropionaat |
|
442-860-3 |
87333-22-0 |
R43 N; R50-53 |
Xi; N R: 43-50/53 S: (2-)24-37-60-61 |
|
|
607-663-00-0 |
bis(2-ethylhexyl)naftaleen-2,6-dicarboxylaat |
|
442-980-6 |
127474-91-3 |
R53 |
R: 53 S: 61 |
|
|
607-664-00-6 |
methyl-2-chloorsulfonyl-4-(methaansulfonylaminomethyl)benzoaat |
|
443-120-2 |
393509-79-0 |
Xi; R41 N; R51-53 |
Xi; N R: 41-51/53 S: (2-)26-39-61 |
|
|
607-665-00-1 |
trans-methyl-2-ethyl-but-2-enoaat |
|
443-150-6 |
101226-85-1 |
R10 |
R: 10 S: 23 |
|
|
607-666-00-7 |
(2S)-5-(benzyloxy)-2-(1,3-dioxo-1,3-dihydro-2H-isoindool-2-yl)-5-oxopentaanzuur |
|
443-560-5 |
88784-33-2 |
Xi; R36 |
Xi R: 36 S: (2-)26 |
|
|
607-667-00-2 |
chloor-1-ethylcyclohexylcarbonaat |
|
444-950-8 |
99464-83-2 |
Muta.Cat.3; R68 R43 |
Xn R: 43-68 S: (2-)23-36/37 |
|
|
607-668-00-8 |
trans-2-isopropyl-5-carboxy-1,3-dioxaan |
|
445-770-2 |
42031-28-7 |
Xi; R41 R52-53 |
Xi R: 41-52/53 S: (2-)22-26-39-61 |
|
|
607-669-00-3 |
methyl(9-acetoxy-3,8,10-triethyl-7,8,10-trimethyl-1,5-dioxa-9-azaspiro[5.5]undec-3-yl)octadecanoaat |
|
445-990-9 |
376588-17-9 |
R43 R53 |
Xi R: 43-53 S: (2-)24-37-61 |
|
|
607-670-00-9 |
dibutyl-3-(4-(5-ammonio-2-butyl)benzofuraan-3-yl)carbonyl)fenoxy)propylammoniumoxalaat; (5-amino-2-butylbenzofuraan-3-yl)[4-(3-dibutylaminopropoxy)fenyl]methanon, dioxalaat |
|
448-700-9 |
500791-70-8 |
Xn; R48/22 Xi; R41 R43 N; R50-53 |
Xn; N R: 41-43-48/22-50/53 S: (2-)22-26-36/37/39-60-61 |
C ≥ 10 %: Xn, N; R41-43-48/22-50/53 5 % ≤ C < 10 %: Xi, N; R36-43-50/53 2,5 % ≤ C < 5 %: Xi, N; R43-50/53 1 % ≤ C < 2,5 %: Xi, N; R43-51/53 0,25 % ≤ C < 1 %: N; R51/53 0,025 % ≤ C < 0,25 %: R52/53 |
|
607-671-00-4 |
diethyl-1,4-cyclohexaandicarboxylaat |
|
417-310-0 |
72903-27-6 |
N; R51-53 |
N R: 51/53 S: 61 |
|
|
607-672-00-X |
mengsel van: 2-hydroxy-3-(methacryloyloxy)propyl(2-benzoyl)benzoaat; 1-hydroxymethyl-2-(methacryloyloxy)ethyl(2-benzoyl)benzoaat; x-hydroxy-y-(methacryloyloxy)propyl(of -ethyl)(2-benzoyl)benzoaat |
|
419-000-0 |
— |
R43 N; R51-53 |
Xi; N R: 43-51/53 S: (2-)24-37-61 |
|
|
607-673-00-5 |
1-ethyl-5,6,7,8-tetrahydrochinoliniumtosylaat |
|
419-570-0 |
— |
Xn; R22 R52-53 |
Xn R: 22-52/53 S: (2-)61 |
|
|
607-674-00-0 |
branched C10-alkyl benzoates |
|
421-090-1 |
131298-44-7 |
Xn; R20 |
Xn R: 20 S: (2-)23 |
|
|
607-675-00-6 |
mengsel van: cis-9-octadeceendizuur; cis-9-cis-12-octadecadieendizuur; hexadecaandizuur; octadecaandizuur |
|
422-260-8 |
— |
Xi; R41 N; R50-53 |
Xi; N R: 41-50/53 S: (2-)26-39-60-61 |
|
|
607-676-00-1 |
mengsel van: 2-methylnonaandizuur; 2,4-dimethyl-4-methoxycarbonylundecaandizuur; 2,4,6-trimethyl-4,6-dimethoxycarbonyltridecaandizuur; 8,9-dimethyl-8,9-dimethoxycarbonylhexadecaandizuur |
|
423-670-1 |
— |
Xi; R41 R43 |
Xi R: 41-43 S: (2-)24-26-37/39 |
|
|
607-677-00-7 |
2,5-dioxopyrrolidine-1-yl-N-{[methyl[[2-(1-methylethyl)-4-thiazolyl]methyl]amino]carbonyl}-L-valinaat |
|
424-660-8 |
— |
Xn; R48/22 Xi; R41 R43 |
Xn R: 41-43-48/22 S: (2-)22-26-36/37/39 |
|
|
607-678-00-2 |
mengsel van: ethyl-(2R,3R)-3-isopropylbicyclo[2.2.1]hept-5-een-2-carboxylaat; ethyl-(2S,3S)-3-isopropylbicyclo[2.2.1]hept-5-een-2-carboxylaat |
|
427-090-8 |
— |
R43 N; R51-53 |
Xi; N R: 43-51/53 S: (2-)23-25-36/37-61 |
|
|
607-679-00-8 |
mengsel van: 3-{5-[3-(4-{1,6-dihydro-2-hydroxy-4-methyl-1-[3-(methylammonio)propyl]-6-oxo-3-pyridylazo}benzamido)fenylazo]-1,2-dihydro-6-hydroxy-4-methyl-2-oxo-1-pyridyl}propyl(methyl)ammoniumdi(acetaat); 3-{5-[4-(3-{1,6-dihydro-2-hydroxy-4-methyl-1-[3-(methylammonio)propyl]-6-oxo-3-pyridylazo}benzamido]fenylazo]-1,2-dihydro-6-hydroxy-4-methyl-2-oxo-1-pyridyl}propyl(dimethyl)ammoniumdi(acetaat); 3-{5-[3-(4-{1-[3-(dimethylammonio)propyl]-1,6-dihydro-2-hydroxy-4-methyl-6-oxo-3-pyridylazo}benzamido)fenylazo]-1,2-dihydro-6-hydroxy-4-methyl-2-oxo-1-pyridyl}propyl(dimethyl)ammoniumdi(acetaat) |
|
431-440-5 |
— |
Xi; R41 N; R51-53 |
Xi; N R: 41-51/53 S: (2-)22-26-39-61 |
|
|
607-680-00-3 |
tert-butyl(6-{2-[4-(4-fluorfenyl)-6-isopropyl-2-[methyl(methylsulfonyl)amino]pyrimidine-5-yl]vinyl}(4S,6S)-2,2-dimethyl[1,3]dioxaan-4-yl)acetaat |
|
432-810-9 |
— |
R53 |
R: 53 S: 61 |
|
|
607-681-00-9 |
mengsel van: 9-nonyl-10-octyl-19-carbonyloxyhexadecylnonadecaanzuur; 9-nonyl-10-octyl-19-carbonyloxyoctadecylnonadecaanzuur; dihexadecyl-9-nonyl-10-octylnonadecaandioaat; 1-octadecyl,19-hexadecyl-9-nonyl-10-octylnonadecaandioaat; dioctadecyl-9-nonyl-10-octylnonadecaandioaat |
|
432-910-2 |
— |
R53 |
R: 53 S: 61 |
|
|
607-682-00-4 |
complex mengsel van Chinese gomhars, post reacted met acrylzuur |
|
434-230-1 |
144413-22-9 |
R53 |
R: 53 S: 61 |
|
|
607-683-00-X |
mengsel van: methyl-3-((1E)-2-methylprop-1-enyl)-2,2-dimethylcyclopropaancarboxylaat; methyl-3-((1Z)-2-methylprop-1-enyl)-2,2-dimethylcyclopropaancarboxylaat (20:80) |
|
435-450-0 |
— |
R43 N; R51-53 |
Xi; N R: 43-51/53 S: (2-)24-37-61 |
|
|
607-684-00-5 |
alkenen, C12-14, hydroformyleringsproducten, destillatieresiduen, C-(waterstofsulfobutaandioaten), dinatriumzouten |
|
435-660-2 |
243662-67-1 |
Xi; R38 R43 |
Xi R: 38-43 S: (2-)24-37 |
|
|
607-685-00-0 |
ammonium-2-cocoyloxyethaansulfonaat |
|
441-050-7 |
— |
Xi; R38-41 |
Xi R: 38-41 S: (2-)26-37/39 |
|
|
607-686-00-6 |
6,6′-bis(diazo-5,5′,6,6′-tetrahydro-5,5′-dioxo)[methyleen-bis(5-(6-diazo-5,6-dihydro-5-oxo-1-naftylsulfonyloxy)-6-methyl-2-fenyleen]di(naftaleen-1-sulfonaat) |
|
441-550-5 |
— |
E; R2 F; R11 Carc. Cat. 3; R40 |
E; Xn R: 2-11-40 S: (2-)7-22-36/37 |
|
|
607-687-00-1 |
mengsel van: 2-{3,6-bis[(2-ethylfenyl)methylamino]xanthylium-9-yl}benzeensulfonaat (2-10 %); 2-{3,6-bis[(2,3-dimethylfenyl)methylamino]xanthylium-9-yl}benzeensulfonaat (2-10 %); 2-{3,6-bis[(2,4-dimethylfenyl)methylamino]xanthylium-9-yl}benzeensulfonaat (2-10 %); 2-{3,6-bis[(2,5-dimethylfenyl)methylamino]xanthylium-9-yl}benzeensulfonaat (2-10 %); 2-{3-[(2,3-dimethylfenyl)methylamino]-6-[(2-ethylfenyl)methylamino]xanthylium-9-yl}benzeensulfonaat (7-20 %); 2-{3-[(2,4-dimethylfenyl)methylamino]-6-[(2-ethylfenyl)methylamino]xanthylium-9-yl}benzeensulfonaat (7-20 %); 2-{3-[(2,5-dimethylfenyl)methylamino]-6-[(2-ethylfenyl)methylamino]xanthylium-9-yl}benzeensulfonaat (7-20 %); 2-{3-[(2,3-dimethylfenyl)methylamino]-6-[(2,4-dimethylfenyl)methylamino]xanthylium-9-yl}benzeensulfonaat (7-20 %); 2-{3-[(2,3-dimethylfenyl)methylamino]-6-[(2,5-dimethylfenyl)methylamino]xanthylium-9-yl}benzeensulfonaat (7-20 %); 2-{3-[(2,4-dimethylfenyl)methylamino]-6-[(2,5-dimethylfenyl)methylamino]xanthylium-9-yl}benzeensulfonaat (7-20 %) |
|
442-800-6 |
— |
Xi; R38 N; R51-53 |
Xi; N R: 38-51/53 S: (2-)37-61 |
|
|
607-688-00-7 |
(R)-1-cyclohexa-1,4-dienyl-1-methoxycarbonylmethylammoniumchloride |
|
444-320-2 |
— |
Xn; R22 |
Xn R: 22 S: (2-) |
|
|
607-689-00-2 |
mengsel van: methyl-1,4-dimethylcyclohexaancarboxylaat („para-isomeer” inclusief cis-en trans-isomeren); methyl-1,3-dimethylcyclohexaancarboxylaat („meta-isomeer” inclusief cis-en trans-isomeren) |
|
444-920-4 |
— |
R52-53 |
R: 52/53 S: 61 |
|
|
607-690-00-8 |
dimethyl[2S,2S′]-6,6,6′6′-tetramethoxy-2,2′-[N,N′-bis(trifluoracetyl)-S,S′-bi(L-homocysteinyl)diimino]dihexanoaat |
|
432-860-1 |
255387-46-3 |
R43 |
Xi R: 43 S: (2-)24-37 |
|
|
607-691-00-3 |
magnesiumzouten, vetzuren, C16-18 en C18 onverzadigd, vertakt en lineair |
|
448-690-6 |
— |
R53 |
R: 53 S: 61 |
|
|
607-692-00-9 |
zinkzouten, vetzuren, C16-18 en C18 onverzadigd, vertakt en lineair |
|
446-470-4 |
— |
R53 |
R: 53 S: 61 |
|
|
607-693-00-4 |
hexyl-2-(1-(diethylaminohydroxyfenyl)methanoyl)benzoaat |
|
443-860-6 |
302776-68-7 |
R53 |
R: 53 S: 61 |
|
|
607-694-00-X |
ethyl-5,5-difenyl-2-isoxazoline-3-carboxylaat |
|
443-870-0 |
163520-33-0 |
Xn; R22 R43 N; R50-53 |
Xn; N R: 22-43-50/53 S: (2-)22-36/37-60-61 |
|
|
608-042-00-7 |
(S)-2,2-difenyl-2-(3-pyrrolidinyl)acetonitril hydrobromide |
|
421-810-4 |
194602-27-2 |
Xn; R22 Xi; R41 R43 N; R51-53 |
Xn; N R: 22-41-43-51/53 S: (2-)24-26-37/39-61 |
|
|
608-059-00-X |
5-amino-1-(2,6-dichloor-4-(trifluormethyl)fenyl)-1H-pyrazool-3-carbonitril |
|
421-240-6 |
120068-79-3 |
N; R51-53 |
N R: 51/53 S: 22-61 |
|
|
608-060-00-5 |
5-methyl-2-[(2-nitrofenyl)amino]-3-thiofeencarbonitril |
|
421-300-1 |
138564-59-7 |
N; R50-53 |
N R: 50/53 S: 22-60-61 |
|
|
608-062-00-6 |
2-fluor-4-hydroxybenzonitril |
|
422-810-7 |
82380-18-5 |
Xn; R22 Xi; R41 N; R51-53 |
Xn; N R: 22-41-51/53 S: (2-)22-26-39-61 |
|
|
608-063-00-1 |
(S)-α-hydroxy-3-fenoxybenzeenacetonitril |
|
441-070-6 |
61826-76-4 |
T; R25 Xi; R41 R43 N; R50-53 |
T; N R: 25-41-43-50/53 S: (1/2-)9-26-36/37/39-45-60-61 |
|
|
608-064-00-7 |
cyanomethyltrimethylammoniummethylsulfaat |
|
433-720-2 |
— |
R52-53 |
R: 52/53 S: 61 |
|
|
609-069-00-7 |
muskusketon; 3,5-dinitro-2,6-dimethyl-4-tert-butylacetofenon; 4′-tert-butyl-2′,6′-dimethyl-3′,5′-dinitroacetofenon |
|
201-328-9 |
81-14-1 |
Carc. Cat. 3; R40 N; R50-53 |
Xn; N R: 40-50/53 S: (2-)36/37-46-60-61 |
|
|
611-154-00-9 |
trinatrium-5-benzamido-4-hydroxy-3-(4-methyl-2-sulfonatofenylazo)naftaleen-2,7-disulfonaat |
|
403-670-6 |
92408-46-3 |
R52-53 |
R: 52/53 S: 61 |
|
|
611-155-00-4 |
4,4′-oxybis(benzeensulfonylazide) |
|
431-850-4 |
7456-68-0 |
E; R3 F; R11 Xn; R48/22 N; R50-53 |
E; Xn; N R: 3-11-48/22-50/53 S: (2-)14-22-33-35-36-60-61 |
|
|
611-156-00-X |
triammonium-4-[4-[7-(4-carboxylatoanilino)-1-hydroxy-3-sulfonato-2-naftylazo]-2,5-dimethoxyfenylazo]benzoaat |
|
432-270-4 |
221354-37-6 |
Repr. Cat. 3; R62 Xn; R48/22 N; R51-53 |
Xn; N R: 48/22-62-51/53 S: (2-)36/37-61 |
|
|
611-157-00-5 |
benzeensulfonzuur, 3,3′-(methyleenbis((dihydroxyfenyleen)azo))bis-, kaliumnatriumzout; kaliumnatrium-3-[(E)-(6-{3,4-dihydroxy-2-[(Z)-(3-sulfonatofenyl)diazenyl]benzyl}-2,3-dihydroxyfenyl)diazenyl]benzeensulfonaat |
|
432-590-4 |
243869-48-9 |
Xi; R36 R52-53 |
Xi R: 36-52/53 S: (2-)26-61 |
|
|
611-158-00-0 |
reactiemengsel van: 2,3,4,2′,3′,4′-hexahydroxy-5,5′-diacetyldifenylmethaan en 6-diazo-5,6-dihydro-5-oxo-1-naftaleensulfonylchloride en 3-diazo-3,4-dihydro-6-methoxy-4-oxo-1-naftaleensulfonylchloride |
|
421-520-8 |
— |
F; R11 R53 |
F R: 11-53 S: (2-)3-12-16-33-61 |
|
|
611-159-00-6 |
dinatrium-4-amino-6-((4-((4-(2,4-diaminofenyl)azo)fenylsulfamoyl)fenyl)azo)-5-hydroxy-3-((4-nitrofenyl)azo)naftaleen-2,7-disulfonaat |
|
421-880-6 |
— |
Xi; R41 R52-53 |
Xi R: 41-52/53 S: (2-)26-39-61 |
|
|
611-160-00-1 |
mengsel van: 1,1,1-tris(fenyl-4′-(3″-diazo-3″,4″-dihydro-4″-oxonaftaleen-1″-sulfonato)ethaan; 1,1,1-tris(fenyl-4′-(6″-diazo-5″,6″-dihydro-5″-oxonaftaleen-1″-sulfonato)ethaan; reactieproduct van 1,1,1-tris(p-hydroxyfenyl)ethaan met 6-diazo-5,6-dihydro-5-oxo-1-naftylsulfonylchloride en 3-diazo-3,4-dihydro-4-oxo-1-naftylsulfonylchloride (2:1); reactieproduct van 1,1,1-tris(p-hydroxyfenyl)ethaan met 6-diazo-5,6-dihydro-5-oxo-1-naftylsulfonylchloride en 3-diazo-3,4-dihydro-4-oxo-1-naftylsulfonylchloride (1:2) |
|
422-760-6 |
— |
F; R11 R53 |
F R: 11-53 S: (2-)3-12-33-61 |
|
|
611-161-00-7 |
trinatrium[1,2′-(2-(8-amino-3,5-disulfonatonaftaleen)azo)-(4′-nitrobenzeen)diolato-O,O,N][(Z)-2,2-((fenylcarbamoylprop-1′-enyl)azo)-5-sulfamoylbenzeen)diolato-O,O,N]chromaat(III) |
|
423-100-1 |
— |
Xi; R41 |
Xi R: 41 S: (2-)26-39 |
|
|
611-162-00-2 |
2,4-bis(((2-(dimethylammonio)ethyloxy)carbonyl)fen-2-ylazo)benzeen-1,3-diolbis(methaansulfonaat) |
|
429-600-4 |
— |
Xn; R22 Xi; R41 N; R51-53 |
Xn; N R: 22-41-51/53 S: (2-)22-26-39-61 |
|
|
611-163-00-8 |
2,4-bis(((2-(dimethylammonio)ethyloxy)carbonyl)fen-2-ylazo)benzeen-1,3-diolsulfaat |
|
429-610-9 |
— |
Xn; R22 Xi; R41 N; R51-53 |
Xn; N R: 22-41-51/53 S: (2-)22-26-39-61 |
|
|
611-164-00-3 |
mengsel van: 2,2′-dimethyl-2,2′-azobutaannitril; 2-methylpentaannitril-2-azo-2′-(2′-methylpropaannitril); 2,2′-dimethyl-2,2′-azoheptaannitril; 2-methylheptaannitril-2-azo-2′-(2′-methylpropaannitril); 2-methylheptaannitril-2-azo-2′-(2′-methylbutaannitril) |
|
429-710-2 |
— |
R10 R32 R44 Xn; R22 N; R51-53 |
Xn; N R: 10-22-32-44-51/53 S: (2-)12-15-16-47-51-61 |
|
|
611-165-00-9 |
mengsel van: tetranatrium-4-amino-6-(5-(2,6-difluorpyrimidine-4-ylamino)-2-sulfonatofenylazo)-5-hydroxy-3-(4-(sulfatoethylsulfonyl)fenylazo)naftaleen-2,7-disulfonaat; tetranatrium-4-amino-6-(5-(4,6-difluorpyrimidine-2-ylamino)-2-sulfonatofenylazo)-5-hydroxy-3-(4-(2-sulfatoethylsulfonyl)fenylazo)naftaleen-2,7-disulfonaat |
|
431-830-5 |
— |
R52-53 |
R: 52/53 S: 61 |
|
|
611-166-00-4 |
mengsel van: pentanatrium-4-amino-5-hydroxy-3-{(E)-4-[2-(sulfonatooxy)ethylsulfonyl]fenylazo}-6-{(E)-2-sulfonato-4-[2-(sulfonatooxy)ethylsulfonyl]fenylazo}naftaleen-2,7-disulfonaat; tetranatrium-4-amino-5-hydroxy-3-{(E)-4-[2-(sulfonatooxy)ethylsulfonyl]fenylazo}-6-[(E)-2-sulfonato-4-(vinylsulfonyl)fenylazo]naftaleen-2,7-disulfonaat; tetranatrium-4-amino-5-hydroxy-6-{(E)-2-sulfonato-4-[2-(sulfonatooxy)ethylsulfonyl]fenylazo}-3-[(E)-4-(vinylsulfonyl)fenylazo]naftaleen-2,7-disulfonaat |
|
432-100-9 |
— |
Xi; R41 R52-53 |
Xi R: 41-52/53 S: (2-)26-39-61 |
|
|
611-167-00-X |
natriumbis[tris(2-hydroxyethyl)ammonium][6-anilino-4′-(4,8-disulfonato-2-naftylazo)-5′-methyl-3-sulfonatonaftaleen-2-azobenzeen-1,2′-diolato]cupraat(II) |
|
435-240-9 |
— |
R52-53 |
R: 52/53 S: 61 |
|
|
611-168-00-5 |
mengsel van: 3-[[4-chloor-6-[[7-[(1,5-disulfo-2-naftalenyl)azo]-8-hydroxy-3,6-disulfo-1-naftalenyl]amino]-1,3,5-triazine-2-yl]amino]-5-[[4-chloor-6-[[8-hydroxy-3,6-disulfo-7-[(2-sulfofenyl)azo]-1-naftalenyl]amino]-1,3,5-triazine-2-yl]amino]benzoëzuur; 3,5-bis[[4-chloor-6-[[7-[(1,5-disulfo-2-naftalenyl)azo]-8-hydroxy-3,6-disulfo-1-naftalenyl]amino]-1,3,5-triazine-2-yl]amino]benzoëzuur |
|
435-440-6 |
— |
Xi; R41 |
Xi R: 41 S: (2-)22-26-39 |
|
|
611-169-00-0 |
natrium-5-(2-carboxyfenylazo)-6-hydroxynaftaleen-2-sulfonaat |
|
435-800-2 |
— |
R52-53 |
R: 52/53 S: 61 |
|
|
611-170-00-6 |
mengsel van: trinatrium-2-((1-(2-hydroxy-κ-O-5-(2-sulfonatoethaansulfonyl)fenylazo-κ-N 2)-1-fenylmethyl)azo-κ-N 1)-4-sulfonatobenzoaat(5-)-κ-O)cupraat(II); dinatrium-2-((1-(5-etheensulfonyl-2-hydroxy-κ-O-fenylazo-κ-N 2)-1-fenylmethyl)azo-κ-N 1)-4-sulfonatobenzoaat-κ-O-(5-))cupraat(II) |
|
435-880-9 |
— |
R52-53 |
R: 52/53 S: 22-61 |
|
|
611-171-00-1 |
mengsel van: trinatrium-3-(5-(2,6-difluorpyrimidine-4-ylamino)-2-sulfonatofenylazo)-5-(4-fluor-6-morfoline-4-yl-1,3,5-triazine-2-ylamino)-4-hydroxy-2,7-naftaleendisulfonaat; trinatrium-3-(5-(4,6-difluorpyrimidine-2-ylamino)-2-sulfonatofenylazo)-5-(4-fluor-6-morfoline-4-yl-1,3,5-triazine-2-ylamino)-4-hydroxy-2,7-naftaleendisulfonaat |
|
436-890-6 |
— |
Xi; R41 R52-53 |
Xi R: 41-52/53 S: (2-)22-26-39-61 |
|
|
611-172-00-7 |
mengsel van: triammonium-6-amino-3-((2,5-diethoxy-4-(3-fosfonofenyl)azo)fenyl)azo-4-hydroxy-2-naftaleensulfonaat; diammonium-3-((4-((7-amino-1-hydroxy-3-sulfonaftaleen-2-yl)azo)-2,5-diethoxyfenyl)azo)benzoaat |
|
438-310-7 |
— |
E; R2 Repr. Cat. 3; R62 Xn; R22-48/22 R52-53 |
E; Xn R: 2-22-48/22-62-52/53 S: (2-)22-35-36/37-61 |
|
|
611-173-00-2 |
mengsel van: 3-[3-carbamoyl-5-(5-{4-chloor-6-[4-(2-sulfonatooxyethylsulfonyl)anilino]-1,3,5-triazine-2-ylamino}-2-sulfonatofenylazo)-1,2-dihydro-6-hydroxy-4-methyl-2-oxo-1-pyridyl]propaanzuur, trinatriumzout; 3-[3-carbamoyl-5-(5-{4-chloor-6-[4-(vinylsulfonyl)anilino]-1,3,5-triazine-2-ylamino}-2-sulfonatofenylazo)-1,2-dihydro-6-hydroxy-4-methyl-2-oxo-1-pyridyl]propaanzuur, dinatriumzout |
|
440-510-4 |
— |
Xi; R41 R43 |
Xi R: 41-43 S: (2-)22-26-36/37/39 |
|
|
611-174-00-8 |
mengsel van: 3-[5-(4-etheensulfonylbutyrylamino)-2-sulfofenylazo]-5-{4-chloor-[6-(4-(3-amino-5-hydroxy-2,7-disulfonaftaleen-4-ylazo)-3-sulfofenylamino]-1,3,5-triazine-2-ylamino}-4-hydroxynaftaleen-2,7-disulfonzuur, natriumzout; 3-[5-(4-(2-chloorethaansulfonyl)butyrylamino)-2-sulfofenylazo]-5-{4-chloor-[6-(4-(3-amino-5-hydroxy-2,7-disulfonaftaleen-4-ylazo)-3-sulfofenylamino]-1,3,5-triazine-2-ylamino}-4-hydroxynaftaleen-2,7-disulfonzuur, natriumzout |
|
442-290-5 |
457624-86-1 |
Xi; R41 |
Xi R: 41 S: (2-)22-26-39 |
|
|
611-175-00-3 |
mengsel van: trinatrium-5-{4-chloor-6-[N-ethyl-(3-(2-sulfonatooxy)ethylsulfonyl)anilino]-1,3,5-triazine-2-ylamino}-4-hydroxy-3-[4-(vinylsulfonyl)fenylazo]naftaleen-2,7-disulfonaat; trinatrium-5-{4-chloor-6-[N-ethyl-3-(vinylsulfonyl)anilino]-1,3,5-triazine-2-ylamino}-4-hydroxy-3-[4-(2-(sulfonatooxy)ethylsulfonyl)fenylazo]naftaleen-2,7-disulfonaat; dinatrium-5-{4-chloor-6-[N-ethyl-3-(vinylsulfonyl)anilino]-1,3,5-triazine-2-ylamino}-4-hydroxy-3-[(4-vinylsulfonyl)fenylazo]naftaleen-2,7-disulfonaat; tetranatrium-5-{4-chloor-6-[N-ethyl-3-(2-(sulfonatooxy)ethylsulfonyl)anilino]-1,3,5-triazine-2-ylamino}-3-[4-(2-(sulfonatooxy)ethylsulfonyl)fenylazo]-4-hydroxynaftaleen-2,7-disulfonaat |
|
444-050-5 |
— |
Xi; R41 R52-53 |
Xi R: 41-52/53 S: (2-)22-26-39-61 |
|
|
611-176-00-9 |
2,6-bis(2,3,4-trihydroxybenzyl)-p-kresol, ester met 6-diazo-5,6-dihydro-5-oxo-1-naftaleensulfonaat |
|
444-250-2 |
— |
E; R2 F; R11 N; R51-53 |
E; N R: 2-11-51/53 S: (2-)22-61 |
|
|
611-177-00-4 |
mengsel van: pentanatriumbis[6-anilino-3,5′-disulfonatonaftaleen-2-azobenzeen-1,2′-diolato]kobaltaat(III); tetranatrium[6-anilino-3,5′-disulfonatonaftaleen-2-azobenzeen-1,2′-diolato][6-anilino-5′-sulfamoyl-3-sulfonatonaftaleen-2-azobenzeen-1,2′-diolato]kobaltaat(III); trinatriumbis[6-anilino-5′-sulfamoyl-3-sulfonatonaftaleen-2-azobenzeen-1,2′-diolato]kobaltaat(III) |
|
444-290-0 |
508202-43-5 |
Xi; R41 R43 R52-53 |
Xi R: 41-43-52/53 S: (2-)22-24-26-37/39-61 |
|
|
611-178-00-X |
mengsel van: pentanatrium-4-amino-5-hydroxy-3-{(E)-4-[2-(sulfonatooxy)ethylsulfonyl]fenylazo}-6-{(E)-2-sulfonato-4-[2-(sulfonatooxy)ethylsulfonyl]fenylazo}naftaleen-2,7-disulfonaat; tetranatrium-4-amino-5-hydroxy-3-{(E)-4-[2-(sulfonatooxy)ethylsulfonyl]fenylazo}-6-[(E)-2-sulfonato-4-(vinylsulfonyl)fenylazo]naftaleen-2,7-disulfonaat; tetranatrium-4-amino-5-hydroxy-6-[(E)-2-sulfonato-4-[2-(sulfonatooxy)ethylsulfonyl]fenylazo}-3-[(E)-4-(vinylsulfonyl)fenylazo]naftaleen-2,7-disulfonaat; trinatrium-4-amino-5-hydroxy-3-[(E)-4-(vinylsulfonyl)fenylazo]-6-[(E)-2-sulfonato-4-(vinylsulfonyl)fenylazo]naftaleen-2,7-disulfonaat; trinatrium-4-amino-5-hydroxy-3-[(2-hydroxyethylsulfonyl)fenylazo]-6-[(E)-2-sulfonato-4-(vinylsulfonyl)fenylazo]naftaleen-2,7-disulfonaat; trinatrium-4-amino-5-hydroxy-3-[(E)-4-(vinylsulfonyl)fenylazo]-6-[2-sulfonato-4-(2-hydroxyethylsulfonyl)fenylazo]naftaleen-2,7-disulfonaat |
|
445-280-9 |
— |
Xi; R41 R43 R52-53 |
Xi R: 41-43-52/53 S: (2-)24-26-37/39-61 |
|
|
611-179-00-5 |
mengsel van: pentanatrium-2-[[8-[[4-chloor-6-[[4-(2-sulfonatoethylsulfonyl)]fenyl]amino]-1,3,5-triazine-2-yl]amino-1-hydroxy-3,6-disulfonato-2-naftalenyl]azo]naftaleen-1,5-disulfonaat; 2-[[8-[[4-chloor-6-[[4-[[2-ethenyl]sulfonyl]fenyl]amino]-1,3,5-triazine-2-yl]amino]-1-hydroxy-3,6-disulfonato-2-naftalenyl]azo]naftaleen-1,5-disulfonaat |
|
450-010-8 |
— |
Xi; R41 R43 |
Xi R: 41-43 S: (2-)22-24-26-37/39 |
|
|
611-180-00-0 |
ijzer, complexen met gediazoteerd 4-aminobenzeensulfonamide, gediazoteerd 3-aminobenzeensulfonzuur, gediazoteerd 3-amino-4-hydroxybenzeensulfonamide, gediazoteerd 3-amino-4-hydroxy-N-fenylbenzeensulfonamide, gediazoteerd 5-amino-2-(fenylamino)benzeensulfonzuur en resorcinol, natriumzouten |
|
417-850-7 |
— |
N; R51-53 |
N R: 51/53 S: 22-61 |
|
|
612-238-00-8 |
(3-chloor-2-hydroxypropyl)trimethylammoniumchloride …% |
B |
222-048-3 |
3327-22-8 |
Carc. Cat. 3, R40 R52-53 |
Xn R: 40-52/53 S: 36/37-61 |
|
|
612-239-00-3 |
bifenyl-3,3′,4,4′-tetrayltetraamine; diaminobenzidine |
|
202-110-6 |
91-95-2 |
Carc. Cat. 2; R45 Muta. Cat. 3; R68 |
T R: 45-68 S: 53-45 |
|
|
612-240-00-9 |
pyrimethanil (ISO); N-(4,6-dimethylpyrimidine-2-yl)aniline |
|
— |
53112-28-0 |
N; R51-53 |
N R: 51/53 S: 61 |
|
|
612-241-00-4 |
piperazine hydrochloride; [1] piperazine dihydrochloride; [2] piperazinefosfaat [3] |
|
228-042-7 [1] 205-551-2 [2] 217-775-8 [3] |
6094-40-2 [1] 142-64-3 [2] 1951-97-9 [3] |
Repr. Cat. 3; R62-63 Xi; R36/38 R42/43 R52-53 |
Xn R: 36/38-42/43-62-63-52/53 S: (1/2-)22-36/37-45-63-61 |
|
|
612-242-00-X |
cyprodinil (ISO); 4-cyclopropyl-6-methyl-N-fenylpyrimidine-2-amine |
|
— |
121552-61-2 |
R43 N; R50-53 |
Xi; N R: 43-50/53 S: (2-)24-37-46-60-61 |
C ≥ 2,5 %: Xi, N; R43-50/53 1 % ≤ C < 2,5 %: Xi, N; R43-51/53 0,25 % ≤ C < 1 %: N; R51/53 0,025 % ≤ C < 0,25 %: R52/53 |
|
612-243-00-5 |
(1S-cis)-4-(3,4-dichloorfenyl)-1,2,3,4-tetrahydro-N-methyl-1-naftaleenamine-2-hydroxy-2-fenylacetaat |
|
420-560-3 |
79617-97-3 |
Xi; R41 N; R50-53 |
Xi; N R: 41-50/53 S: (2-)26-39-60-61 |
C ≥ 10 %: Xi, N; R41-50/53 5 % ≤ C < 10 %: Xi, N; R36-50/53 2,5 % ≤ C < 5 %: N; R50/53 0,25 % ≤ C < 2, 5 %: N; R51/53 0,025 % ≤ C < 0,25 %: R52/53 |
|
612-244-00-0 |
3-(piperazine-1-yl)-benzo[d]isothiazool hydrochloride |
|
421-310-6 |
87691-88-1 |
Repr. Cat. 3; R62 Xn; R22 Xi; R36 R43 N; R50-53 |
Xn; N R: 22-36-43-62-50/53 S: (2-)22-26-36/37/39-60-61 |
|
|
612-245-00-6 |
2-ethylfenylhydrazine hydrochloride |
|
421-460-2 |
19398-06-2 |
Carc. Cat. 3; R40 T; R48/25 Xn; R22 Xi; R41 R43 N; R50-53 |
T; N R: 22-40-41-43-48/25-50/53 S: (1/2-)22-26-36/37/39-45-60-61 |
C ≥ 25 %: T, N; R22-40-41-43-48/25-50/53 10 % ≤ C < 25 %: T, N; R40-41-43-48/25-50/53 5 % ≤ C < 10 %: Xn, N; R36-40-43-48/22-50/53 2,5 % ≤ C < 5 %: Xn, N; R40-43-48/22-50/53 1 % ≤ C < 2,5 %: Xn, N; R40-43-48/22-51/53 0,25 % ≤ C < 1 %: N; R51/53 0,025 % ≤ C < 0,25 %: R52/53 |
|
612-246-00-1 |
(2-chloorethyl)(3-hydroxypropyl)ammoniumchloride |
E |
429-740-6 |
40722-80-3 |
Carc. Cat. 2; R45 Muta. Cat. 2; R46 Xn; R48/22 R43 R52-53 |
T R: 45-46-43-48/22-52/53 S: 53-45-61 |
|
|
612-247-00-7 |
N-[3-(1,1-dimethylethyl)-1H-pyrazool-5-yl]-N′-hydroxy-4-nitrobenzeencarboximidamide |
|
423-530-8 |
152828-23-4 |
T; R48/25 Xn; R22 R52-53 |
T R: 22-48/25-52/53 S: (1/2-)22-36-45-61 |
|
|
612-248-00-2 |
reactieproduct van difenylamine, fenothiazine en alkenen, vertakt (C8-10, C9-rijk) |
|
439-540-0 |
— |
Xi; R38 R43 R53 |
Xi R: 38-43-53 S: (2-)24-37-61 |
|
|
612-249-00-8 |
4-[(3-chloorfenyl)(1H-imidazool-1-yl)methyl]-1,2-benzeendiamine dihydrochloride |
|
425-030-5 |
159939-85-2 |
Repr. Cat. 3; R62 Xn; R22 C; R34 R43 N; R51-53 |
C; N R: 22-34-43-62-51/53 S: (1/2-)22-26-36/37/39-45-61 |
|
|
612-250-00-3 |
chloor-N,N-dimethylformiminiumchloride |
E |
425-970-6 |
3724-43-4 |
R14 Repr. Cat. 2; R61 Xn; R22 C; R35 |
T; C R: 61-14-22-35 S: 53-45 |
|
|
612-251-00-9 |
cis-1-(3-chloorallyl)-3,5,7-triaza-1-azoniaadamantaanchloride |
|
426-020-3 |
51229-78-8 |
F; R11 Repr. Cat. 3; R63 Xn; R22 Xi; R38 R43 N; R51-53 |
F; Xn; N R: 11-22-38-43-63-51/53 S: (2-)7-22-33-36/37-61 |
|
|
612-252-00-4 |
imidacloprid (ISO); 1-(6-chloorpyridine-3-ylmethyl)-N-nitroimidazolidine-2-ylideenamine |
|
428-040-8 |
138261-41-3 |
Xn; R22 N; R50-53 |
Xn; N R: 22-50/53 S: (2-)22-57-60-61 |
|
|
612-253-00-X |
7-methoxy-6-(3-morfoline-4-ylpropoxy)-3H-chinazoline-4-on; [met < 0,5% formamide (EC-nr. 200-842-0)] |
|
429-400-7 |
199327-61-2 |
R52-53 |
R: R52/53 S: 61 |
|
|
612-253-01-7 |
7-methoxy-6-(3-morfoline-4-ylpropoxy)-3H-chinazoline-4-on; [met ≥ 0,5% formamide (EC-nr. 200-842-0)] |
|
429-400-7 |
199327-61-2 |
Repr. Cat. 2; R61 R52-53 |
T R: 61-52/53 S: 53-45-61 |
|
|
612-254-00-5 |
reactieproducten van diisopropanolamine met formaldehyde (1:4) |
|
432-440-8 |
220444-73-5 |
Carc. Cat. 3; R40 Xn; R22 C; R34 R43 N; R51-53 |
C; N R: 22-34-40-43-51/53 S: (1/2-)13-25-26-36/37/39-45-61 |
|
|
612-255-00-0 |
1-(3-methoxypropyl)-4-piperidinamine |
|
431-950-8 |
179474-79-4 |
Xn; R21/22 C; R34 R52-53 |
C R: 21/22-34-52/53 S: (1/2-)26-36/37/39-45-61 |
|
|
612-256-00-6 |
benzyl-(S)-2-[(2′-cyanobifenyl-4-ylmethyl)pentanoylamino]-3-methylbutyraat |
|
427-470-3 |
137864-22-3 |
Xn; R22 R43 |
Xn R: 22-43 S: (2-)36/37 |
|
|
612-257-00-1 |
tripropylammoniumdiwaterstoffosfaat |
|
433-700-3 |
35687-90-2 |
Xn; R22 |
Xn R: 22 S: (2-)22 |
|
|
612-259-00-2 |
N-ethyl-3-trimethoxysilyl-2-methylpropaanamine |
|
437-720-3 |
227085-51-0 |
Xi; R41 |
Xi R: 41 S: (2-)26-39 |
|
|
612-261-00-3 |
3,5-dichloor-2-fluor-4-(1,1,2,3,3,3-hexafluorpropoxy)aniline |
|
441-190-9 |
121451-05-6 |
Xn; R22 R43 N; R50-53 |
Xn; N R: 22-43-50/53 S: (2-)24-37-60-61 |
C ≥ 25 %: Xn, N; R22-43-50/53 2,5 % ≤ C < 25 %: Xi, N; R43-50/53 1 % ≤ C < 2,5 %: Xi, N; R43-51/53 0,25 % ≤ C < 1 %: N; R51/53 0,025 % ≤ C < 0,25 %: R52/53 |
|
612-265-00-5 |
bis(2-hydroxyethyl)(2-hydroxypropyl)ammoniumacetaat |
|
444-360-0 |
191617-13-7 |
R52-53 |
R: 52/53 S: 61 |
|
|
612-266-00-0 |
3-chloor-4-(3-fluorbenzyloxy)aniline |
|
445-590-4 |
202197-26-0 |
Muta. Cat. 3; R68 Xn; R22-48/22 N; R50-53 |
Xn; N R: 22-48/22-68-50/53 S: (2-)22-36/37-60-61 |
|
|
612-267-00-6 |
bis(gehydrogeneerde talk C16-18-alkyl)hydroxylamine |
|
418-370-0 |
— |
R43 R53 |
Xi R: 43-53 S: (2-)36/37-61 |
|
|
612-269-00-7 |
mengsel van: 1-[di(4-octylfenyl)aminomethyl]-5-methyl-1H-benzotriazool; 1-[di(4-octylfenyl)aminomethyl]-4-methyl-1H-benzotriazool; mengsel van: N-[(5-methyl-1H-benzotriazool-1-yl)methyl]-4-octyl-N-(4-octylfenyl)aniline; N-[(4-methyl-1H-benzotriazool-1-yl)methyl]-4-octyl-N-(4-octylfenyl)aniline |
|
420-720-2 |
— |
R53 |
R: 53 S: 22-61 |
|
|
612-270-00-2 |
(S)-azetidine-2-carbonzuur 4-cyanobenzylamide hydrochloride |
|
433-010-2 |
— |
Xn; R22 R43 R52-53 |
Xn R: 22-43-52/53 S: (2-)22-36/37-61 |
|
|
612-271-00-8 |
mengsel van: ethyl-2-((4-(5,6-dichloorbenzothiazool-2-ylazo)fenyl)ethylamino)benzoaat; ethyl-2-((4-(6,7-dichloorbenzothiazool-2-ylazo)fenyl)ethylamino)benzoaat |
|
434-970-5 |
160987-57-5 |
R53 |
R: 53 S: 61 |
|
|
612-272-00-3 |
ammonium-(η-6-2-(2-(1,2-dicarboxylatoethylamino)ethylamino)butaan-1,4-dioato(4-))ijzer(3+) monohydraat |
|
435-210-5 |
— |
N; R51-53 |
N R: 51/53 S: 61 |
|
|
612-273-00-9 |
alkyl(koolzaadolie), bis(2-hydroxyethyl)ammoniumfluoride |
|
435-650-8 |
— |
Xn; R22 C; R35 N; R50-53 |
C; N R: 22-35-50/53 S: (1/2-)26-36/37/39-45-60-61 |
|
|
612-274-00-4 |
(R,S)-1-[2-amino-1(4-methoxyfenyl)ethyl]cyclohexanolacetaat |
|
445-750-3 |
— |
Xn; R22 Xi; R41 R43 R52-53 |
Xn R: 22-41-43-52/53 S: (2-)22-24-26-37/39-61 |
|
|
612-275-00-X |
vetzuren, C18-onverzadigd, dimeren, reactieproducten met 1-piperazineethaanamine en tallolie |
|
447-880-6 |
206565-89-1 |
Xi; R38-41 R43 N; R50-53 |
Xi; N R: 38-41-43-50/53 S: (2-)23-26-36/37/39-60-61 |
C ≥ 20 %: Xi, N; R38-41-43-50/53 10 % ≤ C < 20 %: Xi, N; R41-43-50/53 5 % ≤ C < 10 %: Xi, N; R36-43-50/53 2,5 % ≤ C < 5 %: Xi, N; R43-50/53 1 % ≤ C < 2,5 %: Xi, N; R43-51/53 0,25 % ≤ C < 1 %: N; R51/53 0,025 % ≤ C < 0,25 %: R52/53 |
|
612-276-00-5 |
1-amino-4-[(4-amino-2-sulfofenyl)amino]-9,10-dihydro-9,10-dioxo-2-antraceensulfonzuur, dinatriumzout, reactieproducten met 2-[[3-[(4,6-dichloor-1,3,5-triazine-2-yl)ethylamino]fenyl]sulfonyl]ethylwaterstofsulfaat, natriumzouten |
|
451-430-4 |
500717-36-2 |
Xi; R41 R43 R52-53 |
Xi R: 41-43-52/53 S: (2-)22-24-26-36/37/39-61 |
|
|
612-277-00-0 |
mengsel van: 4-amino-3-(4-etheensulfonyl-2-sulfonatofenylazo)-5-hydroxy-6-(5-{4-chloor-6-[4-(2-sulfonatooxyethaansulfonyl)fenylamino]-1,3,5-triazine-2-ylamino}-2-sulfonatofenylazo)naftaleen-2,7-disulfonaat kalium/natrium; 4-amino-5-hydroxy-6-(5-{4-chloor-6-[4-(2-sulfonatooxyethaansulfonyl)fenylamino]-1,3,5-triazine-2-ylamino}-2-sulfonatofenylazo)-3-(2-sulfonato-4-(2-sulfonatooxyethaansulfonyl)fenylazo)naftaleen-2,7-disulfonaat kalium/natrium |
|
451-440-9 |
586372-44-3 |
Xi; R41 |
Xi R: 41 S: (2-)22-26-39 |
|
|
612-278-00-6 |
ethidiumbromide; 3,8-diamino-1-ethyl-6-fenylfenantridiniumbromide |
|
214-984-6 |
1239-45-8 |
Muta. Cat. 3; R68 T+; R26 Xn; R22 |
T+ R: 22-26-68 S: (1/2-)28-36/37-45-63 |
|
|
612-279-00-1 |
(R,S)-2-amino-3,3-dimethylbutaanamide |
|
447-860-7 |
144177-62-8 |
Repr. Cat. 3; R62 Xn; R48/22 Xi; R36/38 R43 |
Xn R: 36/38-43-48/22-62 S: (2-)22-26-36/37 |
|
|
612-280-00-7 |
3-amino-9-ethylcarbazool; 9-ethylcarbazool-3-ylamine |
H |
205-057-7 |
132-32-1 |
Carc. Cat. 2; R45 |
T R: 45 S: 53-45 |
|
|
613-116-01-4 |
tolylfluanide (ISO); dichloor-N-[(dimethylamino)sulfonyl]fluor-N-(p-tolyl)methaansulfenamide; [met < 0,1 % (g/g) deeltjes met een aerodynamische diameter van minder dan 50 μm] |
|
211-986-9 |
731-27-1 |
Xi; R36/37/38 R43 N; R50 |
Xi; N R: 36/37/38-43-50 S: (2-)25-36/37-46-61 |
C ≥ 20 %: Xi, N; R36/37/38-43-50 2,5 % ≤ C < 20 %: Xi, N; R43-50 1 % ≤ C < 2,5 %: Xi; R43 |
|
613-280-00-X |
tetrahydro-1,3-dimethyl-1H-pyrimidine-2-on; dimethylpropyleenureum |
|
230-625-6 |
7226-23-5 |
Repr. Cat. 3; R62 Xn; R22 Xi; R41 |
Xn R: 22-41-62 S: 26-36/37/39 |
|
|
613-281-00-5 |
chinoline |
E |
202-051-6 |
91-22-5 |
Carc. Cat. 2; R45 Muta. Cat. 3; R68 Xn; R21/22 Xi; R36/38 N; R51-53 |
T; N R: 45-21/22-36/38-68-51/53 S: 53-45-61 |
|
|
613-282-00-0 |
triticonazool (ISO); (RS)-(E)-5-(4-chloorbenzylideen)-2,2-dimethyl-1-(1H-1,2,4-triazool-1-methyl)cyclopentanol |
|
— |
131983-72-7 |
N; R51-53 |
N R: 51/53 S: 61 |
|
|
613-283-00-6 |
ketoconazool; 1-[4-[4-[[(2SR,4RS)-2-(2,4-dichloorfenyl)-2-(imidazool-1-ylmethyl)-1,3-dioxolaan-4-yl]methoxy]fenyl]piperazine-1-yl]ethanon |
E |
265-667-4 |
65277-42-1 |
Repr. Cat. 2; R60 T; R25 Xn; R48/22 N; R50-53 |
T; N R: 60-25-48/22-50/53 S: 53-45-60-61 |
|
|
613-284-00-1 |
metconazool (ISO); (1RS,5RS;1RS,5SR)-5-(4-chloorbenzyl)-2,2-dimethyl-1-(1H-1,2,4-triazool-1-ylmethyl)cyclopentanol |
|
— |
125116-23-6 |
Repr. Cat. 3; R63 Xn; R22 N; R51-53 |
Xn; N R: 22-63-51/53 S: (2-)36/37-46-61 |
|
|
613-285-00-7 |
1-hydroxybenzotriazool, watervrij; [1] 1-hydroxybenzotriazool, monohydraat [2] |
|
219-989-7 [1] 219-989-7 [2] |
2592-95-2 [1] 123333-53-9 [2] |
E; R2 |
E R: 2 S: 16-35 |
|
|
613-286-00-2 |
kalium-1-methyl-3-morfolinocarbonyl-4-[3-(1-methyl-3-morfolinocarbonyl-5-oxo-2-pyrazoline-4-ylideen)-1-propenyl]pyrazool-5-olaat; [met < 0,5 % N,N-dimethylformamide (EC Nr 200-679-5)] |
|
418-260-2 |
183196-57-8 |
R43 |
Xi R: 43 S: (2-)24-37 |
|
|
613-286-01-X |
kalium-1-methyl-3-morfolinocarbonyl-4-[3-(1-methyl-3-morfolinocarbonyl-5-oxo-2-pyrazoline-4-ylideen)-1-propenyl]pyrazool-5-olaat; [met ≥ 0,5 % N,N-dimethylformamide (EC Nr 200-679-5)] |
|
418-260-2 |
183196-57-8 |
Repr. Cat. 2; R61 R43 |
T R: 61-43 S: 53-45 |
|
|
613-287-00-8 |
1-(3-jood-4-aminobenzyl)-1H-1,2,4-triazool |
|
419-540-7 |
160194-26-3 |
Xn; R22 R43 N; R51-53 |
Xn; N R: 22-43-51/53 S: (2-)24-37-61 |
|
|
613-288-00-3 |
1,3-bis(dimethylcarbamoyl)imidazoliumchloride |
|
420-930-4 |
135756-61-5 |
Xn; R22 Xi; R41 R52-53 |
Xn R: 22-41-52/53 S: (2-)22-26-37/39-61 |
|
|
613-289-00-9 |
3-(4-chloor-2-fluor-5-methylfenyl)-1-methyl-5-(trifluormethyl)-1H-pyrazool |
|
432-020-4 |
142623-48-1 |
N; R50-53 |
N R: 50/53 S: 60-61 |
|
|
613-290-00-4 |
4-hydroxy-7-(2-aminoethyl)-1,3-benzothiazool-2(3H)-on hydrochloride |
|
432-470-1 |
189012-93-9 |
Xi; R41 R43 N; R50-53 |
Xi; N R: 41-43-50/53 S: (2-)24-26-37/39-60-61 |
|
|
613-291-00-X |
2,4-dihydro-4-(4-(4-(4-hydroxyfenyl)-1-piperazinyl)fenyl)-2-(1-methylpropyl)-3H-1,2,4-triazool-3-on |
|
434-820-9 |
106461-41-0 |
Xn; R48/22 N; R50-53 |
Xn; N R: 48/22-50/53 S: (2-)22-36-60-61 |
|
|
613-292-00-5 |
N,N′,N″-tris(2-methyl-2,3-epoxypropyl)perhydro-2,4,6-oxo-1,3,5-triazine |
|
435-010-8 |
26157-73-3 |
Muta. Cat. 3; R68 R52-53 |
Xn R: 68-52/53 S: (2-)36/37-61 |
|
|
613-293-00-0 |
2-(4-tert-butylfenyl)-6-cyano-5-[bis(ethoxycarbonylmethyl)carbamoyloxy]-1H-pyrrolo[1,2-b][1,2,4]triazool-7-carbonzuur, 2,6-di-tert-butyl-4-methylcyclohexylester |
|
448-050-6 |
444065-11-6 |
R53 |
R: 53 S: 61 |
|
|
613-294-00-6 |
2-hexyldecaanzuur, [4-(6-tert-butyl-7-chloor-1H-pyrazolo[1,5-b][1,2,4]triazool-2-yl)fenylcarbamoyl]methylester |
|
448-260-8 |
379268-96-9 |
R53 |
R: 53 S: 61 |
|
|
613-295-00-1 |
11-amino-3-chloor-6,11-dihydro-5,5-dioxo-6-methyldibenzo[c,f][1,2]thiazepine hydrochloride |
|
448-720-8 |
363138-44-7 |
Xn; R22 Xi; R41 R52-53 |
Xn R: 22-41-52/53 S: (2-)22-26-39-61 |
|
|
613-296-00-7 |
pentakalium-2-(4-(5-[1-(2,5-disulfonatofenyl)-4,5-dihydro-3-methylcarbamoyl-5-oxopyrazool-4-ylideen]-3-methylpenta-1,3-dienyl)-3-methylcarbamoyl-5-oxidopyrazool-1-yl)benzeen-1,4-disulfonaat |
|
418-270-7 |
— |
R43 R52-53 |
Xi R: 43-52/53 S: (2-)24-37-47-61 |
|
|
613-297-00-2 |
5-(2-broomfenyl)-2-tert-butyl-2H-tetrazool |
|
420-820-6 |
— |
R10 Xn; R22 N; R51-53 |
Xn; N R: 10-22-51/53 S: (2-)16-61 |
|
|
613-298-00-8 |
bis(6-hydroxy-4-methyl-5-(3-methylimidazolium-1-yl)-3-(4-fenylazo)-1H-pyridine-2-on)ethyleendilactaat |
|
421-560-6 |
— |
Xn; R48/22 Xi; R41 N; R51-53 |
Xn; N R: 41-48/22-51/53 S: (2-)22-26-36/39-61 |
|
|
613-299-00-3 |
hoofdcomponent 1 (isomeer 1): 2-{6-fluor-4-[3-(2,5-disulfofenylazo)-4-hydroxy-2-sulfonaft-7-ylamino]-1,3,5-triazine-2-ylamino}-3-{6-fluor-4-[3-(1,5-disulfonaft-2-ylazo)-4-hydroxy-2-sulfonaft-7-ylamino]-1,3,5-triazine-2-ylamino}propaan, natriumzout; hoofdcomponent 1 (isomeer 2): 2-{6-fluor-4-[3-(2,5-disulfofenylazo)-4-hydroxy-2-sulfonaft-7-ylamino]-1,3,5-triazine-2-ylamino}-3-{6-fluor-4-[3-(2,5-disulfofenylazo)-4-hydroxy-2-sulfonaft-7-ylamino]-1,3,5-triazine-2-ylamino}propaan, natriumzout; hoofdcomponent 2: 2,3-bis{6-fluor-4-[3-(2,5-disulfofenylazo)-4-hydroxy-2-sulfonaft-7-ylamino]-1,3,5-triazine-2-ylamino}propaan, natriumzout; hoofdcomponent 3: 2,3-bis{6-fluor-4-[3-(1,5-disulfonaft-2-ylazo)-4-hydroxy-2-sulfonaft-7-ylamino]-1,3,5-triazine-2-ylamino}propaan, natriumzout |
|
422-610-1 |
— |
Xi; R41 |
Xi R: 41 S: (2-)22-26-39 |
|
|
613-300-00-7 |
1-imidazool-1-yloctadecaan-2-ol |
|
434-120-3 |
— |
R43 R53 |
Xi R: 43-53 S: (2-)24-37-61 |
|
|
613-301-00-2 |
dimethyl-1-{[2-methoxy-5-(2-methylbutoxycarbonyl)fenylcarbamoyl][2-octadecyl-1,1-dioxo-1,2,4-benzothiadiazine-3-yl]methyl}imidazool-4,5-dicarboxylaat |
|
443-910-7 |
— |
R53 |
R: 53 S: 61 |
|
|
613-302-00-8 |
dinatrium-2-(5-carbamoyl-1-ethyl-2-hydroxy-4-methyl-6-oxo-1,6-dihydropyridine-3-ylazo)-4-(4-fluor-6-(4-(2-sulfonyloxyethylsulfonyl)fenylamino)-1,3,5-triazine-2-ylamino)benzeensulfonaat |
|
432-980-4 |
243858-60-8 |
Xi; R41 |
Xi R: 41 S: (2-)22-26-39 |
|
|
613-303-00-3 |
2-(1-methyl-2-(4-fenoxyfenoxy)ethoxy)pyridine |
|
429-800-1 |
95737-68-1 |
N; R50-53 |
N R: 50/53 S: 60-61 |
|
|
613-304-00-9 |
5,6-dihydroxy-2,3-dihydro-1H-indoliumbromide |
|
421-170-6 |
138937-28-7 |
Xn; R22 Xi; R41 |
Xn R: 22-41 S: (2-)22-26-39 |
|
|
613-305-00-4 |
2-(2-hydroxy-4-octyloxyfenyl)-2H-benzotriazool |
|
448-630-9 |
3147-77-1 |
R53 |
R: 53 S: 61 |
|
|
613-306-00-X |
(2,5-dioxopyrrolidine-1-yl)-9H-fluoreen-9-ylmethylcarbonaat |
|
433-520-5 |
82911-69-1 |
Xn; R22 R43 N; R51-53 |
Xn; N R: 22-43-51/53 S: (2-)24-37-61 |
|
|
613-307-00-5 |
clothianidine (ISO); 3-[(2-chloor-1,3-thiazool-5-yl)methyl]-2-methyl-1-nitroguanidine |
|
— |
210880-92-5 |
Xn; R22 N; R50-53 |
Xn; N R: 22-50/53 S: (2-)46-60-61 |
C ≥ 25 %: Xn, N; R22-50/53 2,5 % ≤ C < 25 %: N; R50/53 0,25 % ≤ C < 2,5 %: N; R51/53 0,025 % ≤ C < 0,25 %: R52/53 |
|
613-308-00-0 |
2-amino-5-methylthiazool |
|
423-800-5 |
7305-71-7 |
Xn; R22-48/22 N; R50-53 |
Xn; N R: 22-48/22-50/53 S: (2-)22-36-60-61 |
|
|
613-309-00-6 |
3-fenyl-1-methyl-1-piperazine |
|
431-180-2 |
5271-27-2 |
Xn; R21/22 Xi; R38-41 R52-53 |
Xn R: 21/22-38-41-52/53 S: (2-)26-36/37/39-61 |
|
|
613-310-00-1 |
(-)(3S,4R)-4-(4-fluorfenyl)-3-(3,4-methyleendioxyfenoxymethyl)-N-benzylpiperidine hydrochloride |
|
432-360-3 |
105813-13-6 |
Xn; R22 R43 N; R50-53 |
Xn; N R: 22-43-50/53 S: (2-)22-24-37-60-61 |
|
|
613-311-00-7 |
methyl-5-nitrofenylguanidine |
|
435-500-1 |
152460-07-6 |
Xn; R22 Xi; R36 R43 R52-53 |
Xn R: 22-36-43-52/53 S: (2-)22-24-26-37-61 |
|
|
613-312-00-2 |
2-(2-fenyl-4-methyl-1-piperazinyl)benzeenmethanol monohydrochloride |
|
420-200-5 |
— |
Xn; R22 Xi; R41 R43 R52-53 |
Xn R: 22-41-43-52/53 S: (2-)22-26-36/37/39-61 |
|
|
613-313-00-8 |
2-(4-(4-(3-pyridinyl)-1H-imidazool-1-yl)butyl)-1H-isoindool-1,3(2H)-dion |
|
442-780-9 |
173838-67-0 |
R52-53 |
R: 52/53 S: 61 |
|
|
613-314-00-3 |
4-decyloxazolidine-2-on; 4-decyl-1,3-oxazolidine-2-on |
|
443-770-7 |
7693-82-5 |
N; R50-53 |
N R: 50/53 S: 22-24-60-61 |
|
|
613-315-00-9 |
tetrakalium-4-[5-[3-carboxylato-4,5-dihydro-5-oxo-1-(4-sulfonatofenyl)pyrazool-4-ylideen]-3-(piperidinocarbonyl)penta-1,3-dienylideen]-5-hydroxy-1-(4-sulfonatofenyl)pyrazool-3-carboxylaat |
|
430-390-1 |
— |
Xn; R20 R52-53 |
Xn R: 20-52/53 S: (2-)25-61 |
|
|
613-316-00-4 |
trimethylolpropaantris(3-aziridinylpropanoaat); (TAZ) |
H |
257-765-0 |
52234-82-9 |
Muta. Cat. 3; R68 Xi; R41 R43 |
Xn R: 41-43-68 S: 26-36/37/39-42 |
|
|
615-044-00-1 |
4-chloorfenylisocyanaat |
|
203-176-9 |
104-12-1 |
T+; R26 Xn; R22 Xi; R37/38-41 R42 N; R50-53 |
T+; N R: 22-26-37/38-41-42-50/53 S: (1/2-)26-28-36/37/39-45-63-60-61 |
|
|
615-045-00-7 |
4,4′-methyleenbis(3-chloor-2,6-diethylfenylisocyanaat) |
|
420-530-1 |
— |
R42/43 R53 |
Xn R: 42/43-53 S: (2-)23-24-37-45-61 |
|
|
616-126-00-X |
1-methyl-4-nitro-3-propyl-1H-pyrazool-5-carboxamide |
|
423-960-6 |
139756-01-7 |
Xn; R22-48/22 R52-53 |
Xn R: 22-48/22-52/53 S: (2-)22-36/37-61 |
|
|
616-164-00-7 |
dimoxystrobin (ISO); (E)-2-(methoxyimino)-N-methyl-2-[α-(2,5-xylyloxy)-o-tolyl]aceetamide |
|
— |
149961-52-4 |
Carc. Cat. 3; R40 Repr. Cat. 3; R63 Xn; R20 N; R50-53 |
Xn; N R: 20-40-63-50/53 S: (2-)36/37-46-60-61 |
C ≥ 25 %: Xn, N; R20-40-63-50/53 5 % ≤ C < 25 %: Xn, N; R40-63-50/53 2,5 % ≤ C < 5 %: Xn, N; R40-50/53 1 % ≤ C < 2,5 %: Xn, N; R40-51/53 0,25 % ≤ C < 1 %: N; R51/53 0,025 % ≤ C < 0,25 %: R52-53 |
|
616-165-00-2 |
beflubutamide (ISO); (RS)-N-benzyl-2-(α,α,α,4-tetrafluor-m-tolyloxy)butyramide |
|
— |
113614-08-7 |
N; R50-53 |
N R: 50/53 S: 60-61 |
C ≥ 0,25 %: N; R50/53 0,025 % ≤ C < 0,25 %: N; R51/53 0,0025 % ≤ C < 0,025 %: R52/53 |
|
616-166-00-8 |
cyazofamide (ISO); 4-chloor-2-cyano-N,N-dimethyl-5-p-tolylimidazool-1-sulfonamide |
|
— |
120116-88-3 |
N; R50-53 |
N R: 50/53 S: 60-61 |
C ≥ 2,5 %: N; R50/53 0,25 % ≤ C < 2,5 %: N; R51-53 0,025 % ≤ C < 0,25 %: R52/53 |
|
616-167-00-3 |
N,N-dibutyl(2,5-dihydro-5-thioxo-1H-tetrazool-1-yl)aceetamide |
|
418-290-6 |
168612-06-4 |
Xi; R36 R43 |
Xi R: 36-43 S: (2-)24-26-37 |
|
|
616-168-00-9 |
1-dimethylcarbamoyl-4-(2-sulfonatoethyl)pyridinium |
|
418-440-0 |
136997-71-2 |
R43 |
Xi R: 43 S: (2-)22-24-37 |
|
|
616-169-00-4 |
4-[4-(2,2-dimethylpropaanamido)]fenylazo-3-(2-chloor-5-(2-(3-pentadecylfenoxy)butylamido)anilino)-1-(2,4,6-trichloorfenyl)-2-pyrazoline-5-on |
|
420-220-4 |
92771-56-7 |
R43 R53 |
Xi R: 43-53 S: (2-)24-37-61 |
|
|
616-170-00-X |
(2R)-2-amino-2-fenylaceetamide |
|
420-370-0 |
6485-67-2 |
Xi; R36 R43 |
Xi R: 36-43 S: (2-)22-26-36/37 |
|
|
616-171-00-5 |
2-(p-chloorfenyl)glycinamide |
|
420-830-0 |
102333-75-5 |
Xi; R41 R43 |
Xi R: 41-43 S: (2-)24-26-37/39 |
|
|
616-172-00-0 |
N-(2,2,6,6-tetramethyl-1-oxylpiperidine-4-yl)aceetamide; (4-aceetamido-2,2,6,6-tetramethyl-1-piperidinyl)oxidanyl |
|
423-840-3 |
14691-89-5 |
Xn; R22 |
Xn R: 22 S: (2-)22 |
|
|
616-174-00-1 |
2-butyl-1,3-diazaspiro[4.4]non-1-een-4-on hydrochloride |
|
424-560-4 |
151257-01-1 |
Xn; R22 Xi; R36 |
Xn R: 22-36 S: (2-)22-26 |
|
|
616-175-00-7 |
2-(2-hexyldecyloxy)benzamide |
|
431-230-3 |
202483-62-3 |
R53 |
R: 53 S: 61 |
|
|
616-176-00-2 |
3-N,N-bis(methoxyethyl)aminoaceetanilide |
|
432-530-7 |
24294-01-7 |
Xn; R22 R52-53 |
Xn R: 22-52/53 S: (2-)22-24-61 |
|
|
616-177-00-8 |
(3-(4-(2-(butyl(4-methylfenylsulfonyl)amino)fenylthio)-5-oxo-1-(2,4,6-trichloorfenyl)-4,5-dihydro-1H-pyrazool-3-ylamino)-4-chloorfenyl)tetradecaanamide; N-[3-({4-[(2-{butyl[(4-methylfenyl)sulfonyl]amino}fenyl)thio]-5-oxo-1-(2,4,6-trichloorfenyl)-4,5-dihydro-1H-pyrazool-3-yl}amino)-4-chloorfenyl]tetradecaanamide |
|
432-970-1 |
217324-98-6 |
R53 |
R: 53 S: 61 |
|
|
616-178-00-3 |
N-(5-(bis(2-methoxyethyl)amino)-2-((2-cyano-4,6-dinitrofenyl)azo)fenyl)aceetamide |
|
434-500-9 |
52583-35-4 |
R53 |
R: 53 S: 22-61 |
|
|
616-179-00-9 |
2-chloor-N-(4-methylfenyl)aceetamide |
|
435-170-9 |
16634-82-5 |
Xi; R41 R43 N; R50-53 |
Xi; N R: 41-43-50/53 S: (2-)22-26-36/37/39-60-61 |
|
|
616-180-00-4 |
N,N-(dimethylamino)thioaceetamide hydrochloride |
|
435-470-1 |
27366-72-9 |
Repr. Cat. 2; R61 N; R50-53 |
T; N R: 61-50/53 S: 53-45-60-61 |
|
|
616-181-00-X |
4′-methyldodecaan-1-sulfonanilide |
|
435-490-9 |
17417-32-2 |
N; R50-53 |
N R: 50/53 S: 60-61 |
|
|
616-182-00-5 |
N′-(1,3-dimethylbutylideen)-3-hydroxy-2-naftohydrazide |
|
435-860-1 |
214417-91-1 |
R43 N; R51-53 |
Xi; N R: 43-51/53 S: (2-)24-37-61 |
|
|
616-183-00-0 |
N-dodecyl-4-methoxybenzamide |
|
442-340-6 |
1854-15-5 |
R53 |
R: 53 S: 61 |
|
|
616-184-00-6 |
3-methyl-N-(5,8,13,14-tetrahydro-5,8,14-trioxonaft[2,3-c]acridine-6-yl)benzamide |
|
442-560-2 |
105043-55-8 |
R53 |
R: 53 S: 61 |
|
|
616-186-00-7 |
N,N′-(2-chloor-1,4-fenyleen)bis(3-oxobutaanamide) |
|
443-010-4 |
53641-10-4 |
R52-53 |
R: 52/53 S: 61 |
|
|
616-188-00-8 |
2-(5,5-dimethyl-2,4-dioxooxazolidine-3-yl)-4,4-dimethyl-3-oxo-N-(2-methoxy-5-octadecanoylaminofenyl)pentaanzuuramide |
|
443-980-9 |
221215-20-9 |
R43 R53 |
Xi R: 43-53 S: (2-)24-37-61 |
|
|
616-189-00-3 |
N-[5-(bis(2-methoxyethyl)amino]-2-(6-broom-2-methyl-1,3-dioxo-2,3-dihydro-1H-isoindool-5-ylazo)fenyl]aceetamide |
|
444-780-4 |
452962-97-9 |
R53 |
R: 53 S: 61 |
|
|
616-190-00-9 |
N-decyl-4-nitrobenzamide |
|
445-880-0 |
64026-19-3 |
R53 |
R: 53 S: 61 |
|
|
616-191-00-4 |
2-ethyl-N-methyl-N-(3-methylfenyl)butaanamide |
|
446-190-2 |
406488-30-0 |
Xn; R22 Xi; R36/38 R43 N; R51-53 |
Xn; N R: 22-36/38-43-51/53 S: (2-)24-26-37-61 |
|
|
616-192-00-X |
2-[2-(3-butoxypropyl)-1,1-dioxo-1,2,4-benzothiadiazine-3-yl]-5′-tert-butyl-2-(5,5-dimethyl-2,4-dioxo-1,3-oxazolidine-3-yl)-2′-[(2-ethylhexyl)thio]aceetanilide |
|
448-060-0 |
727678-39-9 |
R53 |
R: 53 S: 61 |
|
|
616-193-00-5 |
N-[2-(2-butyl-4,6-dicyano-1,3-dioxo-2,3-dihydro-1H-isoindool-5-ylazo)-5-diethylaminofenyl]aceetamide |
|
449-940-7 |
368450-39-9 |
R53 |
R: 53 S: 61 |
|
|
616-194-00-0 |
2,2-diethoxy-N,N-dimethylaceetamide |
|
449-950-1 |
34640-92-1 |
Xi; R36 |
Xi R: 36 S: (2-)26 |
|
|
616-196-00-1 |
dinatriumzout van 1-hydroxy-4-(β-(4-(1-hydroxy-3,6-disulfo-8-acetylamino-2-naftylazo)fenoxy)ethoxy)-N-dodecyl-2-naftamide |
|
419-990-4 |
— |
N; R50-53 |
N R: 50/53 S: 60-61 |
|
|
616-197-00-7 |
mengsel van: kalium-N-[3-(dimethyloxidoamino)propyl]-1,1,2,2,3,3,4,4,5,5,6,6,7,7,8,8,8-heptadecafluoroctaansulfonamidaat; N-[3-(dimethyloxidoamino)propyl]-1,1,2,2,3,3,4,4,5,5,6,6,7,7,8,8,8-heptadecafluoroctaansulfonamide |
|
422-500-1 |
— |
Xn; R48/22 |
Xn R: 48/22 S: (2-)22-36 |
|
|
616-198-00-2 |
1,3-bis[12-hydroxyoctadecaanamide-N-methyleen]benzeen |
|
423-300-7 |
— |
R43 R53 |
Xi R: 43-53 S: (2-)24-37-61 |
|
|
616-200-00-1 |
mengsel van: N,N′-ethaan-1,2-diylbis(hexaanamide); 12-hydroxy-N-[2-[(1-oxyhexyl)amino]ethyl]octadecaanamide; N,N′-ethaan-1,2-diylbis(12-hydroxyoctadecaanamide) |
|
432-430-3 |
— |
R43 R53 |
Xi R: 43-53 S: (2-)24-37-61 |
|
|
616-201-00-7 |
12-hydroxyoctadecaanzuur, reactieproducten met 1,3-benzeendimethaanamine en hexamethyleendiamine |
|
432-840-2 |
220926-97-6 |
Xn; R20 R53 |
Xn R: 20-53 S: (2-)22-61 |
|
|
616-202-00-2 |
mengsel van: 2,2′-[(3,3′-dichloor[1,1′-bifenyl]-4,4′-diyl)bis(azo)]bis[N-(2,4-dimethylfenyl)]-3-oxobutaanamide; 2-[[3,3′-dichloor-4′-[[1[[(2,4-dimethylfenyl)amino]carbonyl]-2-oxopropyl]azo][1,1′-bifenyl]-4-yl]azo]-N-(2-methylfenyl)-3-oxobutaanamide; 2-[[3,3′-dichloor-4′-[[1[[(2,4-dimethylfenyl)amino]carbonyl]-2-oxopropyl]azo][1,1′-bifenyl]-4-yl]azo]-N-(2-carboxylfenyl)-3-oxobutaanamide |
|
434-330-5 |
— |
Carc. Cat. 3; R40 R43 R53 |
Xn R: 40-43-53 S: (2-)36/37-61 |
|
|
616-203-00-8 |
mengsel van: N-[5-[bis(2-methoxyethyl)amino]-2-(2-butyl-4,6-dicyano-1,3-dioxo-2,3-dihydro-1H-isoindool-5-ylazo)fenyl]aceetamide; N-[2-(2-butyl-4,6-dicyano-1,3-dioxo-2,3-dihydro-1H-isoindool-5-ylazo)-5-diethylaminofenyl]aceetamide |
|
442-280-0 |
— |
R53 |
R: 53 S: 61 |
|
|
616-204-00-3 |
N,N″-(methyleendi-4,1-fenyleen)bis[N′-octylureum] |
|
451-060-3 |
122886-55-9 |
R53 |
R: 53 S: 61 |
|
|
617-022-00-7 |
mengsel van: 1,2-dimethylpropylideendihydroperoxide; dimethyl-1,2-benzeendicarboxylaat |
|
442-480-8 |
— |
O; R7 Xn; R22 C; R34 R43 N; R51-53 |
O; C; N R: 7-22-34-43-51/53 S: (1/2-)3/7-14-26-36/37/39-45-50-61 |
|
|
647-017-00-5 |
laccase |
|
420-150-4 |
80498-15-3 |
R42 |
Xn R: 42 S: (2-)23-45 |
|
|
BIJLAGE 1C
De vermeldingen in bijlage I met de volgende nummers worden geschrapt:
024-004-01-4, 603-037-01-3, 603-155-00-8, and 611-084-00-9.